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Annex 99 Preface 
T
his issue of the 'Employment and soci-
al affairs' series focuses on public 
health and the work we are doing to 
give effect to the new competence in this area 
that the Treaty on European Union gave to the 
Community. 
Almost immediately after the Treaty came into 
force in November 1993, the Commission 
took the first step towards implementing its 
public health provisions by adopting my 
proposal for a series of priority programmes 
within an overall framework for action in the 
field of public health.' A large part of that 
framework has now been put into place. 
The health problems facing the Community 
are too urgent and too large in scale to allow 
complacency. Every year in Europe millions die 
prematurely or suffer ill health from serious 
conditions that could have been prevented. 
At the same time health systems throughout 
the Community are coming under increasing 
strain as a result of the mounting demands 
being made upon them and the difficult fi-
nancial situation that Member States are fac-
ing. The pressures of having to cope with rap-
idly changing medical technology, with an 
ageing population with ever-growing needs 
for health care and social support and with 
people's constantly rising expectations about 
health services are therefore forcing Member 
States to take sweeping measures to reform 
their health systems and to control costs. 
Against this backdrop, Community policies 
must be geared to supporting Member States 
in their efforts to make their health systems as 
effective as possible so that the health of the 
population is protected and improved. We 
must also ensure that our actions have prac-
tical value for individual citizens by, for exam-
ple, working to secure the continuity of ser-
vices across internal borders. To make a real 
impact on this situation implies a continuing 
and growing long-term effort and commit-
ment both by the Community and by the 
Member States individually. Viewed from that 
perspective, our work to date is an important 
first step. 
Indeed, it is now time to begin thinking about 
what the future will hold. So, in close contact 
with the Member States, we are now begin-
ning discussions in order to determine the 
strategy to be followed in the first years of the 
new millennium. 
I hope that this issue of the series devoted to 
public health will help bring to the fore both 
what has already been achieved and the main 
problems that remain to be resolved. In this 
way it can help inform public discussion and 
debate on public health and show how the is-
sues to be faced and the actions we are taking 
are not only of the greatest importance in 
their own right, but are also vital elements of 
the Community's social policy as a whole. 
Pádraig Flynn 
Member of the European Commission 
with responsibility for employment and 
social affairs 
COMÍ93) 559 final of 24 November 1993. I 
Public health policy in 
the European Union Public health in today's European Community 
I
t is one of the great paradoxes of public health in the 
European Community today that while the population 
has never been healthier, the demand on Member States ' 
health systems, and thus the tendency towards increased 
expenditure, is ever-growing and expenditure on health is 
being constantly forced upwards. The Community's public 
health strategy has been developed against this background 
and is designed to reflect and respond to the problems which 
are putting pressure on Member States ' health services; 
pressure which is likely to become even greater in the future. 
Pressure on health services 
What are the causes of this pressure? The first 
of these is that of ageing populations. The 
falling birth rate and lengthening life expec-
tancy means that progressively there will be 
larger numbers of elderly people who are dis-
proportionate users of health services. Not 
only do elderly people need more medical 
treatment services than younger people, but 
they also make more demands on social and 
health-care services. Moreover, the effect of 
the ageing population is made more acute be-
cause it also means that the burden of paying 
for these services will fall increasingly on a 
relatively smaller working population. 
Second, the development of powerful new 
technologies for diagnosis and treatment, in-
cluding new and costly pharmaceutical prod-
ucts, has a considerable impact on health-
care expenditure. The use of new technology 
does not always involve greater costs per pa-
tient or course of treatment. Indeed with, for 
example, increased use of day surgery and 
out-patient care, these costs may well drop. 
However, the technology is also leading to a 
much larger number of patients being treat-
ed for a much wider range of conditions, with 
the result that it is adding to the overall costs 
of health care. 
Third, and linked to the improvements in ther-
apy, there are rising expectations among the 
public about what health services can provide, 
and rising demands about what they should 
provide. One factor behind this is the grow-
ing knowledge of and interest in health of the 
ordinary citizen resulting notably from im-
proved health education and information ac-
tivities. Another is the increasing awareness of 
differences in levels and standards of provi-
sion within and between Member States re-
sulting from increasing travel and mobility. Fourth, increasing population mobility can be 
a factor in the spread of communicable dis-
eases and may also lead to the establishment 
of migrant communities which have particu-
lar health needs that can put increased strain 
on local health services. 
States are facing serious economic difficul-
ties, such as slow growth and persistent high 
levels of unemployment. The pressures on 
public finances have led Member States to 
place constraints on public expenditure, in-
cluding health and social benefits. 
Finally, there are mounting levels of certain 
diseases which arise in part from changes in 
the natural and working environments, such 
as rising levels of asthma and allergic disor-
ders and certain forms of cancer, as well as 
the return of certain communicable diseases 
which had almost been vanquished, such as 
tuberculosis. 
Health expenditure 
As a result of these developments health 
spending has risen rapidly in the Community 
over the last two decades, although it is now 
tending to stabilize, the Community average 
in 1991 being 7.4% of GDP. Moreover, this 
has been happening at a time when Member 
In recent years Member States have made 
strenuous efforts to control the rise in health 
expenditure and in certain cases, notably 
Sweden and Ireland, have managed to stabi-
lize or even to reduce health-care spending as 
a proportion of GDP. Some States have tried 
to control health spending by taking 
measures to reduce what is supplied, for ex-
ample by limiting the numbers of doctors 
being trained, limiting the range of drugs 
they can prescribe, or imposing charges on 
patients. A number have introduced wide-
ranging reforms of their health systems and 
methods of financing health care. But al-
though controlling expenditure by these 
means can help to improve the efficiency of 
the health system, it does nothing to remove 
the underlying pressures. 
The development of 
powerful new technologies 
for diagnosis and treatment 
has a considerable impact on 
health-care expenditure. One way to reply to such pressures is to place 
greater emphasis on prevention of disease 
and promotion of health. It is a truism that 
prevention is better than cure, but it is also 
true that it is likely to be more effective in fi-
nancial terms in the active part of the popu-
lation. It has been calculated that smoking is 
responsible for half a million deaths each year 
in the Community. Over-indulgence in alco-
hol, poor and unbalanced diets and lack of 
physical exercise are other important contrib-
utors to morbidity and thus to the demand for 
health services. If one adds to these drug 
abuse, sexually-transmitted diseases, traffic, 
work and domestic accidents, the effects on 
health services are only too apparent. 
face. We can also help draw attention to spe-
cific issues that would not be so evident if 
viewed from a purely national perspective. 
In conclusion, the work that the Community 
is doing in public health is still at a very early 
stage, but it is already clear that its emphasis 
on prevention and promotion is of great 
value in complementing the actions of the 
Member States and in helping them to over-
come the difficulties they face today, and will 
progressively face in the future. 
It is exactly in these areas that the public 
health work 'of the Commission can make a 
significant impact. And it can do so in several 
ways. First, the actions in our programmes 
can complement and strengthen the preven-
tion and promotion activities in the Member 
States. We can, for example, help organiza-
tions to join with others in multinational 
work, so promoting exchanges of ideas and 
experience and spreading best practice. In ad-
dition, the use of European weeks, for in-
stance, can provide a focus and catalyst for 
activities in the Member States. 
Second, as we are urged to do by the Treaty, 
we can bring attention to bear on the health 
aspects of other Community policies and, by 
extension, the policies of Member States. 
Health promotion and disease prevention can 
best succeed if proper attention is paid to the 
environmental, economic and social determi-
nants of health together with actions to in-
crease people's awareness of their impact on 
health and to address any potentially adverse 
consequences. 
Third, for health policies to be effective they 
must be based on accurate and up-to-date in-
formation. We can help the Member States by 
improving the collection, analysis and dissem-
ination of information about health status 
across the Community and about the 
measures being taken in the Member States. 
By providing such comparative data, we can 
enable all concerned to see their situation in 
a wider context, and thus gain a better appre-
ciation of the effectiveness of their actions 
and the extent of the problems they have to 
10 Integration of health requirements in 
Community policies 
T
he growing importance of health at the level of the 
European Community has been increasingly recog-
nized by its progressive addition to the texts of the 
Treaties. The European Coal and Steel Treaty of 1952 did 
not contain any mention of health. Yet it rapidly gave rise to 
social research covering health and safety at work, based on 
its Article 55. In contrast, the Euratom Treaty, adopted five 
years later, contains an entire chapter on health and safety, 
and this led to the development of ionizing radiation stan-
dards designed to protect the general population and workers. 
Introduction 
As regards the EEC Treaty, one of its underly-
ing objectives is that of raising the standard of 
living (Article 2), which clearly has a health di-
mension. Community legislation based on 
this Treaty has given rise to a significant body 
of legislation with a health component. This 
includes dangerous substances, pharmaceuti-
cal products or foodstuffs. The Single Act 
strengthened the legal basis for measures re-
lating to health protection, in particular by ex-
tending the scope of Community action to 
the health and safety of workers, environ-
mental and consumer protection and the re-
quirement for legal measures establishing the 
market to ensure a high level of health protec-
tion. 
TheTreaty on European Union, which amend-
ed the Treaty establishing the European Com-
munity, continued the gradual evolution of 
Community policy on health. First, the spe-
cific Community competence on public 
health as provided by Articles 3(o) and 129 of 
the EC Treaty opened up, for the first time, the 
prospect of developing a consistent Commu-
nity approach to public health which would 
integrate the various strands of action into a 
coherent overall strategy. Second, it intro-
duced or strengthened provisions in a number 
of policy areas with an impact on health such 
as transport, consumer protection and educa-
tion. 
An important element of the new public 
health competence provided for in Article 129 
of the Treaty is the link it creates with other 
policy areas: 'Health protection requirements 
shall form a constituent part of the 
Community's other policies'. This puts an ob-
ligation on the Community institutions and 
the Member States to take health require-
ments into account when agreeing Commu-
nity policies. 
I I One of the underlying 
objectives of the EEC Treaty 
is that of raising the standard 
of living (Article 2). 
A structure for consultation 
and coordination 
The Commission has already set up a mech-
anism to respond to this obligation. When 
developing policies, services themselves are 
obliged to ensure that health requirements 
are met by their proposals. Under Commis-
sion rules, they are then required to proceed 
with a consultation on proposals with a bear-
ing on health. The Commission Interservice 
Group on Health serves as a forum for discus-
sion and information exchange for the Com-
mission services on health-related questions. 
Finally, the Commission reports annually on 
the integration of health requirements into 
the different areas of policy. This is supported 
by the European Parliament, which, in its Res-
olution on the medium-term social action pro-
gramme, called upon the Commission to 
present guidelines on incorporating health 
protection requirements into the other Com-
munity policies. In 1995, the first of these an-
nual reports — covering activities in 1994 — 
was adopted by the Commission. A second 
report dealing with 1995 followed in 1996. 
These reports are unique in the Community 
and a model on which similar efforts could be 
undertaken in the Member States. In welcom-
ing the first report, the Council regarded it as 
an important step towards giving effect to the 
provisions of Article 129 and reaffirmed the 
need for coordination, consistency and com-
plementarity for all Community activities with 
a health dimension. The Council suggested a 
number of priority areas for future reports 
and called upon the Commission to provide 
an early and transparent evaluation of the im-
pact of Community policies on human health. 
12 The reports attempt to give an overview of all 
areas of Community policy with repercussions 
on health. Ideally, they should spell out clear-
ly the health implications in qualitative and, if 
possible, quantitative terms. This is not always 
possible, as is the case in the 1994 report. 
Often, there will not be a clear recognition of 
the health dimension of a certain policy area. 
But, as such reports become an annual exer-
cise, these initial difficulties should gradually 
be overcome. 
The reports cover almost all areas of Commu-
nity activity but concentrate on those areas 
which are considered as having the most 
bearing on health. In 1995 these were social 
policy, the internal market, agriculture, food 
and fisheries, research and development, en-
vironment, energy and transport, as well as 
international cooperation. 
Interaction between health 
and other activities 
The result of these activities is that, for the first 
time, a clearer picture is emerging of the dif-
ferent ways in which public health and other 
Community activities interact. In the first 
place, it can clearly be seen that other Com-
munity policies can have a considerable im-
pact on public health. This is the case for pol-
icies which are not primarily directed at health 
protection, but at rather different areas such 
as transport and energy. Other policies may 
have a more direct influence, such as meas-
ures leading to the improvement of the qual-
ity of the environment or activities in agricul-
tural policy. 
Pharmaceuticals isan 
example of an area where 
supplementary public health 
activities concerning their 
role in the public health 
system may be needed. 
13 The reports demonstrate, secondly, that other 
Community policies which have an impact on 
health may themselves need to be comple-
mented by public health measures to ensure 
that their consequences on health are as ben-
eficial and effective as possible. One example 
is the area of pharmaceuticals, where supple-
mentary public health activities may be need-
ed concerning, for example, their role in the 
public health system, and also concerning 
labile blood components. 
Thirdly, the reports demonstrate that the con-
verse is also true, namely that public health 
activities themselves need to be accompanied 
by measures in other areas if they are to be 
fully effective. HIV/AIDS provides an interest-
ing example of this. As a global and multifac-
eted phenomenon, AIDS requires a response 
spanning a number of areas of policy. The 
Community's public health actions, which 
cover the areas of prevention, education and 
support, are therefore complemented both 
by a large-scale commitment within the 
Biorned programme and by a programme of 
AIDS-related development cooperation. 
An ongoing task 
Council meetings devoted to health have now 
become a regular feature of the European 
Community agenda. The wide range of top-
ics that are now discussed by Health Ministers 
demonstrates their interest and involvement 
in dossiers that are important to them both at 
national level and in the Community context. 
This is also reflected in the demand from the 
general public for more information on health 
matters. To satisfy these demands the Com-
munity has to continue to develop its re-
sponse to the obligations laid down by Article 
129 of the Treaty on European Union. The 
Commission has already set out a strategy 
which allows a gradual implementation of the 
provisions of the Treaty and adaptation to 
changing conditions and needs. The success 
of this policy, however, depends on the will-
ingness of all concerned to achieve these aims 
as quickly as possible. 
Finally, the reports illustrate how Community 
policies can contribute to improving human 
health while maintaining a balance between 
economic and social interests. 
By outlining interrelationships between dif-
ferent policy areas, the reports aim to rein-
force the ¡ntersectoral coordination of health 
protection aspects in Community policy. Such 
coordination can increase synergy and avoid 
duplication of effort and thus improve the ef-
ficiency and effectiveness of the operations 
undertaken to the benefit of all Community 
citizens. 
14 Report on the state of health in the 
European Community 
I
n July 1995, the Commission produced its first report on 
the state of health in the European Community.' This re-
port presents an overview of health in the Community at 
the end of 1994, including a description of the main demo-
graphic trends and patterns of morbidity and mortality, and 
a discussion of the main determinants of health. It also con-
tains information about some of the major Community activ-
ities which have implications for health.
2 The Commission's 
intention, as set out in the communication on the framework 
for action in the field of public health, is that these reports 
will be published each year. General overviews, like the first 
report, will be produced at intervals of about five years to re-
flect important new developments and changing trends. But 
in the other intervening years each report will focus on one 
specific issue. The 1995 report concentrates on women's 
health in the Community. 
Vehicles for information 
In presenting this first report, Pádraig Flynn set 
out its objectives in the following words: 'This 
report reveals clearly the main factors influ-
encing people's health in the Community and 
what needs to be done to improve it further. 
It is vital that messages about the causes of ill 
health and death are widely understood. This 
report will help get those messages across. It 
is an important step towards fulfilling the 
commitment we have made to provide accu-
rate information about the health situation in 
the Community'. 
In short, the Commission sees these reports as 
important vehicles for the provision and dis-
semination of key health information. Such 
information can be used to underpin the de-
velopment of policies and the selection of pri-
orities both at Community level and in Mem-
ber States, for example by helping to estab-
lish a baseline against which new trends and 
developments in health — both good and 
bad — can be assessed. 
Specifically in terms of health promotion and 
disease prevention, the reports can assist in 
focusing the attention of health professionals 
and the general public on the key messages 
and issues about the determinants of health 
and the causes of ill health. Finally, the reports 
will also help to explain to the citizens of the 
Community the reasons behind our public 
health strategy and make the impact of our 
actions more visible. 
COM(95) 357 final of 19 July 1995. A full colour version of 
the report has been published by the Office for Official Pub-
lications of the European Communities. 
The report does not cover the three new Member States since 
it is based on work carried out before their accession. 
15 In the Community the 
numbers of old people both 
in absolute terms and as a 
proportion of the total 
population are rising. 
Demographic change 
Several main themes emerge from the first re-
port. The first is that of the importance of 
demographic change and its impact on 
health. Throughout the Community, life ex-
pectancy is increasing: the average was 76.5 
years in 1991. Women are living longer than 
men: in 1991, the average male life expect-
ancy was 73 years, while for women it was 
just under 80 years. Differences still remain 
between Member States in life expectancy. 
but these have narrowed greatly in the last 20 
years. 
The infant mortality rate has also been falling; 
the Community average is under 10 per 
thousand. These welcome trends have, how-
ever, been accompanied by a significant fall in 
the fertility rate since the 1970s. The result is 
that the population is ageing: the proportion 
of children in the population is falling and the 
numbers of old people both in absolute terms 
and as a proportion of the total population 
are rising. 
In the next 15 years the proportion of people 
aged 65 or over is projected to rise from 15 to 
17%, which will be matched by a fall in the 
proportion of those aged 15 to 64. 
This ageing of the population has important 
consequences for the provision and financing 
of health services. Older people consume 
more health services than younger people 
and the increase in the proportion of the eld-
erly and very elderly therefore means that 
there will be greater pressure on services and 
at the same time fewer people of working age 
to pay for them. 
Premature deaths 
A second major theme is that, despite the 
lengthening in average life expectancy, too 
many people in the Community are dying pre-
maturely. One fifth of all deaths occur below 
the age of 65. It is also striking that between 
the ages of 15 and 34, three times as many 
men die as women. The main causes are heart 
disease, strokes, cancer and accidents. Many 
factors are responsible, but there is no doubt 
that lifestyle and risky behaviour play a key 
role. 
It is well known, for example, that cigarette 
smoking is responsible for much ill health and 
very many deaths. Yet in 1992, despite the 
great efforts that have been made to deter 
people from smoking, across the Community 
as a whole as many as 42% of men and 28% 
of women were smokers. Moreover, although 
the general trend in the Community is for 
fewer men to smoke, more women appear to 
be doing so. This may well lead to a rise in pre-
mature deaths among women. 
16 Differences across 
the Community 
A third theme is that of the substantial differ-
ences that exist in patterns of mortality and 
morbidity within the overall Community pop-
ulation. Differences persist between Member 
States, between areas within individual Mem-
ber States and between population groups. 
The report contains some notable examples 
of these. In terms of behavioural determi-
nants, for example, there are large variations 
between countries. Only 12% of women in 
Portugal smoke, compared to 42% in Den-
mark. Some 55% of men in Greece smoke, 
but only 35% in the UK and Ireland. There are 
similarly wide disparities in relation to alcohol 
consumption. For example, the average con-
sumption per head in France in 1990 was 
12.6 litres, compared to 7.4 litres in Ireland. 
There were similarly very large differences in 
causes of mortality and morbidity. For exam-
ple, in 1992, the rate of recorded suicides was 
nearly seven times higher in Denmark than in 
Greece, and the occupational accident death 
rate was over five times as high in Italy and 
Luxembourg as in Ireland and the Nether-
lands. 
Another important determinant of health 
status is socioeconomic status. There is evi-
dence that people with higher income and 
educational levels have longer life expectancy 
and lower mortality rates. The report cites a 
survey in Germany, for example, which sug-
gested that blue-collar workers had a life ex-
pectancy of some two years lower than that 
of white-collar workers. 
Finally, the report emphasizes the wide 
variety of influences on people's health. These 
include the environment, the social and 
economic context, the structure of health ser-
vice provision in a country, individuals' genetic 
make-up and their behaviour. 
The importance of 
prevention and promotion 
In the light of this complex range of factors 
which affect health, the report reaches the 
conclusion that to improve the health status 
of the population of the European Commu-
nity the provision of effective health care and 
treatment is likely to be of less importance 
than preventive and promotion measures ad-
dressing the relevant behavioural, economic 
and social issues. 
17 Public health framework programme — Article 129 
U
nder the Treaty on European Union, the European 
Community was given a new competence in public 
health. Article 3(o) of the Treaty establishes a broad 
aim of making 'a contribution to the attainment of a high 
level of health protection ', and Article 129 then goes on to 
set out how the Community should pursue this aim. 
Under the Treaty, the Community is required to make a con-
tribution towards ensuring a high level of health protection. 
The main vehicles for doing so, under Article 129, are: 
(i) the encouragement of cooperation 
between the Member States and, if necessary, 
the provision of support to their action; 
(ii) the promotion of coordination of policies 
and programmes of the Member States in the 
areas of disease prevention, research into 
causes and transmission of diseases, health 
information, and health education; 
(iii)the fostering of cooperation with third 
countries and the competent international or-
ganizations in the sphere of public health. 
The communication on 
public health 
The Commission set out how it intended to 
implement the new provisions in its commu-
nication on the framework for action in the 
field of public health (COM(93) 559), which 
was published in November 1993. The first 
part of the communication describes the con-
text in which Community public health strat-
egy has to be developed. This includes the 
principles that govern Community action, 
such as subsidiarity and proportionality, and 
also the demographic background, the deter-
minants of health and the present pattern of, 
and main trends in, Community mortality and 
morbidity. 
A number of significant problems are identi-
fied which are increasing the pressure upon 
Member States' health systems. Clearly the 
Community could not, and should not, at-
tempt to address every major health problem 
at the same time. Indeed, to be effective 
Community actions must be properly fo-
cused. The communication therefore puts for-
ward a number of criteria on which to base 
the choice of priorities. These are: 
(i) a disease's impact on mortality and mor-
bidity; 
(ii) a disease's socioeconomic impact; (iii) how far a disease is amenable to effective 
preventive action, and of particular impor-
tance; 
(iv) how far there is scope for Community ac-
tions to complement and add value to what 
is being done by the Member States. 
Priority action programmes 
On the basis of the analysis of the general 
health situation and in the light of the criteria 
advanced, the communication proposes that 
the Community's public health strategy until 
the end of the century should be centred on 
the development of eight action pro-
grammes. Of these, six would focus on spe-
cific disease areas and health problems — the 
major scourges mentioned by the Treaty. But, 
in order to help cement the overall strategy 
and ensure that these disease-specific pro-
grammes worked in a synergistic manner, 
they were to be complemented by two fur-
ther 'horizontal' programmes, one on health 
monitoring and the other on health promo-
tion. 
The strategy set out in the communication 
was given a broad welcome by the other 
Community institutions, and in the last two 
years considerable progress has been made in 
bringing it into effect. 
Five of the eight proposed action programmes 
have so far been put forward by the Commis-
sion. Of these, three have now been adopted 
by co-decision and are being brought into ef-
fect. These are the programmes on AIDS and 
other communicable diseases and on cancer, 
together with the horizontal programme on 
health promotion, information, education 
and training. It is expected that the pro-
gramme on drug dependence will be adopt-
ed by co-decision shortly. The Commission's 
proposals for the fifth programme on health 
monitoring were published in October 1995. 
This programme contains three parts: the es-
tablishment of a set of health indicators, the 
creation of an electronic network for the dis-
semination of data, and the development of 
the capacity to undertake analyses of infor-
mation. It is currently under consideration in 
the co-decision procedure, and it is hoped 
that it will be adopted soon for implementa-
tion from 1997. 
Finally, work is in hand on the preparation of 
the three remaining action programmes pro-
posed in the communication. These are on 
rare diseases, pollution-related diseases and 
accidents and injuries. The Commission will 
be putting forward its proposals on these pro-
grammes shortly. 
One important aspect of all these action pro-
grammes is the emphasis placed on their 
thorough evaluation; and in this connection 
work is currently under way aimed at devel-
oping possible mechanisms for the evaluation 
and assessment of public health measures. 
Article 3(o) of the Treaty 
establishes a broad aim of 
making 'a contribution to 
the attainment of a high 
level of health protection'. 
19 Other initiatives 
In addition to these action programmes, the 
public health strategy contains several other 
important elements which are also referred to 
in the communication. These include work on 
the setting-up of a network for the surveil-
lance and control of communicable diseases 
at Community level, on which the Commis-
sion has put forward a proposal, and on coop-
eration concerning blood safety and self-suf-
ficiency in the Community. The Commission 
has also committed itself to the production of 
two annual reports: first, on the state of 
health in the Community and, second, on the 
integration of health protection requirements 
into other policies. The first such reports were 
published in 1995. 
Work is also being undertaken to assist Mem-
ber States with the issues of fundamental 
choices in health policy and in cost contain-
ment. Support has been given, for example, 
to comparative surveys of choices and prior-
ities in Member States undertaken by the Lon-
don School of Economics and its partners in 
the European health policy research network. 
As a means of developing the process of con-
sultation with Member States, a high-level 
Committee on Health, consisting of represen-
tatives of the Member States, meets regular-
ly to discuss both overall strategy and partic-
ular issues, and so facilitate such cooperation. 
In parallel, an initiative is under way aimed at 
discovering more about the general public's 
views on the effectiveness of their national 
health systems and their priorities for spend-
ing on health by means of a Eurobarometer 
survey. The results of this survey will be avail-
able in 1997. 
These actions together amount to a substan-
tial programme of work. When it is combined 
with actions under way elsewhere in the 
Commission — for example, the Biomed re-
search programme, the work on consumer 
protection and on the environment — it 
should make a significant contribution to the 
efforts being made across the Community to 
protect and improve public health. 
20 A new Community action programme 
on health monitoring 
T
he collection of health indicators, such as infant mor-
tality and life expectancy, dates back to the second 
half of the 17th century, when the majority of deaths 
were due to infectious diseases. This century's developments 
in public health, standards of living, and medical advances 
have to a large extent reduced or even eradicated these 
scourges. As a result, the traditional health indicators have 
come to be viewed as insufficient to portray the health status 
of a population. Consequently, the last few decades have 
seen the development and proliferation of a large number of 
health indicators. 
Background 
Today every country in the European Commu-
nity collects a variety of health indicators. 
Moreover, international organizations, partic-
ularly the World Health Organization (WHO) 
and the Organization for Economic Coopera-
tion and Development (OECD), collect a num-
ber of health data and indicators at the na-
tional level. Yet despite this proliferation of 
health data and indicators, the much desired 
goal of obtaining accurate and comparable 
data remains elusive. Many of the data that 
do exist are collected by different methods 
and indicators are defined differently, making 
cross-country comparisons fraught with prob-
lems. Furthermore, in a number of areas there 
are virtually no data, or data are available for 
only a few countries. 
Why is this a Community concern? The 
answer is to be found in Articles 3(o) and 129 
of the Treaty which state that the Community 
is to 'ensure a high level of health protection' 
through health promotion and disease pre-
vention activities. One of the prerequisites for 
ensuring a high level of health protection is 
knowledge about the health problems facing 
citizens in the European Community. Appro-
priate measures to monitor health and its de-
terminants, as well as a capacity for the mon-
itoring and evaluation of actions, are there-
fore needed. 
In its communication of 24 November 1993, 
the Commission defined a framework for 
Community action in the field of public health 
in order to attain the objectives on health pro-
tection contained in the Treaty. This frame-
work identified a number of priority areas for 
Community action. Among these priorities 
was the development of appropriate health 
data and indicators. 
21 One of the prerequisites for 
ensuring a high level of 
health protection is 
knowledge about the health 
problems facing citizens in 
the European Community. 
The action programme on 
health monitoring 
Addressing itself to this priority, the Commis-
sion recently (October 1995) launched a new 
initiative to establish a Community action pro-
gramme on health monitoring. The proposed 
programme, for which ECU 13.8 million over 
five years is earmarked, has three aims: 
(i) to permit measurement of health and 
health determinants throughout the Commu-
nity and comparisons with third countries; 
(ii) to facilitate planning, monitoring, imple-
mentation and evaluation of Community pro-
grammes and actions; 
(iii) to provide Member States with high-qual-
ity, comparative health indicators and appro-
priate health information which support and 
add value to their national health monitoring 
systems and contribute to the development of 
national health policies. 
To achieve these objectives, the development 
of a Community health monitoring system is 
proposed, involving the establishment of a 
set of health indicators, a network to collect 
and disseminate the data, as well as a capac-
ity to undertake analyses of the health indica-
tors. 
The health indicators collected would consist 
of two types, core and background. Core in-
dicators are those essential to Community 
health policy, such as on health status and 
health determinants (for example, alcohol 
and tobacco consumption). Background indi-
cators are linked indirectly to public health but 
are nevertheless important for health policy 
purposes. As priorities change over time, the 
indicators to be collected (both core and 
background) will have to cover a wide range 
to permit a good understanding of the inter-
play of various factors impinging on health 
and allow future problems to be anticipated. 
22 The principles 
behind the system 
The development of the Community health 
monitoring programme is to be guided by a 
number of principles. The system should: 
(i) build on readily available European data 
and indicators, such as those held by Member 
States, international organizations, notably 
the WHO and OECD, and the Commission; 
Under the ENS-CARE programme of the third 
framework programme on research and tech-
nological development, the infrastructure for 
such a system was developed in a pilot pro-
ject. This infrastructure is in the process of fur-
ther development under the programme of 
telematic interchange of data between ad-
ministrations (IDA). The IDA health network is 
being designed so as to ensure compatibility 
with the needs of the health monitoring pro-
gramme. 
(ii) avoid any unnecessary duplication of 
work: the work already being carried out by 
international organizations, European net-
works and the Commission should be mutu-
ally complementary and congruent; 
(iii) avoid imposing unnecessary burdens on 
Member States which already transmit health 
data to a number of international organiza-
tions, networks and the Commission; 
(iv) carefully assess available options for devel-
oping the various parts of the system with re-
spect to the costs and benefits involved; 
(v) be as flexible as possible in order to be ca-
pable of adapting to future changes in needs 
and priorities; 
(vi) respect data protection requirements. 
A Community-wide 
electronic network 
The principles guiding the development of 
the health information system have a number 
of implications, in particular as regards the 
mechanism for collecting and disseminating 
the health data and indicators. In order to 
minimize the burden of data collection im-
posed on Member States, and to provide the 
most cost-effective method of data collection 
and dissemination, the Commission intends 
to promote the development of a Commu-
nity-wide electronic network which would 
link the competent authorities in the Member 
States. Such a system would also have the ad-
vantage of providing Member States with 
easy and timely access to the health informa-
tion contained in the system. 
Uses of the health data 
and indicators 
The data to be contained in the proposed 
Community health information system would 
be of little value if they were not put to good 
use. The Commission therefore intends to 
build the capacity to undertake a variety of 
analyses, including health status and health 
trends reports, analyses of specific health 
problemsand health determinants, and analy-
ses of the impact on health of other policies. 
These analyses would make a useful contribu-
tion to the further development of Commu-
nity policies. 
Conclusions 
The proposed Community health monitoring 
programme is intended to fill an important 
gap in the information currently available at 
Community level. The programme involves a 
major developmental effort, which means 
that considerable time is likely to elapse be-
fore the proposed Community health moni-
toring system becomes fully operational, even 
if the programme starts as expected in 1997. 
23 A safe and secure blood supply 
O
f the many public health issues facing Member 
States, perhaps the one that elicits the strongest 
feelings among the citizens of the Community is the 
safety of blood. Since blood donation first came to be viewed 
as an altruistic gesture and blood transfusion became an in-
tegral and indispensable part of medical treatment, the gen-
eral public and the health-care community came to count on 
its relative innocuousness. It was only with the onset of the 
AIDS pandemic and confirmation of the direct link between 
blood and the human immunodeficiency virus (HIV), which 
causes the disease, that such complacency was shattered. 
Community self-sufficiency 
Fully recognizing the immense importance of 
safeguarding public health while ensuring the 
free circulation of the vital medicinal products 
industrially prepared from human blood and 
plasma, within the internal market of the 
European Community, the Council of Minis-
ters adopted Directive 89/381/EEC to ensure 
the quality, safety and efficacy of these prod-
ucts. The Community, through this Directive, 
also committed itself to the goal of reliance 
upon its own citizens, through voluntary un-
paid donations, for the blood and plasma re-
quired both for direct transfusion and for the 
preparation of medicinal products. This has 
become known as Community self-suf-
ficiency. 
Following an extensive survey
2 of the situation 
regarding self-sufficiency in the Member 
States, the Commission informed the Coun-
cil
3 that in 1989 the Community was self-suf-
ficient in the labile components used for 
transfusion but that there was a significant 
deficit in the source plasma used for the prep-
aration of medicinal products. Subsequent 
surveys carried out on the situation in 1991
4 
and 1993
5 supported these findings, although 
there is evidence that some progress is being 
made, albeit slowly. 
Council Directive 89/381/EEC, 0J L 181/44, 28.6.1989. 
Collection and use of human blood and plasma in Europe. 
W.G. van Aken, Council of Europe, 1993, p. 31 (ISBN 92-871-
2240-7). 
Communication from the Commission to the Council, the Eu-
ropean Parliament and the Economic and Social Committee 
on blood self-sufficiency in the European Community 
(C0M(93) 198 final (Brussels) of 25 May 1993, p. 13). 
The collection and use of human blood and plasma in the 
European Community in 1991. W. G. van Aken, July 1994, 
European Commission, EC/LUX/V/F/159/94, p. 39. 
The collection and use of human blood and plasma in the 
European Community in 1993. F. M. Delaney, November 
1995, European Commission, EC/LUX/V/F/1/33/95, p. 43. 
24 Reaffirming the need to achieve self-suffi-
ciency through cooperation between Mem-
ber States, the Council, in its conclusions 
(94/C15/03)' on blood self-sufficiency in the 
European Community, also agreed, inter alia, 
to continue to promote the quality and safe-
ty of blood collection and blood-derivative 
production. It requested the Commission to 
report on the legal provisions and current 
practices in the Member States regarding the 
collection, control and treatment of blood 
and the distribution of and trade in blood and 
blood products with a view to proposing com-
mon safety criteria. Recognizing that Directive 
89/381/EEC specifically excludes whole 
blood, plasma and blood cells of human ori-
gin, the Commission's report
2 to the Council 
addressed the safety aspects of the entire 
blood transfusion chain, and identified issues 
and problems that required further attention. 
The report also presented the significant find-
ings of a survey
3 carried out in 1994 among 
some 13 000 European citizens aged 15 or 
over, on a nationally representative basis in 12 
Member States, regarding their perception 
and understanding of questions relating to 
blood. The findings of this survey showed 
that, while Community citizens are reason-
ably well-informed about blood itself, there is 
a considerable number of misconceptions and 
lack of information regarding blood-related 
issues. Among them is the erroneous fear of 
contracting HIV/AIDS from a blood donation 
and the general lack of awareness about the 
Community's goal of self-sufficiency through 
voluntary unpaid donations. 
OJC 15, 18.1.1994. p. 6. 
Communication from the Commission on blood safety and 
self-sufficiency in the European Community (COM(94) 652 
final (Brussels) of 21 December 1994). 
Eurobarometer 41. Europeans and blood, INRA (Europe), 
February 1995, p. 69. 
The Community has 
committed itself to the goal 
of reliance upon its own 
citizens, through voluntary 
unpaid donations, for blood 
and plasma. 
25 Reinforcing trust 
Recognizing that one of the major determin-
ing factors in achieving self-sufficiency 
throughout the Community is the willing-
ness of the citizens of the Community to 
donate, the Council, in its Resolution 
(95/C 164/01)' of 2 June 1995, called on the 
Commission to define a strategy for reinforc-
ing trust in the safety of the blood transfusion 
chain and for promoting self-sufficiency in the 
Community through voluntary unpaid dona-
tions. The Commission is now considering, in 
collaboration with the Member States, how 
best to address the issues raised, including: 
the policies and procedures in the donor se-
lection process; efficient, validated and reli-
able screening tests; quality assessment crite-
ria and good manufacturing practices; educa-
tional programmes related to optimal use of 
blood and blood products; basic criteria for 
the inspection and training of inspectors; and 
the dissemination of information on blood 
and blood products. The Commission has al-
ready authorized a feasibility study on the es-
tablishment of a haemovigilance network in 
the Community and has prepared a proposal 
for a Directive regarding the safety and reli-
ability of in vitro diagnostic medical devices 
which cover reagents and equipment specifi-
cally intended for the examination of blood. 
The concern of the Council and the Commis-
sion about the safety of blood and its deriva-
tives is also shared by the European Parlia-
ment, which supports the goal of Community 
self-sufficiency, as reflected in reports,
2·
3 nu-
merous written and oral questions, as well as 
in the adoption of three Resolutions.
4·
5·
5 
Sharing the concern of the Council, the Euro-
pean Parliament and the Member States over 
the quality, safety and supply of blood and 
blood products, the Commission intends to 
define a blood strategy which will reinforce 
trust in the safety of the blood transfusion 
chain and promote self-sufficiency in the 
Community. 
OJC 164, 30.6.1995. 
Report of the Committee on the Environment, Public Health 
and Consumer Protection on self-sufficiency in and safety of 
blood and its derivatives in the European Community. A. Ce-
ci, European Parliament, 25 February 1993 (A3-0075/93), 
p. 20. 
Draft report of the Committee on the Environment, Public 
Health and Consumer Protection on the communication from 
the Commission on blood safety and self-sufficiency in the 
European Community. C. Cabrai, European Parliament, 25 
October 1995 (EP 214.692), p. 10. 
OJC 268,4.10.1993, p. 29. 
OJC 329, 6.12.1993, p. 268. 
EP Resolution on blood safety in the European Union (EP 
192.561, pp. 38-40). 
26 27 The 'Europe against cancer' programme and its 
third action plan (1996-2000) 
C
ommunity action against cancer began in 1985 when 
the Heads of State or Government, recognizing the 
severity of its impact on the European population, 
called on the European Commission to define a common 
strategy to fight the disease. 
Introduction 
The Commission responded with the 'Europe 
against cancer' programme, which was 
adopted in 1987 and was the first Commu-
nity initiative in the field of health. The pro-
gramme has since been implemented 
through multiannual action plans, with spe-
cific priority objectives. 
The first action plan ran from 1987 to 1989 
and was followed by a second for the period 
1990 to 1994. These plans focused on four 
areas: cancer prevention, screening and early 
detection, training of health professionals and 
support for cancer research. 
The third action plan, which covers the period 
1996 to 2000 has been adopted by the Euro-
pean Parliament and the Council,
1 provides 
for the natural continuation and further de-
velopment of the measures carried out in the 
earlier action plans, but also contains some 
new elements, deriving from the ratification 
in November 1993 of the Treaty on European 
Union. 
The new framework for 
Community action in the 
field of health 
The third action plan to combat cancer was the 
first Community programme to be presented 
by the Commission under Article 129 of the 
Treaty on European Union. It is a follow-up to 
the Commission communication on the frame-
work for action in the field of public health 
(COM(93) 559 final), which also includes 
measures to combat other major health 
scourges and horizontal measures. 
The main objective of the programme's third 
action plan, which will run from 1996 to 
2000, is to increase understanding of the 
causes of cancer and its prevention. Coherent 
and more widely disseminated information 
1 OJ L95, 16.4.1996. 
28 for the public should make it easier to achieve 
the objectives which Article 129 sets for the 
Community in the field of health protec-
tion. 
Priorities for Community 
action to combat cancer 
The Commission's communication on the 
framework for action in the field of public 
health proposes four objectives for Commu-
nity action: 
(i) to prevent premature death, which par-
ticularly affects the young; 
(ii) to increase life expectancy without dis-
ability or sickness; 
(iii) to promote the quality of life by improv-
ing general health; 
(iv) to promote the general well-being of the 
population, particularly by minimizing the 
economic and social consequences of ill 
health. 
The 'Europe against cancer' programme ad-
dresses all these objectives; the new Commu-
nity measures to combat cancer are designed 
to help Member States achieve their own ob-
jectives and will be implemented with the aim 
of maximizing the benefits of working on a 
European scale. 
Against this backdrop, priority will be given to 
selection of the following kinds of Commu-
nity measures: 
(i) activities which, because of their scale, 
cannot be carried out wholly satisfactor-
ily by the Member States — European 
scale; 
(ii) activities whose joint implementation 
would have clear advantages, in spite of 
initial higher costs — European added 
value; 
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(iii) complementary activities, which would 
have significant impact in the Community 
— complementary activities in the indi-
vidual Member States; 
(iv) activities leading to the establishment of 
rules of good practice — establishment of 
European standards and/or criteria for 
good practice; 
(v) activities which help to strengthen soli-
darity and social cohesion — promotion 
of greater European solidarity in the field 
of public health. 
The aim of the third action 
plan is to help to improve 
the European citizen's 
understanding of the causes 
of cancer and how to 
prevent it. 
29 Priorities for the third 
action plan 
The Annex to the Decision of the European 
Parliament and the Council adopting a third 
action plan to combat cancer within the 
framework of public health (1996-2000) con-
tains a description of the key areas for action 
during the period in question, and the objec-
tives for each area. 
A total of 22 different types of action will re-
ceive special attention under the Europe 
against cancer programme, grouped into the 
following headings: 
(i) data collection and research 
(ii) health education and information 
(iii) early detection and screening 
(iv) training and quality control. 
The objectives in the field of data collection 
and cancer research are to extend and im-
prove understanding of cancer and to make 
it easier to collect reliable data, which will be 
used chiefly to calculate trends in the inci-
dence and prevalence of the disease, to carry 
out epidemiological studies at European level 
and to establish research priorities. 
In the field of health education and informa-
tion, the aim of the third action plan is to help 
to improve the European citizen's understand-
ing of the causes of cancer and how to pre-
vent it, and to encourage the adoption of a 
healthy lifestyle. The programme will promote 
and evaluate policies and measures linked to 
the causes and risks of cancer. 
As regards early detection and screening, the 
aim is to improve and extend the possibilities 
of early detection, chiefly by developing effec-
tive screening programmes and appropriate 
practices. 
Finally, the third action plan of the Europe 
against cancer programme will help to de-
velop training networks for health profession-
als and will support the exchange of experi-
ence at European level and pilot projects in 
the field of quality assurance. 
30 European cancer prevention weeks 
S
ince the Europe against cancer programme was first 
launched in 1987, information campaigns have been 
organized each year to draw the public's attention to 
specific aspects of cancer prevention. These campaigns are 
organized under the programme, in close cooperation with 
the cancer leagues and associations, in all Member States, 
during the second week in October ('European cancer pre-
vention week') and focus on a different theme each year. The 
1995 week highlighted the European code against cancer, a 
set of 10 simple recommendations which carry essential 
messages for cancer prevention; the 1996 campaign targets 
the prevention of skin cancers. 
Informing the public — 
a priority 
The importance of informing the public in any 
strategy to combat cancer is self-evident, 
given that it is generally accepted that some 
70% of cancer-related deaths have their root 
cause in personal lifestyle and environmental 
choices. Consequently, irrespective of medical 
progress, a significant reduction in cancer and 
cancer-related mortality can be achieved only 
if the public can be persuaded to change cer-
tain habits and attitudes, and knowledge is a 
prerequisite for the adoption of a lifestyle af-
fording the maximum protection against can-
cer — although the risk can never be com-
pletely eliminated. 
Information for the public is therefore a very 
important aspect of the third action plan 
against cancer. The plan provides for the 
following information measures: 
(i) the organization, each year, of a Euro-
pean cancer prevention week; 
(ii) improvement of the dissemination and 
impact of the cancer prevention mess-
ages; 
(¡ii) support for networks for the exchange of 
information and experience in the field of 
cancer prevention; 
(iv) the promotion of information and aware-
ness-raising campaigns for specific target 
groups; 
(v) the encouragement of European-scale 
cancer prevention projects, focusing on 
smoking. 
31 The European code against 
cancer — getting the 
message across to the 
general public 
When the Europe against cancer pro-
gramme was first launched, a prestigious 
group of cancer experts from all Member 
States was asked to draw up a set of easily 
remembered recommendations outlining 
the basic essentials of cancer prevention. 
This resulted, in 1987, in the first edition of 
the European code against cancer. The text 
was revised in 1995 on the basis of new sci-
entific findings (see box). The code has be-
come the linchpin of the programme, partic-
ularly as regards information for the public. 
Indeed, it is normally one of the code's 10 
'commandments' which is chosen as the 
subject for the European week; in 1995, the 
new revised code as a whole was the theme 
of the campaign. 
Cancer prevention? One 
third of Europeans thought 
it impossible! 
A Eurobarometer survey conducted in the 
1 5 Member States of the European Union in 
spring 1995 — prior to the promotion of the 
code during the 1995 European week — 
drew attention to the need for clear and sim-
ple guidelines on cancer prevention for the 
general public. 
The most striking finding was that one Euro-
pean in three (and in some countries 50% 
of the population) did not believe that can-
cer could be prevented: too many Euro-
peans were therefore still unaware that they 
could reduce the risk of cancer. The code's 
recommendations may appear simplistic or 
obvious, but effective and original commu-
nication campaigns are necessary if they are 
to be understood and followed by the 
public. 
European cancer prevention 
weeks — information 
campaigns with a strong 
European flavour 
Large-scale initiatives are therefore needed to 
make Europeans more aware of what they 
can do to prevent cancer, hence the idea of 
organizing a European cancer prevention 
week each year in the second week in Octo-
ber. During the week, a Europe-wide informa-
tion campaign is organized on a subject relat-
ing to cancer prevention (1993: dangers of 
passive smoking; 1994: benefits of eating 
fresh fruit and vegetables; 1995: promotion 
of the code; 1996: prevention of skin can-
cers). The programme attaches great impor-
tance to the close involvement in the weeks, 
from the outset, of the cancer leagues and as-
sociations, and the resources which the 40 or 
more leagues and associations involved each 
year can offer to the campaigns are a tremen-
dous asset. 
As regards practical organization, the pro-
gramme and the leagues involved aim, above 
all, to make the weeks truly European, based 
on a common idea and with a common foun-
dation. To this end, in 1995, the programme 
issued a public invitation to tender and sel-
ected a professional communication agency, 
with offices in nearly all Member States. This 
network, with the help of the cancer leagues, 
is responsible for attracting the media interest 
so necessary if any genuine impact is to be 
made on the public. 
A reassuring and simple 
message for the general 
public 
All the players involved in cancer prevention 
stress that campaigns aimed at the general 
public must be positive, that they must en-
courage and motivate rather than issue orders 
or attach blame. 
32 Information for the public is 
a very important aspect of 
the third action plan against 
cancer. 
The weeks' mass media information uses very 
simple language, but very great importance is 
nonetheless attached to its underlying scien-
tific content. It is for this reason that, each 
year, a scientific coordinator is appointed to 
ensure that the campaign is soundly based 
and coherent. 
During the week itself, the cancer leagues 
and associations have the task of distributing 
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the information material — posters and leaf-
lets in the 11 Community languages, all with 
the same presentation and content. 
There are also press notices, television broad-
casts and more specific activities depending 
on the subject of the week (e.g. promotional 
activities by the producers and distributors of 
fresh fruit and vegetables during the 1994 
week, which focused on healthy eating). Dur-
ing the week, the cancer leagues and associ-
ations also organize a wide range of events in 
most of the Member States, at national, re-
gional and local level. Although these activ-
ities are not supported directly by the Europe 
against cancer programme, they draw atten-
tion to the European origins of the campaign 
of which they are part. 
A second target group: 
health professionals 
In addition to the general public, the informa-
tion campaigns organized for the weeks are 
also aimed at health professionals. Indeed, 
the programme calls on them to relay the can-
cer prevention messages to their patients; the 
role of GPs, for example, in educating their 
patients is self-evident, since they are the first 
line of health care for the population as a 
whole. It was for this reason that, for the 
1995 campaign, with the active collaboration 
of the national associations of general practi-
tioners, the Europe against cancer pro-
gramme published a brochure on the code, 
geared primarily to the information needs of 
this group; it was distributed just before the 
week began, to all of the European Union's 
325 000 GPs. 
Assessment: considerable 
impact 
Assessment of the quantitative impact of the 
weeks shows that the campaigns have exten-
sive media coverage. For example, efforts 
made in 1995 allowed 150 million people to 
be reached through free advertising space ob-
\ tained in the media (equivalent to about ECU 
! 1 million) and a further 105 million through 
: newspaper articles and TV and radio broad-
} casts. 
33 The Eurobarometer survey mentioned earlier 
is a useful indicator of the qualitative impact 
which a campaign of this sort can have. The 
questions used in the spring 1995 survey 
were asked again in November of the same 
year. Comparison between these two surveys 
shows that the awareness of European citi-
zens increased significantly following the 
1995 campaign, the number of Europeans 
who did not believe it was possible to prevent 
cancer having fallen by 7%. A more detailed 
analysis shows that this increased awareness 
of the role which each individual can play in 
protecting his or her own health is directly 
linked to the quantitative impact: in other 
words, in countries where a larger number of 
people were reached by the campaign, the fall 
in the number of persons who did not believe 
in cancer prevention was particularly marked 
(for example, 14% in Germany, which means 
that after the 1995 European campaign, 10 
million more Germans believed in the pos-
sibility of preventing cancer than had in the 
spring). 
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2. 
3. 
4. 
5. 
6. 
European code 
Certain cancers can be 
avoided and general 
health improved if you 
adopt a healthier lifestyle 
Do not smoke. Smokers, stop as quickly 
as possible and do not smoke in the 
presence of others. If you do not 
smoke, do not try it. 
If you drink alcohol, whether beer, wine 
or spirits, moderate your consumption. 
Increase your daily intake of vegetables 
and fresh fruit. Eat cereals with a high 
fibre content frequently. 
Avoid becoming overweight, increase 
physical activity and limit intake of fatty 
foods. 
Avoid excessive exposure to the sun 
and avoid sunburn especially in chil-
dren. 
Apply strictly regulations aimed at pre-
venting exposure to known cancer-
causing substances. Follow all health 
against cancer 
and safety instructions on substances 
which may cause cancer. 
More cancers could be cured if 
7. 
8. 
9. 
10 
detected early 
See your doctor if you notice a lump, a 
sore which does not heal (including in the 
mouth), a mole which changes shape. 
size or colour, or any abnormal bleeding. 
See your doctor if you have persistent 
problems, such as a persistent cough. 
persistent hoarseness, a change in 
bowel or urinary habits or an unex-
plained weight loss. 
For women 
Have a cervical smear regularly. Partici-
pate in organized screening pro-
grammes for cervical cancer. 
. Check your breasts regularly. Participate 
in organized mammographie screening 
programmes if you are over 50. 
35 Smoking and tobacco 
T
he consumption of tobacco is an extremely serious 
problem for public health. Studies have shown that 
about half of regular smokers will eventually be killed 
by their habit. The worldwide toll from smoking is estimated 
at about three million persons per year. If current smoking 
patterns continue, that toll will have risen to 10 million 
deaths a year by 2025. This is not to mention the levels of 
illness caused by smoking, or by the effects of passive smok-
ing. In these circumstances, reduction of smoking must be a 
priority for all those concerned with the public's health. 
Europe against cancer 
programme 
Much Community action in the area of smok-
ing has hitherto been concentrated in the 
context of the Europe against cancer pro-
gramme, given that approximately 30% of 
cancer deaths are attributable to smoking. 
There are about 1.3 million new cancer cases 
and about 840 000 deaths from cancer annu-
ally in the European Union. 
As part of the Europe against cancer pro-
gramme and its various action plans (1987-
89, 1989-94, and the current third action plan 
1995-99), the Community has given priority 
to the reduction of tobacco consumption. 
This has been done in particular by the fi-
nancing of projects carried out either at Mem-
ber State level, as part of a network, or at 
European level. Specific mention can be made 
of projects to prevent tobacco addiction in 
target groups such as young people, women, 
teachers and health staff. Other projects were 
created to teach anti-smoking techniques to 
health personnel. Information projects were 
supported, aimed at warning the general 
public about the dangers of smoking, and 
promoting anti-smoking rules at the work-
place or in other public areas. 
In its latest action plan (1996-2000), the Com-
mission aims to encourage projects with a 
European dimension relating to the preven-
tion of tobacco consumption, and assessment 
of the implementation of recommendations 
on the use of tobacco in public places, partic-
ularly on public transport and in educational 
establishments. The new plan will promote a 
policy aimed at protecting the most vulner-
able groups from the risks of passive smoking, 
in particular pregnant women and children. 
There will be an assessment of measures 
36 taken in the Member States to reduce to-
bacco consumption, for example by the 
banning or control of direct or indirect adver-
tising or exclusion of tobacco from the price 
index. The action plan will also support the 
creation of networks of no-smoking towns, 
hospitals and youth clubs. Pilot projects will 
also be supported on identifying the best 
methods for reducing tobacco consumption 
through liaison with health workers. 
Preventive actions 
In its 1993 campaign on cancer prevention, 
the Commission identified several specific 
preventive actions to reduce, discourage or 
prevent tobacco consumption: 
(i) alerting at risk groups such as children 
and pregnant women to the dangers of 
smoking — a charter could be drawn up 
for these groups; 
(ii) the protection of non-smokers, particu-
larly in public places and at the work-
place; 
(¡ii) the development of existing networks 
(non-smoking towns, non-smoking 
hospitals, clubs for young non-smok-
ers); 
(iv) support for implementation of the most 
effective methods of preventing smoking is 
and of helping people to give up smok- S 
ing; 
(ν) support for educational campaigns di-
rected at teachers and adults responsible 
for educating young persons outside the 
school context; 
(vi) closer involvement with information 
campaigns organized by the WHO, par-
ticularly World No Tobacco Day (31 May 
each year); 
(vii) an upward harmonization of tobacco 
prices across the Community; 
(viii) encouragement of a cost of living index 
excluding the price of tobacco, and eval-
uation of the effects of this measure in 
the countries where it has been intro-
duced; 
(¡x) evaluation of anti-tobacco policies, es-
pecially restrictions on direct and indirect 
advertising of tobacco products which 
have been implemented in Member 
States. 
These orientations for future policy will short-
ly be developed in a Commission communi-
cation on smoking prevention. 
The worldwide toll from 
smoking is estimated at 
about three million persons 
per year. 
37 Public health: wider issues 
The Commission communication on the 
framework for action in the field of public 
health proposes a horizontal approach aimed 
at eliminating or reducing the impact of par-
ticular causal factors related to several dis-
eases. In this context, it is important to re-
member that while smoking and cancer are 
closely linked, other diseases such as cardio-
vascular and respiratory ailments also have 
significant links with smoking. Therefore, the 
Commission proposes actions in health infor-
mation, education and promotion addressing 
tobacco as part of a general approach to a 
healthy lifestyle, and aimed at the general 
public or at particular groups in society. 
Legal measures 
Action to reduce smoking has also extended 
to the adoption of Community legislative 
measures. Legislation has been introduced on 
the maximum tar content of cigarettes (Coun-
cil Directive 90/239/EEC) and on labelling of 
tobacco products with agreed warning mes-
sages (Council Directive 89/622/EEC as 
amended by Directive 92/41/EEC). 
Advertising of tobacco products on television 
is banned by Council Directive 89/552/EEC. A 
proposal for a Directive to introduce a wider 
ban on advertising is currently being exam-
ined by the European Parliament and the 
Council. 
As regards smoking in public places, the po-
sition is weaker, with the existence of a non-
binding Council Resolution of 1989 on ban-
ning smoking in public places which has since 
been the subject of a report on its implemen-
tation by the Commission. This area is identi-
fied as one needing further attention in the 
third cancer action plan, by means of assess-
ments of existing practice and by financing of 
pilot projects. A further Commission report on 
implementation by Member States of the 
Council Resolution has just been published. 
38 EPIC — European prospective investigation into cancer 
and nutrition 
M
any cancers are related to lifestyle and behav-
ioural factors and can therefore, at least to some 
extent, be avoided. Some experts believe that 30% 
of cancer-related deaths are linked to diet. Eating too many 
fatty foods also seems to be a significant risk factor, as does 
being overweight, particularly for women. 
Diet and cancer 
It is generally acknowledged that a balanced 
diet, including a sufficient amount of fruit and 
vegetables, offers significant protection 
against some of the most common cancers. 
Better eating habits could, therefore, mean 
fewer cancer patients and cancer-related 
deaths in Europe in the future, and for this 
reason the Europe against cancer programme 
has focused a great deal of attention on diet. 
The European code against cancer contains 
three recommendations concerning diet: 
(i) moderate your consumption of alcoholic 
drinks; 
(ii) frequently eat fresh fruit and vegetables 
and foods with a high fibre content; 
(iii) avoid becoming overweight and limit 
your intake of fatty foods. 
These prevention measures need to be based 
on epidemiological research, in other words 
on the factors which determine the onset of 
the disease, in conjunction with the charac-
teristics of the individual and his environment. 
It is on the basis of all this information that the 
risk factors, the reasons for the development 
of the disease and the appropriate treatment 
methods can be determined. 
The EPIC survey 
As the amount of epidemiological data avail-
able was too limited for all the cancers definite-
ly attributable to dietary factors to be identified 
with any certainty, the programme actively en-
couraged and financed studies on specific as-
pects of the diet/cancer relationship, and set up 
a network of prospective studies on cancer, 
diet and health. European cooperation in this 
area is extremely valuable. The very diversity of 
the EU Member States allows comparison 
between populations with the same quality of 
life but different social and dietary habits. 
39 The purpose of the EPIC study is to try to 
identify risk factors which are unknown or 
only suspected for the most common cancers 
in men and women living in industrialized 
countries. 
Better eating habits could 
mean fewer cancer patients 
and cancer-related deaths in 
Europe in the future. 
Researchers in nine countries (Denmark, Ger-
many, Greece, Spain, France, Italy, the Neth-
erlands, Sweden and the United Kingdom) 
are working together on this Europe-wide 
prospective study, which is coordinated by the 
International Cancer Research Centre in Lyons 
and the Commission. 
The map on the next page shows the coun-
tries and national centres involved. 
Nearly 400 000 Europeans will be monitored 
by these centres over a period of 10 years, so 
that the assessment of their state of health 
can be correlated with their way of life. 
Expected results 
The importance of this large-scale study, 
which will run until the year 2000, is that it is 
prospective rather than retrospective: the sub-
jects are questioned before the emergence of 
the disease and the information is therefore 
of a better quality. The natural tendency of 
patients to find a link between their lifestyle 
and the disease from which they are suffering, 
as can happen in the case of a retrospective 
study, is thus avoided. 
The questions put to participants cover four 
groups of factors: dietary, hormonal, genetic 
and psychological. These are of particular 
importance because little has so far been 
really proved about them. In fact, apart from 
a little, albeit fairly conclusive, evidence for 
the protection afforded against certain can-
cers by eating a diet rich in fruit and vegeta-
bles, the results of retrospective case studies 
on diet and cancer are still contradictory on 
a large number of important points, partic-
ularly on the relationship between diet and 
breast cancer. Subjects will therefore be 
monitored to study the incidence of cancer 
and the cancer mortality rate in relation to 
epidemiological data and biochemical mark-
ers. 
40 This study will therefore be the first to adopt 
a very large-scale epidemiological approach, 
in combination with advanced techniques in 
the fields of molecular biology and biochem-
istry. 
The Commission departments responsible 
for the Europe against cancer programme 
are hoping that the results of the prospective 
studies will enable them to improve the diet-
ary recommendations which will be issued at 
the end of the third action plan against can-
cer, at the beginning of the 21st century. 
Recommendations could be increasingly 
specific, such as which fruit and vegetables 
are best, which fats are to be avoided, and 
so on. 
Map showing centres 
collaborating in the European 
prospective Investigation 
into cancer and nutrition 
(EPIC). 
41 European initiative on breast cancer screening 
reast cancer is the commonest cause of cancer death 
among women in the European Community. Of the 
women currently affected by breast cancer, approxi-
mately 75% are aged 50 or over. The number of breast can-
cer deaths has doubled in absolute terms since 1960, the in-
crease being almost wholly accounted for by the growth in 
the size of the population and the increasing age of the pop-
ulation. 
The benefits of systematic 
screening 
What is surprising is that the sharp increase in 
the incidence of breast cancer in the last 
decade has been accompanied by only a very 
slight increase in the death rate. This means 
that the chances of survival have improved. 
There is a great deal of evidence that biennial 
screening for breast cancer of women aged 
between 50 and 70 leads to mortality reduc-
tion, provided that the quality of the primary 
process as well as the assessment are excel-
lent and negative effects such as misinterpre-
tation of X-rays or failure to recognize cancers 
are limited. Breast cancers detected through 
systematic, high-quality screening are identi-
fied, on average, four years earlier than their 
clinical appearance and the survival rate of 
early diagnosed cancers is therefore signifi-
cantly higher. 
Systematic screening for breast cancer is best 
described as a highly organized programme in 
which the whole process of invitation, screen-
ing, assessment and treatment of women 
meets the highest quality assurance standards. 
The balance between the positive and nega-
tive effects of screening is very subtle. Breast 
cancer screening is only successful in terms of 
mortality reduction and cost efficiency when 
all aspects of the screening process are per-
formed at optimal levels. 
The creation of the 
European pilot network on 
breast cancer screening 
Within the Europe against cancer pro-
gramme, priority was given to reducing the 
burden of breast cancer through secondary 
prevention. The European code against can-
cer reflects this in the 10th recommendation: 
'For women, check your breasts regularly. Par-
ticipate in organized mammographie screen-
ing programmes if you are over 50'. 
42 In order to maximize the effectiveness of 
breast cancer screening in Europe, a pilot net-
work on breast cancer screening was created 
in 1989. The aim of this network was not to 
investigate the benefits to be gained from 
high-quality breast screening, but to establish 
a medium for pooling and dissemination of 
experience and expertise between European 
countries, explore methods of wider imple-
mentation of this service and offer technical, 
scientific and financial support in order to 
achieve high quality standards. 
In the first phase, emphasis was given to the 
methodology and epidemiology of the 
screening programme, i.e. invitation of a large 
There is a great deal of 
evidence that biennial 
screening for breast cancer 
of women aged between 50 
and 70 leads to mortality 
reduction. 
43 group of women (at least 10 000 women a 
year), mandatory double reading of the mam-
mograms to reduce the number of missed 
cancers and statistical evaluation and control 
of the results by epidemiologists. During the 
second cancer action plan (1990-94), a qual-
ity assurance policy was introduced on the ba-
sis of the 'European guidelines for quality as-
surance in mammography screening'. This 
document was drawn up for the Commission 
and describes minimal and optimal conditions 
for quality assurance and quality control of a 
systematic screening programme. A second 
version of these guidelines was issued in June 
1996 and will include new chapters on epi-
demiology, cyto-pathologyand pathology. As 
a result of these guidelines, the concept of 
quality assurance is now better understood, 
and there is a consensus that this quality as-
surance concept is being implemented within 
the network. 
Breast cancer screening 
within the third cancer 
action plan 
The added value of this network is clearly 
demonstrated. The expertise represented in 
this network is needed by countries in the pro-
cess of establishing national screening pro-
grammes. The 'European guidelines for qual-
ity assurance in mammography screening' 
finds its way to numerous East European and 
Latin American countries. The European ex-
perts of the network are often asked to 
present an outline of the quality assurance 
system at international scientific conferences 
and, last but not least, the attention given to 
breast screening quality has a positive impact 
on the management of symptomatic disease. 
Conclusion 
Screening for breast cancer has become an 
important instrument for controlling this dis-
ease and is increasingly becoming a part of 
national public health policy. The Europe 
against cancer programme will continue to 
support high quality screening through the 
European network on breast cancer screen-
ing. 
The third cancer action plan will focus on a 
further implementation of high-quality 
screening and the establishment of breast 
cancer screening reference centres. Tasks of 
prime importance are the quality of medical 
performance, the quality of the technical im-
aging process, the quality of the screening or-
ganization and the quality assurance of epi-
demiological results. 
More cost-effectiveness studies will be con-
ducted in order to evaluate the impact on re-
sources and on the cost of life years saved. A 
conference on breast cancer screening is also 
foreseen. Quality assurance guidelines on the 
surgical management of screen-detected 
lesions are also envisaged. 
The Community added value 
At present, almost all EU countries participate 
in this network. Some countries have decided 
to establish a national screening service, while 
others have devised regional screening pro-
grammes with high quality standards. There is 
a regular exchange of screening personnel 
between the network members, for training 
purposes. 
44 European network of cancer registers 
T
he main purpose of the cancer registers is to collect 
information on new cancer cases within a given geo-
graphical area. Although, owing to lack of resources, 
certain registers are confined to data collection and the pub-
lication of basic statistics on the population in their geo-
graphical area, others provide the basis for a vast range of 
activities, such as health promotion studies, the assessment 
of various types of treatment or epidemiological research. 
There are currently 84 cancer registers in the 
European Union countries, covering 43% of 
the total population, each linked to a specific 
geographical area. There are also several 'spe-
cialized' registers which, while still linked to a 
given population, collect information solely 
on specific cancers or on population sub-
groups. Cancer registers on children are the 
most relevant examples. 
There is total coverage of the population in 
Denmark, Finland, the Netherlands, Sweden 
and the United Kingdom. National registers 
are now being set up in Austria, Belgium, 
Greece, Ireland, Luxembourg and Portugal. 
Elsewhere, registers are regional. 
The European network of cancer registers, set 
up under the EU's Europe against cancer pro-
gramme, has been in operation since 1990. It 
is a joint project run by the Association of 
Cancer Registers of the Scandinavian coun-
tries, the International Association of Cancer 
Registers, the International Cancer Research 
Centre and the Association of Cancer Regis-
ters of Latin-language countries. 
Its main activities are: 
1. defining and maintaining data collection 
standards — this work is carried out by: 
• working groups of experts on cancer 
registration 
• consultancies; 
2. training cancer register personnel (joint 
basic training in data collection and analy-
sis methods); 
45 3. maintaining local and central databases 
on the incidence of cancer and cancer 
mortality within the European Union 
which involves: 
• validating and standardizing local data 
• providing the Eurocim database and 
analysis package 
• monitoring trends in different areas 
overtime; 
4. disseminating information through publi-
cations: 
• Facts and figures of cancer in the Euro-
pean Union 
• Cancer in the European Union 
• information sheets on specific cancers. 
46 Training activities within the Europe against cancer 
programme 
S
ince the start of the Europe against cancer pro-
gramme in 1987, the training of health personnel has 
always been a high-priority objective and one of the 
main fields for specific actions. Under the first action plan, 
which covered the period 1987 to 1989, measures aimed at 
health professionals were focused on the need to improve 
their knowledge in the area of oncology. 
During the second action plan, covering the 
period 1990 to 1994, the same objective was 
confirmed by the Commission Recommenda-
tion of 8 November 1989' concerning the 
training of health personnel in the matter of 
cancer. 
In its Recommendation, the Commission en-
couraged the training of health professionals 
in cancer, following the conclusions of the 
Advisory Committees on Medical Training, 
Training in Nursing and Training of Dental 
Practitioners. 
In particular, the Commission recognized the 
vital role of the different professionals both in 
the prevention and in the early diagnosis of 
cancer, and encouraged undergraduate and 
postgraduate training on screening methods, 
counselling, appropriate methods of treat-
ment, rehabilitation and terminal care. 
Within this general strategy, many initiatives 
have taken place in the course of the first two 
action plans which have had a positive impact 
on the quality of training at national, regional 
and local levels and have thus helped to 
reduce the substantial gaps which exist 
between Member States in their different 
training programmes for doctors, nurses and 
dentists. 
However, the efforts made and the benefits 
already obtained have to be continued to en-
sure that health personnel involved in cancer 
prevention and treatment acquire the neces-
sary knowledge and skills to enable them to 
intervene promptly and decisively. 
OJL 346, 27.11.1989. 
47 Since the start of the Europe 
against cancer programme in 
1987, the training of health 
personnel has been a high 
priority objective. 
For this reason, in its third action plan against 
cancer, for the period 1996 to 2000, the 
Commission has decided to consolidate this 
approach. The Europe against cancer pro-
gramme will continue to encourage new in-
itiatives allowing training programmes for 
doctors, nurses and dentists to include the 
most significant recent advances in preven-
tion, diagnosis and treatment of cancer. Con-
tinuing and in-service training will be the key 
to this action. 
In practice, this will involve the development 
and implementation of networks, joint ac-
tions and information exchange systems. 
The training strategy of the programme will 
incorporate these elements and facilitate the 
mobility of health professionals between 
Member States for training purposes. These 
exchanges will take place in particular 
between centres of excellence offering high-
quality training opportunities where this is not 
covered by existing Community programmes. 
The main objectives can be summarized as 
follows: 
(i) to improve the knowledge and skills of 
health personnel (doctors, nurses, den-
tists) in the matter of cancer, in particular 
its prevention; 
(ii) to promote quality training, in particular 
through the establishment and support of 
training networks (basic training and con-
tinuing training) for health personnel in-
volved in the fight against cancer; 
(iii) to improve the quality of training of other 
categories of health personnel such as 
pharmacists and data managers; 
(iv) to ensure that training also covers the 
psycho-social aspects of cancer. 
48 As regards the group of oncologists directly 
involved in the management of the disease, 
the Europe against cancer programme, 
through the third cancer action plan, will sup-
port the holding of consensus conferences 
with the aim of drawing up and disseminat-
ing recommendations on good practice. 
49 50 Priority attached to drug prevention in the 
Treaty on European Union 
T
he Treaty on European Union reflects the trends 
which have emerged in recent years, both internation-
ally and in the Member States, in the approach to 
drugs and drug dependence. 
Strategies focusing on reducing the supply of 
drugs have been called into question because 
of a number of factors: 
(i) the uninterrupted supply of illegal drugs; 
(ii) the growing misappropriation and abuse 
of legal substances and products; 
(iii) the increased risk of contracting commu-
nicable diseases, such as AIDS and hepa-
titis, particularly through the sharing of 
syringes; 
(iv) the need to meet the health and social 
needs of drug addicts and to develop ap-
proaches which supplement the strict ap-
plication of the law. 
These factors have led to the development of 
integrated approaches to the problem of drug 
dependence, which stress the importance of 
reducing the demand for drugs and, in par-
ticular, preventing drug dependence. 
This trend is confirmed in the EU Treaty, which 
expressly identifies drug dependence as a pri-
ority for Community action in the sphere of 
public health (Article 129). 
On this basis, in June 1994, the Commission 
presented a proposal for a Community action 
programme for the prevention of drug depen-
dence to the Council and the European Par-
liament. This proposal forms part of the 
framework for Community action in the field 
of public health, presented by the Commis-
sion in its communication of November 1993. 
51 There is an increased 
risk of contracting 
communicable diseases, 
such as AIDS and hepatitis, 
particularly through 
the sharing of syringes. 
Organization of the Union's 
drug prevention initiatives 
The Treaties in force before the EU Treaty took 
effect provided for political and legislative 
measures at Community level to combat 
drugs, including measures aimed at reducing 
demand (mobilization of European coopera-
tion through support for coordinated in-
itiatives, European drug prevention weeks, 
etc.), those designed to reduce drug traffick-
ing (intra-Community surveillance and moni-
toring of international trade in drug precur-
sors, prevention of money laundering, a clas-
sification scheme for the dispensing of medic-
aments, establishment of Europol, etc.) and 
international measures. The European Moni-
toring Centre for Drugs and Drug Addiction 
has also been set up to disseminate informa-
tion throughout the Community, providing 
the Member States with a comprehensive pic-
ture of the problem. 
The Treaty on European Union has strength-
ened the Union's capacity to fight the drugs 
problem, both through Article 129 and by 
providing for cooperation in the fields of jus-
tice and home affairs (Article K. 4). 
To ensure that the measures taken by the 
Union to combat drugs are consistent, and to 
take advantage of all the possibilities offered 
by the Treaty to strengthen and broaden its ef-
forts, in June 1994, the Commission pre-
sented the European institutions with an in-
tegrated plan of action on the fight against 
drugs. The draft programme of Community 
action on the prevention of drug dependence 
within the framework of public health is the 
cornerstone of the Union's efforts to reduce 
the demand for drugs. 
52 A programme of Community action 
A
rticle 129 of the Treaty on European Union both 
empowers and requires the Community to take 
action. It formalizes a consensus on the need for 
Community measures to counter drug dependence as part of 
a public health programme. The basic principles of this con-
sensus can be summarized as follows: 
(i) the priority attached to prevention; 
(ii) acceptance of and respect for the cultural and social di-
versity of the Member States; 
(Hi) the need to take account of the many facets of the prob-
lem. 
It was on this basis that the Commission pre-
pared and forwarded to the Council, the 
European Parliament, the Economic and So-
cial Committee and the Committee of the Re-
gions a proposal for a first programme of 
Community action on the prevention of drug 
dependence.
1 The Commission's analysis,of 
Community action in this field is based to a 
large extent on experience gained since 1988, 
the first year in which, on the initiative of the 
European Parliament, a Community budget 
heading was devoted to combating drugs and 
drug dependence. It also derives from the 
agreements reached by the Council and the 
European Parliament since then and, finally, 
from the results of the many exchanges of ex-
perience at European level, carried out with 
Commission support, between players in-
volved in this field wanting to improve their 
routine practices. 
(i) Sociocultural, socio-psychological, legal, 
medical and economic factors all play a 
part in the complex problem of drug de-
pendence. The factors vary from one 
Member State to another and help to de-
termine national narcotics policy. None-
theless, there is general agreement on the 
primary importance of prevention as part 
of a global and integrated policy. 
We still need to define what is meant by 
the prevention of drug dependence. In 
1989, the Council identified where na-
tional approaches converged, stressing 
the need to focus prevention measures on 
the information and health education of 
European citizens, giving priority to spec-
ific groups, and the need to establish clear 
policies to resolve the problems created by 
drug abuse. The Council felt that these 
policies should, in addition to the ultimate 
goal — an end to drug-taking — define 
intermediate objectives, such as a reduc-
tion in the number of deaths, reduction in 
the risk of contamination by HIV and 
Communication COM(94) 223 final presented at the same 
time as the proposal for a decision. 
53 Sociocultural, socio-
psychological, legal, medical 
and economie factors all 
play a part in the complex 
problem of drug 
dependence. 
other infectious agents and a reduction in 
marginalization. 
(ii) All these elements are interpreted and im-
plemented in different ways in the nation-
al prevention policies. There is no single 
answer to the scourge of drug depen-
dence. Each Member State has developed 
its own policy, in some cases gradually, in 
others by sweeping reform. There is now 
a wide spectrum of strategies being fol-
lowed in the Community to address the 
plethora of problems that have been gen-
erated by drugs and drug dependence. 
This diversity is, in many respects, an as-
set to the Community, as it represents a 
vast laboratory in which to try out differ-
ent tactics and conduct various pro-
grammes on drugs and drug depen-
dence. The Community's role is to tap this 
enormous resource, identify the best 
practice and make it known for eventual 
adaptation and use. There is no question 
of harmonization here, as Article 129 
plainly states. The Community action 
should focus on the promotion and facil-
itation of exchanges of information and 
sharing of experience between Member 
States. The benefits are obvious. 
The more we know about the practices 
adopted and results obtained in each 
Member State, in the fields of particular 
interest for each of them — for example, 
risk reduction in the Netherlands and pri-
mary prevention in Sweden — the better 
able we will be to devise or improve drug 
and drug dependence strategies and the 
readier to seek transnational cooperation 
in these matters. This objective is stated 
quite categorically in the Commission's 
communication which was presented to-
gether with the proposal for a decision on 
the programme: the Community's role is 
54 to underpin the efforts of the Member 
States, assist in the formulation and imple-
mentation of objectives and strategies and 
contribute to the provision of health 
across the Community, setting as a target 
the best results already obtained in a given 
area anywhere in the Community. 
(¡ii) The problem of drug dependence cannot 
be tackled in isolation. Firstly, it is only one 
aspect of the efforts to combat drugs in 
general. The global action plan stresses 
the need to ensure a coherent drug pre-
vention policy which takes account of all 
aspects of the problem. For example, 
public health initiatives undertaken to 
prevent drug dependence need to be co-
ordinated with measures introduced in 
implementation of the law. There are 
clear interactions in areas such as alterna-
tives to imprisonment for drug-depen-
dent offenders, or health care for drug 
addicts in prison. The opening-up of pre-
vention to a wide range of people and 
sectors is a trend now visible in all the 
Member States. The importance attached 
to a multidisciplinary approach to preven-
tion and to the creation of a link with, for 
example, cultural, educational, sports, so-
cial and judicial policies and activities, is a 
trend which is common to all national 
programmes, and one to which particular 
attention was drawn in the assessment of 
the European drug prevention week in 
October 1994. 
55 The Community's priorities for the next five years 
(1996-2001) 
T
he priorities are still under discussion in the Euro-
pean Parliament and the Council, on the basis of the 
Commission's proposal and the opinions of the Econ-
omic and Social Committee and the Committee of the 
Regions. 
Certain objectives were approved at the Euro-
pean Council meetings in Cannes and Ma-
drid, in June and December 1995. Subject to 
the opinion of the Parliament after the second 
reading, the European Council recommends 
that the programme pursue two additional 
objectives: 
(i) 'to improve knowledge of the phenome-
non of drugs and drug dependence and 
its consequences and of means and 
methods of prevention of drug depen-
dence and the risks relating thereto, in 
particular by using the information sup-
plied by the EDMC and the possibilities 
offered by existing Community pro-
grammes and instruments'; 
(ii) 'to contribute to improving information, 
education and training aimed at prevent-
ing drug dependence and the associated 
risks, in particular for young people and 
particularly vulnerable groups'. 
The Commission aims to achieve the objec-
tives of the future programme by supporting 
the initiatives of bodies active in the preven-
tion of drug dependence. The development 
of forums for cooperation and the promotion 
of partnerships between different national 
players at Community level will provide the 
basis for a coherent European strategy which 
takes account of the local situation. 
At Community level, experience has shown 
that transnational networks guarantee the 
development of activities in the long term, 
create a better understanding of trends in 
drug dependence and help in the dissemina-
tion of best practices throughout Europe. The 
Commission attaches particular importance 
to the promotion of transnational partner-
ships in this field and to synergy between the 
different European networks. 
56 Review of Community activities since 1993 
O
f all the European initiatives, the European drug 
prevention weeks are undoubtedly the best known. 
In October 1994, a large-scale awareness-raising 
campaign reached around 100 million people, including 
10 million young people, through information and preven-
tion activities and exchanges between professionals, made 
possible by the development of local, regional, national or 
Community-level partnerships. The weeks are part of a long-
term Community programme and are a means of strengthen-
ing European cooperation and underpinning the measures of 
the individual Member States. 
Since 1993, and in the transitional period 
prior to the adoption of the Community pre-
vention programme, measures have been 
grouped into areas likely to benefit from 
Community support: information for the gen-
eral public and for certain target groups; ed-
ucation and training; reducing the risks; early 
detection; social and occupational rehabilita-
tion; data collection; development of research 
and dissemination of the findings. Efforts 
have also been made to ensure that projects 
have a trans-European dimension, with sup-
port for the establishment and extension of 
cross-border European or regional networks 
and their programmes of coordinated activ-
ities. This reflects the concern to avoid spread-
ing the budgetary resources available for 
Community action in this sector too thinly, 
while satisfying the criteria of subsidiarity and 
Community added value and ensuring an op-
timum cost-effectiveness ratio. 
Recent projects 
The Commission supported the action pro-
grammes of the European Foundation of 
Drugs Helpline Services, including the award 
of grants for professionals wanting to find 
out more about the methods of their col-
leagues in other Member States, the provision 
of training for newly-created services, trans-
national discussion of the performance of 
these services and the production of reference 
documents on helplines. 
Professionals working in the field of drugs in 
the Rhine, Meuse and Moselle area set up a 
network in 1986. In 1993 and 1994, with the 
support of the Commission, they organized 
two summer schools on the prevention of 
drug dependence among schoolchildren, 
both at school and outside, which gave 
around 100 teachers and social workers in 
these regions the opportunity to learn the ba-
sic theory and methods for developing and 
implementing coordinated measures to pre-
vent drug dependence, geared to their spe-
cific target group and based on the best prac-
57 tices already in use. It also promoted training 
courses on the prevention of drug depen-
dence for local representatives in the area. 
The Commission also supported the activities 
of the T3E Federation, set up in 1991 and in-
volving 62 institutions in Belgium, Greece, 
Spain, France, Ireland, Italy, the Netherlands, 
Portugal and the United Kingdom active in 
the field of reducing drug demand. Their aim 
is to encourage exchanges of views and prac-
tices between professionals in different insti-
tutions, allowing them to learn from each 
other. In 1994, with the Commission's sup-
Prison officers are likely to 
benefit particularly from 
additional training which 
would help them to adopt 
the right approach. 
58 port, 80 courses were given in 44 institutions 
in nine Member States, by social and health 
professionals. In addition, a summer school 
was held in Portugal, involving about 100 pro-
fessionals, on 'The prevention of drug depen-
dence and public health needs: the answer?'. 
There is a high prevalence of drug addiction 
among prisoners in the Member States, and 
prison officers are likely to benefit particularly 
from additional training which would help 
them to adopt the right approach to this spe-
cific population group. In the last few years, 
the Commission has also lent its support to a 
network of prison officers and external prison 
personnel in Belgium, Germany (Saarland), 
France (Lorraine), Luxembourg and the Neth-
erlands (Limburg). The aim of the project was 
to permit an exchange of information on 
practices adopted in prisons, through trainee-
ships, with a view to the transposai of prac-
tices where appropriate. 
To complement the measures carried out 
under the Europe against AIDS programme, 
the Commission supported a pilot project, set 
up through a transnational network involving 
six Member States of the European Union, to 
train professionals and drug addicts in the 
prevention of the health risks related to the 
use of drugs (particularly HIV infection). Infor-
mation material was produced on problems 
relating to the use of drugs, safer ways of us-
ing drugs and the care and treatment facilities 
in the different Member States. 
59 IV 
AIDS and other 
communicable diseases 
60 The European Community and the AIDS epidemic 
S
ince its emergence at the beginning of the 1980s, the 
threat posed by the AIDS (acquired immune defic-
iency syndrome) epidemic has put the European 
Community on its guard. The Council and the Health Minis-
ters, as well as the Ministers for Development and Research 
and the European Parliament, have repeatedly drawn atten-
tion to this serious public health problem. 
In response to their encouragement and to 
the expectations of European citizens, and in 
view of the urgent need to protect the health 
of Europeans and support the measures 
undertaken by non-Community countries, es-
pecially the developing countries, the Com-
mission has launched several programmes.in 
the fields of public health, research and devel-
opment aid. 
So far, the European Community has spent 
nearly ECU 300 million on these programmes, 
and this effort will continue. 
The current situation and 
the spread of the disease 
in the Community 
AIDS is monitored in the European Commu-
nity by the European Centre for the Epidemi-
ological Monitoring of AIDS, with the support 
of the European Commission and the World 
Health Organization. In each country, a single 
institution recognized by the national author-
ities reports quarterly to the European Centre 
on new AIDS cases. The Centre then pro-
cesses, classifies and harmonizes the data and 
their presentation. 
By 30 September 1996, a total of 175 892
1 
AIDS cases, including 2 802 children under 
the age of 13, had been reported in the 15 
Member States of the European Community. 
Three countries (France, Spain and Italy) alone 
reported 127 231 cases, 72% of all cases in 
the Community. 
Between January and September 1996, 
16 329 AIDS cases were reported in the 15 
Member States. 
In 1995, some 23 814 new cases had been 
diagnosed. 
These figures take into account late reporting of cases diag-
nosed in the previous year. 
61 The incidence of the disease (new cases re-
ported during a year) varies considerably from 
one country to the next. In 1995, the rate of 
incidence (number of cases reported per mil-
lion inhabitants) varied between 7.8 per mil-
lion in Finland and 176.2 per million in Spain. 
Number of cases reported 
per million inha 
in 
Belgium 
Denmark 
Germany 
Greece 
Spain 
France 
Ireland 
Italy 
Luxembourg 
Netherlands 
Austria 
Portugal 
Finland 
Sweden 
United Kingdom 
1995 
bitants 
23.2 
42.3 
20.4 
20.8 
176.2 
88.7 
14.9 
100.4 
36.9 
32.1 
25.4 
76.9 
7.8 
21.9 
29.6 
The breakdown by transmission group of 
cases of adults/adolescents (aged 13 or over) 
reported in 1995 shows that 43.2% of the 
cases are linked to the use of injectable drugs, 
28.3% to male homo/bisexual relations, and 
18.9% to heterosexual relations. The picture 
also varies considerably according to gender. 
Of the female cases, 47.3% are linked to the 
use of injectable drugs and 42.6% to hetero-
sexual relations. Of the male cases, 42.2% are 
linked to the use of injectable drugs, 35.3% 
to homo/bisexual relationsand 13.1 % to het-
erosexual relations. 
Although the total number of new cases re-
ported during a year now seems to be level-
ling off, the proportion of female and hetero-
sexual cases continues to grow. 
Europeans and HIV 
(human immunodeficiency 
virus)/AIDS 
In April 1995, the Eurobarometer
1 survey, car-
ried out at the request of the European Com-
mission, contained an important chapter on 
'Europeans and health', which, among other 
things, looked at Europeans' understanding 
of and attitudes towards the various aspects 
of infection by the HIV virus and AIDS. 
In general, Europeans are concerned about 
AIDS and want to have more information 
about it (79% of replies). Young people are 
even more concerned and more inclined to 
want information than adults. They are also 
less certain than the rest of the population 
about their future and their risk of being con-
taminated. 
On the whole, Europeans are fairly well in-
formed about the ways in which AIDS can be 
transmitted (90 to 96% accurate) and are in-
creasingly aware of the ways in which it can-
not be transmitted, although more informa-
tion on misconceptions of this nature, and es-
pecially on the question of blood, would be 
useful. Although there are differences 
between the Member States, they are mainly 
linked to the length of schooling. There is a 
clear need for information which is specifically 
geared to the less well or poorly educated. 
Young people are generally better informed 
than the older generation, particularly about 
the ways in which AIDS cannot be trans-
mitted. 
A large majority of Europeans (83%) agree on 
the classification of AIDS patients as 'patients 
in need of treatment'. However, an equally 
large proportion of people believe AIDS pa-
tients to be people who 'have taken risks in 
their sex life' (71 %), 'have had unsafe sexual 
relationships' (60%) or are 'a threat to society' 
(41 %). These figures need to be taken into 
consideration when selecting the measures 
to combat the exclusion of and discrimination 
against AIDS sufferers. 
Europeans and health, INRA-Europe, September 1995. 
62 In nearly all European countries, condoms are 
considered by most people to be the best 
method of protection (93%); abstinence is 
felt to be effective by two thirds of Europeans, 
particularly in northern Europe. Trends ob-
served in the 15 to 24 age group show an in-
crease in the population who feel that con-
doms and abstinence are effective. 
In comparison with a survey conducted in 
1990, more Europeans today say that they 
have changed their behaviour because of 
AIDS, in particular in sexual relations: stability 
of partners and precautions during sexual 
intercourse. It is among the younger popula-
tion (15 to 24 year olds) that the change in be-
haviour is most apparent. In 1995, three out 
of four said that they took precautions during 
sexual intercourse because of the risk of AIDS. 
In general, people want more European coop-
eration on measures to combat AIDS. On the 
question of how health policy should try to 
eliminate AIDS, Europeans attach practically 
the same priority to the financing of research 
to find a vaccine as to information campaigns. 
Community measures to 
combat AIDS 
Towards the end of the 1980s, the Commu-
nity developed a series of measures to tackle 
the AIDS problem on various fronts, both in 
Europe and in non-Community countries, in 
four areas in which the Community is compe-
tent: 
(i) Community action in the field of public e 
health
 s 
(ii) research 
(iii) medicines and pharmaceutical policy 
(iv) cooperation with developing countries. 
Some 93% of Europeans 
consider condoms to be the 
best method of protection. 
63 In 1991, as part of the Community action in 
the field of public health, the Council and 
Ministers for Health adopted the first 'Europe 
against AIDS' programme for the period 1991 
to 1993. This was extended to cover 1994 
and 1995 by joint decision of the Council and 
the European Parliament. Under this pro-
gramme, the Community contributed a total 
of ECU 40 million to prevention, information 
and support measures to combat the risk of 
infection by HIV and AIDS. 
The measures were designed to encourage 
cooperation and exchanges of knowledge 
and experience between the Member States, 
and to mobilize cooperation at Community 
level to prevent HIV/AIDS. The projects sup-
ported concerned the main areas of activity 
covered by the programme: 
(i) evaluation of knowledge, attitudes and 
behaviour of the population in general 
and the groups most at risk; information 
and awareness-raising campaigns on 
means of transmission and prevention, 
focusing in particular on the use of con-
doms in sexual relations which might 
present a risk (new partners, multiple 
partners, etc.); 
The Community's framework programme for 
research and technological development in-
cludes a specific programme on biomedicine 
and health (Biomed). The research carried out 
under Biomed I (1991-94), which was devot-
ed specifically to research into HIV/AIDS (mon-
itoring and prevention, viro-immunological 
research, clinical research, trials of medicines, 
research into the development of a vaccine), 
and which was supported and coordinated by 
the Community, has led to some progress in 
the fight against AIDS. 
Under the fourth framework programme for 
research and technological development for 
the period 1994 to 1998, Biomed II focuses 
on the integration of basic and clinical re-
search and covers various fields of activity re-
lating to the fight against AIDS, including: 
(i) viro-immunological research and research 
into the genetics, biology and structure of 
the HIV virus; 
(ii) research into the development of a safe, 
effective vaccine, and anti-viral drugs; 
(iii) clinical research centring on trials for the 
treatment of AIDS and associated oppor-
tunistic diseases. 
(ii) education of children and young people 
on sexuality and the prevention of HIV/ 
AIDS; 
(¡ii) prevention of the transmission of the vi-
rus to groups particularly at risk, or in par-
ticular situations: travel, tourism, border 
areas; prisons; use of injectable drugs, 
prostitution; homo/bisexual relationships; 
mother-child transmission; 
(iv) social and psychological care for persons 
who are HIV positive and for AIDS pa-
tients; measures to combat discrimination 
against persons who are seropositive; 
(v) data collection and epidemiological mon-
itoring of HIV/AIDS. 
The articles in the following sections outline 
some of these large-scale projects and the ex-
periences of European networks on particular 
aspects of the prevention of HIV/AIDS. 
In the pharmaceutical field, Community 
measures to combat AIDS focus on two main 
aspects: firstly, ensuring the safety of blood 
products. Directive 89/381/EEC covers indus-
trially manufactured blood products but does 
not apply to whole blood, plasma or blood 
cells of human origin. 
In December 1994, the Commission adopted 
a communication with a view to improving 
European self-sufficiency in blood products, 
and in 1995, the Commission began work to 
set up a blood monitoring network in the 
Community, which would ensure the system-
atic monitoring of the risks and dangers in-
volved in blood transfusion. 
Secondly, as regards medicines, harmoniza-
tion of the legislation on pharmaceutical pro-
ducts was completed in 1993. In particular, the 
Community set up a European Agency for the 
Evaluation of Medicinal Products, which en-
ables new medicines to be authorized centrally 
prior to marketing in all Member States. 
64 This means that promising new medicines, 
such as new products to treat AIDS, new vac-
cines, and so on, are available to patients 
more quickly and at the same time in all Mem-
ber States. The rapid availability of new med-
icines throughout the European Union is par-
ticularly valuable in view of recent develop-
ments, with hopes being raised by the devel-
opment in United States laboratories of new 
anti-viral products (combining three types of 
treatment) which seem to be making real 
progress in the fight against the spread of the 
disease. 
In the field of general development coopera-
tion, the Community supports the health sec-
tor in the developing African, Carribean and 
Pacific countries through the Lomé Conven-
tions. Launched in 1987, measures to combat 
the HIV/AIDS epidemic focused on support for 
regional and national prevention policies 
aimed, in particular, at the improvement of 
services combating sexually transmitted dis-
eases, the promotion of information and 
awareness-raising campaigns, with particular 
attention to the groups at highest risk, and 
the improvement of transfusion safety. 
Between 1987 and 1994, the EC contributed 
a total of ECU 87 million to measures aimed 
at combating HIV/AIDS in 85 developing 
countries in Africa, Asia and Latin America. 
New programmes for the 
year 2000 and beyond 
The Treaty on European Union gave the Com-
munity specific competence in the field of 
public health (Article 129). 
To help achieve the objectives set by the Treaty 
in this area, the Commission proposed a 
framework, comprising several action 
programmes in priority areas, including 
the prevention of AIDS and certain other 
communicable diseases.
1 
COM(93) 559 of 23 November 1993. 
Biomed II covers various 
fields of activity relating to 
the fight against AIDS, 
including research into the 
development of a safe, 
effective vaccine. 
65 This resulted in the adoption by the Euro- (i) 
pean Parliament and the Council, on 
16 February 1996, of a new programme for 
the prevention of AIDS. A total of ECU 49.6 
million has been allocated to this pro-
gramme, which will run until 31 December 
2000. 
The objectives of the programme will be to 
encourage cooperation between the Member 
States, to support their initiatives and to pro-
mote coordination of their policies and pro- (ii) 
grammes aimed at preventing AIDS and 
communicable diseases. To this end, the 
programme comprises four chapters covering 
the implementation of or support for actions 
in four main areas. 
Monitoring and control of communicable 
diseases: actions in this field will aim to 
improve understanding and the dissemi-
nation of information and data on 
HIV/AIDS and other communicable dis-
eases and to improve the coordination 
both of monitoring systems for these 
diseases and of the Community-wide 
responses, particularly in the event of 
an epidemic. 
Combating transmission: measures will 
aim to prevent the transmission of HIV 
and other sexually transmitted diseases 
(STD), particularly in environments at risk 
(travel, prisons, etc.) and through unsafe 
practices (use of injectable drugs, prosti-
Measures will be aimed at 
educating young people on 
HIV/AIDS and other sexually-
transmitted diseases. 
66 tution, unsafe sexual relations, etc.). The 
aim will be to promote the exchange of 
information and experience on the differ-
ent prevention methods and programmes 
(in particular, the use of condoms) and to 
identify and pinpoint best practices. In ad-
dition, cooperation to ensure maximum 
levels of vaccination against certain com-
municable diseases will be encouraged. 
(iii) Information, education and vocational 
training: measures will be aimed at 
awareness-raising and informing the pub-
lic, as well as educating children and 
young people on HIV/AIDS and other 
STD, with special emphasis on methods 
for assessing the effectiveness of preven-
tion measures and information pro-
grammes. The programme will also con-
tribute to improving the training of health 
professionals and persons responsible for 
psycho-social support for HIV positive 
people. 
(iv) Assistance for HIV/AIDS patients and the 
fight against discrimination: the pro-
gramme will help to provide appropriate 
support for HIV/AIDS patients, chiefly 
through support for and the exchange of 
experience between networks of associa-
tions involved in psycho-social care. The 
programme will also try to combat dis-
crimination in any form against people 
with HIV/AIDS and encourage the devel-
opment of a code of good practice for 
HIV testing. 
In all of the above fields, the Commission will 
give priority to flagship projects implemented 
by organizations or associations which have 
proved themselves in their particularfield. The 
projects selected for Community support 
must comprise a Community dimension or in-
volve cooperation between several Member 
States and have real added value in terms of 
achievement of the programme's objectives at 
Community level. Even more attention than 
before will be paid to the assessment of the 
projects and of the programme, as well as to 
the dissemination of results. 
67 The 'flying condom' a visual code for communication 
T
his was the Europe-wide name adopted for the AIDS 
summer campaigns organized and financed by the 
European Commission in 1994 and 1995; a symbol 
which transcended all language barriers and really got the 
AIDS message across to young people and tourists through-
out the European Union and the surrounding countries: 
AIDS KNOWS NO FRONTIERS, 
GET INFORMED, PROTECT YOURSELF 
The summer holidays very often give young 
people, and tourists in general, a greater 
sense of freedom and offer an escape from 
the daily constraints of a hard-working and 
sometimes stressful year. 
It was for this reason that the first inter-
national mass media AIDS campaign was 
launched during the summer of 1994 
throughout the European Union and in 15 
surrounding countries. 
Its purpose was to get across a universal pre-
vention message during the summer holidays 
using a European 'passport' against AIDS, in-
cluding a condom, a multilingual cartoon strip 
showing how to use it and the 'flying 
condom' logo, a symbol which broke through 
the linguistic and sociocultural barriers of all 
countries and was therefore universally ac-
ceptable. 
The campaign followed the principle of sub-
sidiarity by reinforcing national HIV preven-
tion measures and providing a common code 
for communication which could be adapted 
by the individual countries for the develop-
ment of new prevention tools and strategies. 
The European Commission's investment had a 
significant catalytic effect, since every ecu in-
vested from the Community budget gener-
ated three in the Member States. 
How was the campaign 
organized? 
The campaign was implemented through: 
(i) the International Association of Youth 
Hostels 
(ii) the International Association of Youth 
Cards 
(iii) Interrail 
(iv) the international media 
(v) national coordination. 
68 National coordination focused on govern-
ment bodies and non-governmental organ-
izations involved in combating HIV/AIDS, 
young people, the local mass media and travel 
agencies and tour operators. 
The international media advertised the event 
on television (MTV, MCM, Euronews and 
Eurosport), in the press (The European and 
Marie-Claire) and on the radio (BBC and 
France Inter). Pop star Elton John helped to 
make the campaign a success by producing 
two videos used in the 20 press conferences 
organized to launch the campaign. 
The results 
Increased exchange of information, experi-
ence and cooperation between Member 
States and the recognition of the 'Europe 
against AIDS' message by means of a com-
mon symbol are proof of what the European 
Commission has achieved in the field of pub-
lic health. 
Specific examples are: 
(i) the involvement of the main governmen-
tal and non-governmental organizations 
in the fight against AIDS in 25 countries; 
(ii) a potential television audience of 160 mil-
lion; 
(iii) hundreds of press articles and local and 
international radio programmes promot-
ing the use of the condom; 
(iv) 14 giant flying condoms, between 14 and 
20 metres in length, in the European 
skies; 
(v) six million 'Europe against AIDS' pass-
ports, including a condom and an expla-
nation of how to use it; 
(vi) hundreds of thousands of posters, post-
cards, tee-shirts and badges promoting 
the flying condom. 
The results demonstrate European coopera-
tion on an unprecedented level, aimed at re-
ducing the spread of AIDS among young 
people during the summer months. 
In the light of the results of the campaign, all 
the players agreed that, if the virus is to be 
beaten, there needs to be a commitment by 
all and that, by working together and combin-
ing our experiences, with a common intent, 
we can prevent it from spreading. The cam-
paign also shows that each one of us can help 
to slow the disease's progress by learning 
about it and informing others, by adopting 
and encouraging others to adopt the right be-
haviour to prevent it and by fostering solidar-
ity. 
The outcome of this battle depends on each 
one of us . . . 
69 Prevention of HIV/AIDS in prisons: establishment of a 
European network 
I
t is now widely recognized in Europe that the role of the 
prison is not simply one of punishment and isolation. The 
importance of the rehabilitation of prisoners has long 
been accepted and has been a priority in prisons for many 
years. 
However, less attention has been paid to the 
contribution which it is known the prison 
system could make to public health in the 
Member States by improving the health of 
prisoners and their families. Imprisonment 
can aggravate health problems relating to al-
cohol, drugs, cigarettes and sexually transmit-
ted diseases, as well as mental health prob-
lems, in spite of health care, counselling and 
social welfare. Prisons therefore provide an 
ideal environment for the spread of HIV infec-
tion. Furthermore, all forms of discrimination 
can easily be amplified in the specific condi-
tions of the prison environment. 
In 1988,
1 the Parliamentary Assembly of the 
Council of Europe adopted a Recommenda-
tion on the fight against AIDS in prisons, 
which highlighted the need for the preven-
tion of HIV and AIDS, training and informa-
tion for prison officers and prisoners, and 
medical, social and psychosocial care. Further 
measures included promotion of the condom, 
combating discrimination and tackling the 
specific problems of users of injectable drugs. 
In 1993, as part of the World Health 
Organization's global programme on AIDS 
(GPA), guidelines were issued on the preven-
tion of HIV/AIDS in prisons. In particular, rec-
ognition was given to the fact that prisoners 
have the same rights to health care and pre-
vention as the rest of the population. 
This was followed up in the programme of 
Community action in the field of public health 
'Europe against AIDS', under which a transna-
tional project aimed at setting up a European 
network for the prevention of HIV infection in 
prisons has just been financed. 
In view of the specific nature and problems of 
prisons, it was decided to work in close coop-
eration with the European network of servic-
es for drug-users in prisons, set up under the 
programme of Community action on the pre-
vention of drug dependence within the frame-
work for action in the field of public health. 
1 Recommendation 1080(1988). 
70 The aim is: 
(i) to collect and compare data on the pre-
vention of HIV/AIDS in prisons in the 
Member States involved; 
(ii) to bring all the European partners to-
gether to develop common tools for epi-
demiological monitoring, the observation 
of unsafe behaviour in prisons and the de-
velopment of common strategies for pri-
mary prevention in the European Union; 
(iii) to evaluate the urgency of and conditions 
for the definition of strategies to reduce 
the risk of contamination in European 
prisons; 
(iv) to formulate recommendations, both for 
persons who are infected and for those 
who are not, on the problem of HIV/AIDS 
in prisons and how to resolve it. 
The results expected 
Discussions between European partners in the 
medical, social and administrative sectors will 
enable the foundations to be laid for a com-
mon system for epidemiological monitoring 
and the observation of behaviour in prisons. 
The need for a European analysis of unsafe 
behaviour in prisons will be evaluated on the 
basis of a feasibility study. Above all, the re-
sults will enable a protocol, which could be | 
used in other European countries, to be | 
drawn up and the conditions for cooperation a 
between the administration and health sec- °-
tors in prisons to be defined. 
The results will allow practical recommenda-
tions to be put forward to achieve a definite 
policy on the reduction of the risk of HIV 
transmission in European prisons. 
The Europe against AIDS 
programme finances projects 
aimed at the prevention of 
HIV infection in prisons. 
71 Prevention networks in the field of prostitution 
T
he HIV epidemic which exploded in Europe in the 
1980s forced the European Union to respond in its 
approach to public health. The World Health Organ-
ization defines the health of an individual or group of indi-
viduals on the basis of biological, psychological and social 
characteristics, all of which are in a constant state of flux. 
Health is the capacity of the individual or group of individ-
uals to control the balance between these characteristics. 
Community health requires each individual to be respon-
sible for the protection of his own health and that of others. 
The Community needs to share a common, easily understood 
language if it is to get the prevention message across. 
It is against this background that, in 1993, as 
part of the Community's Europe against AIDS 
programme, the European Commission 
launched HIV/AIDS prevention projects aimed 
at helping prostitutes to act as their own 
health workers. The idea was to encourage 
them to be involved in the development of 
new strategies to combat HIV/AIDS. The 
methodology was based initially on an 'action 
research', to define the needs of this group 
and to identify and obtain the cooperation of 
women whose behaviour was in line with the 
'public health' approach — 'leaders' — and 
who could relay information. Thereafter, var-
ious groups were identified (women, transex-
uais, drug addicts, immigrants) and the extent 
to which action was possible in each of these 
groups was evaluated. 
The cornerstone of this work was the 'preven-
tion alliances' built up between the leaders 
and the health professionals. Communica-
tion, recognition and the feeling of belonging 
to a group with a message and a common 
goal led first to a national and then to a trans-
national movement. Two European preven-
tion networks (Europap and Tampep) were 
established, and mobile units working directly 
with prostitutes were set up. 
The aim was thus to bring to light the prob-
lems created by the marginalization of ah en-
tire social group, existing as a microcosm, 
with its own social strata and different cul-
tural, ethnic and linguistic characteristics, and 
which is constantly changing because of the 
number of migrants, particularly from Central 
and Eastern Europe. 
72 Through the international and national coor-
dination of these European networks, nine 
problem areas were identified; particular em-
phasis is placed on the problems of HIV/AIDS, 
sexually transmissible diseases and drug de-
pendence: 
(i) migrant prostitutes: because of the geo-
political changes of recent years, they are 
the target group for this population and 
specific attention is therefore needed to 
find out more about migratory flows, 
cultures, the influence of the new mafias, 
etc.; 
(ii) the link between injectable drug users 
and prostitutes, which is the chief cause 
of the spread of HIV/AIDS and/or STD 
among prostitutes: Ecstasy and crack are 
added components of the problem; 
(iii) the attitudes of prostitutes towards their 
clients is a difficult problem — the lead-
ers need to work directly with prostitutes 
to encourage more attention to preven-
tion; 
(iv) the judicial and legislative problems of 
prostitution are important aspects, par-
ticularly as regards access to health and 
social services; 
(v) the media/prostitution partnership needs 
to be explored in all forms, in particular 
the Internet network; 
(vi) the collection of epidemiological data is 
an essential first step in tailoring 
HIV/AIDS prevention strategies to prosti-
tutes: the Centre for the Epidemiological 
Monitoring of AIDS in Paris plays a very 
important role here; 
(vii) training, health promotion and other 
health activities must be introduced with 
the participation of prostitutes — sharing 
of responsibilities between prostitutes 
and health professionals would help to 
ensure that the right services are devel-
oped; 
The collection of 
epidemiological data is an 
essential first step in tailoring 
HIV/AIDS prevention 
strategies. 
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European Union for several years have 
been found to be effective in preventing 
HIV/AIDS, because they reach marginal-
ized groups and work in close proximity 
with prostitutes — analysis of the 
STD/HIV/AIDS/drugs-related problems is 
extremely useful and an essential aid for 
prevention; 
(ix) the collection of health education mate-
rial and its accessibility and dissemination 
to prostitutes seem to be making an im-
pact and should therefore be supported. 
The results 
For more than three years now, the Commu-
nity action programme in the field of public 
health 'Europe against AIDS' has sought to re-
duce the risk of contamination by HIV and 
STD through prostitution, by supporting, de-
veloping and extending prevention measures 
aimed at prostitutes. The national and inter-
national coordination of European prevention 
networks has permitted Europe-wide preven-
tion measures in a complex and often hidden 
world. The results are already extremely posi-
tive in terms of prevention, exchange of expe-
rience and information, and the Community 
added value of projects is widely accepted. 
Nonetheless, the events of the last decade 
have led to frequent and often unanticipated 
changes in the prostitute world, and it is 
therefore essential to reinforce prevention 
measures to combat HIV/AIDS/STD and drugs. 
74 Combating discrimination 
iscrimination against people with HIV and AIDS and 
\ those close to them is morally objectionable and 
undermines public health measures. 
In the face of the prejudice and stigma attached to HIV in-
fection, HIV-infected individuals are more likely to conceal 
their seropositivity — or even be deterred from discovering 
their sero-status — and less likely to maintain contact with 
health and social services which could assist them. 
HIV/AIDS must be fought simultaneously on 
two fronts, one against the virus and one 
against psychological distancing and social 
backlash. 
Discrimination may occur particularly in the 
areas of employment, credit, housing, insu-
rance, education or health care. 
In order to increase people's understanding of 
AIDS and HIV and its effects, and to reduce 
the fears and prejudices which can provoke 
discrimination, the European Commission 
supports actions aimed at ensuring that per-
sons living with HIV/AIDS receive assistance in 
line with their needs and are not discrimi-
nated against in any way. To this end, projects 
aimed at the exchange of experience and in-
formation on assistance and support for peo-
ple found to be seropositive, AIDS sufferers 
and persons living with them are now being 
funded; studies and actions on the psychoso-
cial aspects of HIV/AIDS are also encouraged, 
and networks of associations providing infor-
mation and psychosocial support are pro-
moted. 
A further step in Community action in this 
field is the exchange of information and ex-
perience on HIV-testing policies and practices 
which will lead to the drawing-up of a code 
of good practice. The code will be developed 
through a collaborative process and make a 
major contribution to increasing public 
awareness and understanding in this impor-
tant area. 
Since few other areas of public health have to 
contend with the guilt, shame, fear and rejec-
tion which a diagnosis of HIV infection can 
elicit, all issues relating to HIV-testing should 
bear a heavy responsibility to promote non-
stigmatizing and non-discriminatory ap-
proaches. 
75 The objective of ensuring 
that persons suffering from 
HIV/AIDS receive adequate 
assistance and are not dis-
criminated against in any 
way is a strong commitment 
for the European Com-
mission. 
In fact, the above code could remedy or fore-
stall the possible emergence of isolated na-
tional solutions which may lead to confusion, 
inconsistencies, inequalities and hence con-
tinued discrimination amongst different pop-
ulation groups across Europe. 
Discrimination against people with HIV/AIDS 
and various groups of society has already 
been identified as a major 'risk factor' for HIV 
transmission. It has also become clear that dis-
crimination can facilitate HIV transmission in 
many ways, since it can lead to poorer access 
to information and services for prevention 
and treatment, and it can reduce the 
individual's ability to benefit from national 
AIDS programmes because those discrimi-
nated against were excluded from the plan-
ning and implementation processes. 
Moreover, it can subject individuals and 
groups to coercive and punitive measures 
which may encourage individuals to go 
'underground' where they cannot be 
reached, supported and cared for. 
It is clear that the actions undertaken to com-
bat discrimination may also be useful in that 
they could be used to support existing meas-
ures in Member States and to provide guide-
lines on how to avoid inappropriate media 
coverage of the problems of the target 
groups. 
This inappropriate media coverage could en-
courage complacency in those who do not 
identify with such target populations, as well 
as reinforce stereotypes and misplaced con-
cepts of a homogeneity of social groupings. 
To identify barriers to anti-discriminatory 
measures in Member States and to check 
means and processes whereby such discrimi-
nation may be avoided or reduced in collabo-
ration across Member States is a first step in 
this direction. 
Human rights issues lie at the heart of a Euro-
pean approach to informing and increasing 
awareness of the general public and people 
who may be especially vulnerable to HIV/AIDS 
and discrimination, including immigrants, 
refugees, travellers, prostitutes, prisoners, 
homosexual men and young people. That is 
why the objective of ensuring that persons 
suffering from HIV/AIDS receive adequate as-
sistance and are not discriminated against in 
any way is a strong commitment for the Euro-
pean Commission. 
76 Psychosocial support to HIV/AIDS sufferers 
O
ne of the basic objectives of Community action in 
the field of public health is to promote the quality 
of life by improving general health, and to promote 
the general well-being of the population, particularly by 
minimizing the economic and social consequences of ill 
health. As regards the HIV/AIDS epidemic in particular, to 
contribute towards minimizing the adverse consequences of 
the epidemic for individuals and for society is of paramount 
importance. 
In response to these objectives and to the so-
cial and psychological needs of the rising 
numbers of people directly affected by HIV/ 
AIDS and their families, who face enormous 
difficulties, the European Commission esti-
mates that non-governmental bodies can play 
an increasing role in providing information, 
care and social and psychological assistance. 
To assist efforts to ensure that persons living 
with HIV/AIDS receive information and psy-
chosocial support, in 1993 the European 
Commission began funding the European 
self-care manual project for persons with HIV 
and AIDS. Its goal was to develop manuals 
which can be used to improve the quality of 
life of persons living with HIV and AIDS. That 
is why national culturally-specific self-care 
manuals for persons with HIV and AIDS have 
been developed in 10 Member States of the 
European Community, with strong and effec-
tive central coordination from the Foundation 
Augustus, Amsterdam, the Netherlands. 
The Commission intended to ensure the cul-
tural specificity of the self-care manuals to be 
developed in many European countries, and 
that proved possible in a cost-effective way by 
developing the manuals on the basis of the 
existing, tested Dutch self-care manual. 
A self-care manual is a book which provides 
comprehensive and practical information on 
self-care and home care, written in a lan-
guage which is accessible to persons with dif-
ferent levels of education. It aims to increase 
knowledge about HIV- and AIDS-related 
problems and supports self-care. During the 
development stage, the NGOs from different 
Member States made use of the translated 
texts of the abovementioned Dutch self-care 
manual. These texts served as a model and 
were tailored to the specific needs of the 
Member States participating. 
The project began in November 1993 and was 
completed in October 1995. The following 
Member States took part: Belgium (Flanders 
and Wallonia), Denmark, Germany, Greece, 
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United Kingdom. In Italy and the United King-
dom, where a regional self-care manual al-
ready existed, the project has resulted in initia-
tives to use this regional material on a larger 
scale. Because the need for a manual ap-
peared to be very urgent, Italy produced a 
provisional new edition of the old manual. 
The cornerstones of the project are: sharing 
experience and expertise, cooperation 
between Member States, the sharing of exist-
ing materials and central coordination of the 
project as a whole. These cornerstones have 
played an indispensable role in this project 
and made an undoubted contribution. All the 
participating organizations from Member 
States where no manual was available were 
able to produce a national culturally-specific 
self-care manual. 
Because of cultural differences between the 
Member States, the manuals differ in con-
tent, format and presentation, but all of them 
are of high quality and user-friendly. In each 
Member State, distribution of the manuals is 
based on a plan drawn up according to the 
specific national situation. 
It is worth mentioning once again that the 
manuals are culturally-specific. One model for 
all countries would not have done since the 
cultural, social and clinical circumstances vary 
considerably and the development of a self-
care manual is complicated, costly and time-
consuming: in this case it is clear that sharing 
experience and working together has en-
hanced the quality of the end-products, saved 
valuable time and money and, more impor-
tantly, helped to strengthen solidarity and so-
cial cohesion in the Community, lending sup-
port to HIV/AIDS sufferers. 
Finally, this project also holds great potential 
for similar projects in countries outside the 
European Community, and for international 
self-care manual projects for other diseases. It 
would be very worthwhile indeed if, through 
similar, cost-effective programmes, persons 
with AIDS and other diseases could benefit 
from existing materials and experiences. 
The Austrian, Finnish and Swedish versions of 
the manual will be prepared in the near 
future. 
This project went very well: the development 
of national self-care manuals based on an ex-
isting, translated manual proved to be very 
feasible, and was much quicker and cheaper 
than having to produce a manual from 
scratch. Furthermore, the use of the central 
coordination's expertise, through consultancy 
and the mutual contacts of the different par-
ticipants during the central meetings, im-
proved the efficiency and quality of the end 
products. 
Evaluation of this project proved that the 
highly complicated tasks necessary for devel-
oping a self-care manual could be performed 
successfully by highly motivated organizations 
in the different Member States, cooperation 
and consultancy between them and a strong 
central coordination. Pan-European working 
not only proved to be possible, but also 
turned out to be highly effective. 
78 Health promotion 
79 Health promotion: central to the Community's 
objectives and policies 
I
n its broadest sense, health promotion, in other words the 
promotion of the right socioeconomic and environmental 
conditions to allow individuals and communities to opt 
for a healthy way of life, is one of the founding principles of 
the European Community. Indeed, it should always be borne 
in mind that the ideal of its founders was to ensure for the 
people of Europe a climate of peace, stability and exchange. 
Article 2 of the Treaty of Rome (the EEC Treaty) 
assigned the Community the task of promot-
ing throughout the Community a harmonious 
development of economic activities, a contin-
uous and balanced expansion, an increase in 
stability and accelerated standard of living and 
closer relations between the States belonging 
to it. 
The Community then gradually developed a 
series of sectoral policies, some of which have 
a considerable impact on health or are prepar-
atory measures. 
(i) Agricultural policy made it possible to 
guarantee Europeans a regular supply of good 
quality foodstuffs at socially acceptable mar-
ket prices. 
(ii) Economic and social cohesion policy, 
which currently absorbs more than a quarter 
of Community appropriations, aims to reduce 
the disparities in the economic and social 
development of the different Community 
regions. It is supported by the European 
Regional Development Fund (ERDF), the Euro-
pean Social Fund (ESF) and also to some ex-
tent by the European Agricultural Guidance 
and Guarantee Fund (EAGGF). 
(iii) Community policy on the protection of the 
environment and the quality of life has, as one 
of its specific objectives, the health protection 
of individuals. The 'Community programme 
of policy and action in relation to the environ-
ment and sustainable development' contains 
various proposals aimed at improving water, 
air and soil quality, controlling dangerous sub-
stances and industrial activities, monitoring 
radiation and controlling pollution and waste 
disposal. 
80 Protection and prevention 
measures and policies 
In addition to the policies concerning the so-
cioeconomic and environmental conditions 
necessary to ensure individual and collective 
health, the Community has introduced a se-
ries of health protection measures and poli-
cies. 
The adoption of the Single European Act in 
1986 was a considerable boost to the 
Community's efforts to improve the health 
and safety of workers and reduce the risks re-
lating to exposure to carcinogens and other 
dangerous substances as well as the risk of in-
dustrial accidents. 
In the field of consumer protection, a number 
of directives were adopted to improve the 
general safety of manufactured goods on the 
market and various aspects of the safety of 
foodstuffs, such as labelling, materials in con-
tact with foodstuffs, additives. 
As regards health care, the coordination of so-
cial security systems now means that under 
certain conditions insured persons can have 
access to it in other Community countries. 
Recognition of the right to benefit from hu-
man health protection systems, irrespective of 
personal resources, was established in a 
Council Recommendation on the conver-
gence of social protection objectives and pol-
icies. 
The framework research and technological 
development programme contains a specific 
programme on biomedical research, which in-
cludes public health research. 
As regards medicinal products, the Commu-
nity has adopted a series of directives on the 
approximation of the Member States' regula-
tions on test protocols, manufacturing, mar-
keting licences, the transparency of measures 
governing price fixing, classification, labelling 
and advertising. 
One of the main objectives 
laid down in the Resolution 
on future action in the field 
of public health is 'to pro-
mote a healthy lifestyle and 
healthy physical and social 
environments'. From the mid-1980s, the Community began 
to introduce public health measures which 
went further than health monitoring and pro-
tection against the risks present in the envi-
ronment and at the workplace, but which 
were aimed at encouraging and coordinating 
measures to combat diseases and promote 
health in a positive way. 
(i) The Europe against cancer programme, in 
1987, was the first major programme aimed 
at preventing disease; it was followed in 1991 
by the Europe against AIDS programme and 
the European plan to combat drug depen-
dence. 
(ii) In response to the Resolutions of the 
Council of Ministers for Health and for Edu-
cation and the European Parliament, the 
Commission supported various initiatives on 
health education in schools, in particular the 
European network of health-promoting 
schools, in cooperation with the World Health 
Organization and the Council of Europe. 
In future, Community measures in the field of 
public health will focus on two types of com-
plementary measures: 
(i) programmes to combat specific diseases 
or 'scourges': these programmes, some of 
which will be a continuation of current meas-
ures, will cover cancer, AIDS and communi-
cable diseases, drug dependence, accidents 
and suicides, rare diseases and diseases rela-
ted to pollution; 
(ii) in addition, the Community will introduce 
two horizontal programmes on: 
• data, health indicators and the monitoring 
of diseases; 
• health promotion, including health infor-
mation, education and training. 
This new health promotion programme was 
adopted by the Parliament and the Council of 
Ministers for Health on 16 February 1996. 
The Treaty of Maastricht 
With the entry into force on 1 November 
1993 of the Treaty on European Union, the 
Community is given explicit competence in 
the field of public health. Article 129 of the 
Treaty specifies the scope of Community ac-
tion in this field. 
The Council of Ministers for Health, meeting 
on 27 May 1993, adopted a Resolution on fu-
ture action in the field of public health. One 
of the main objectives laid down by the Min-
isters for Health was 'to promote a healthy 
lifestyle and healthy physical and social envi-
ronments'. 
In response to the objectives set by the Treaty 
and the Council of Ministers in the field of 
public health, the Commission, in its commu-
nication of 24 November 1993, identified pri-
ority areas which could be the subject of mul-
tiannual action programmes, and proposed a 
strategy. 
The approach proposed 
by the Commission 
When drawing up its proposal for a health 
promotion programme, the Commission 
adopted a number of principles and concepts. 
The health of an individual or group is deter-
mined by three groups of factors: 
(i) environmental factors and socioeconomic 
conditions; 
(ii) genetic factors, expressed as anatomical 
and physiological characteristics; 
(iii) behavioural factors for which the individ-
ual is responsible (diet, alcohol, smoking, 
physical exercise, drugs, etc.), influenced by 
society, culture, education, training and infor-
mation. 
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health education measures 
geared to young people in 
areas such as leisure and 
sports activities. 
Within the Community, where the overall 
level of health is among the highest in the 
world, there are huge variations in life expec-
tancy, morbidity and mortality in different 
population groups, depending on their socio-
economic situation. 
Improvements in the overall level of health in 
Europe have to take into account the unfa-
vourable conditions of certain groups (such as 
the socially excluded, the poor, the elderly 
and immigrants) and certain communities 
(slum areas, suburbs, rural areas, etc.) be-
cause they are more exposed or more sensi-
tive to certain risk factors, because their socio-
economic conditions are unfavourable or be-
cause their behaviour and way of life make 
them more vulnerable. 
The Commission also adopted the principle 
that health promotion should focus on health 
rather than illness. The promotion of health is 
not concerned directly with treatment or 
medical care; rather, by investing in health, it 
could help to reduce health expenditure and 
guarantee a high level of health for all. Great 
importance should be attached to the need to 
assess health promotion measures and pro-
grammes. 
On the basis of these principles, the Commis-
sion believes that the main objective of the 
Community programme to promote health 
should be the development and encourage-
ment of a 'health promotion' approach in the 
Member States' and Community's health pol-
icies. 
There are five areas for action. 
Health information 
The first requirement for the adoption of a 
healthy lifestyle and behaviour is information 
on the dangers and benefits of a given factor 
or behavioural choice. Health information is 
an essential constant in health promotion. 
The Community will help to improve under-
standing of the mechanisms for devising mes-
sages and assessing health information meas-
ures, by encouraging exchanges of informa-
tion, skills and experience. In addition, the 
Community has an important role to play on 
a general level in promoting the exchange of 
information and documentation between ref-
erence centres at national level and between 
those responsible for public health and health 
promotion policies. 
83 Health education 
Health education is the cornerstone of health 
promotion policy. It is through education that 
the individual can move from simple aware-
ness of a risk to a realization of what the risk 
means in terms of health and, ultimately, to 
the adoption of a responsible and positive be-
haviour and lifestyle. 
The Community will support the efforts of 
the Member States to set up and implement 
health education programmes in schools and 
training programmes for teachers. It will en-
courage exchanges of experience and teach-
ing materials and the implementation and 
evaluation of pilot education projects. 
The Community will also support health edu-
cation measures at the workplace and meas-
ures geared to adolescents and young people 
in areas such as leisure and sports activities. 
Vocational training in public health 
and health promotion 
In this area, the Community will try to devel-
op and adapt training of the various types of 
players involved. Measures will concern 
understanding of what is available in public 
health and health promotion training at Com-
munity level, and will involve coordination 
between the Member States on the content 
of training. 
Specific prevention and health 
promotion measures 
These are aimed at particularly vulnerable or 
deprived groups (the poor, the socially exclu-
ded, communities of immigrants, the elderly, 
adolescents, etc.). 
Health promotion structures and 
strategies 
There is at present a fairly wide discrepancy 
between the Member States in the level of de-
velopment and implementation of an overall 
health promotion strategy. The structures and 
resources used also differ considerably. By en-
couraging exchanges of experience and eval-
uation of the results of these policies, the 
Community can help to develop joint strate-
gies. 
84 The European network of health-promoting schools 
(EIUHPS) 
T
he European network of health-promoting schools is a 
concrete example of a health promotion activity that 
has successfully incorporated the energies of three 
major European agencies in the joint pursuit of their goals 
in school health promotion. Since 1991, the project has been 
a tripartite activity, launched by the European Commission 
(EC), the Council of Europe and the World Health Organiza-
tion Regional Office for Europe (WHO/EURO). 
Introduction 
The joint planning and management of the 
ENHPS was one of the recommendations of 
the EC, the Council and WHO/EURO Confer-
ence on Health Education (Strasbourg, 20 to 
22 September 1990). It builds on the collab-
orative work done in the 1980s under the pi-
lot project 'Education for health'. This joint 
venture is in line with WHO'S current priorities 
for health promotion and it is also in the spirit 
of the EC Council Resolution of 23 November 
1988 on the implementation of health educa-
tion in schools and the European Conference 
on Health Education and Prevention in 
schools organized by the EC and held in Dub-
lin from 7 to 11 February 1990. On several oc-
casions European Member States praised this 
collaboration between the EC, the Council 
and WHO/EURO in setting up this network. 
Such pragmatic collaboration is essential to 
avoid duplication and provide a framework 
within which to foster and sustain innova-
tion, disseminate models of good practice 
and make opportunities for health promotion 
in schools more equitably available through-
out Europe. 
This innovative project has generated great 
motivation within Europe. This is demon-
strated by the rapid nature of its develop-
ment, from a small pilot activity involving four 
countries in 1991, to the project we see today, 
in which 37 countries participate, including all 
15 Member States of the European Union and 
22 other countries beyond the EU. 
Countries committed to this pan-European 
initiative are addressing their energies in 
school health promotion towards the ultimate 
goal of creating in schools environments 
which are conducive to health. These are be-
ing pursued through the development, as 
part of the curriculum, of health and safety, 
85 teaching and learning styles, and so on. The 
project will make schools better equipped to 
improve results. No doubt these are very am-
bitious goals, but the challenge facing a fast-
changing Europe demands the type of 
change, innovation and the climate of care 
and support in schools which are embodied 
within the ENHPS. 
What is a health-promoting 
school? 
The health-promoting school aims at achiev-
ing healthy lifestyles for the total school pop-
ulation by developing supportive environ-
ments conducive to the promotion of health. 
It offers opportunities for, and requires com-
mitment to, the provision of a safe and 
health-enhancing social and physical environ-
ment. A health-promoting school will, 
through its management structures, its inter-
nal and external relationships, the teaching 
and learning styles it adopts and the methods 
it uses to establish synergy with its social en-
vironment, create the means for all who live 
and work within it to take control over and 
improve their physical and emotional health. 
The health-promoting school, as an invest-
ment, is one that European countries cannot 
afford to delay. 
The health-promoting school 
aims at fostering a healthy 
and happy school environ-
ment. 
86 Background 
The ENHPS is a timely project, given the chal-
lenges facing Europe in the 1990s. The aim of 
the project is to set up a network of demon-
stration site schools in countries to illustrate, 
through the development of good practice, 
the impact of health promotion in the school 
setting. Project schools will then be used 
throughout the health and education sectors 
to disseminate experiences and learning and 
influence policy and practice in school health 
promotion, nationally and internationally. 
Since collaboration between the EC, the 
Council and WHO/EURO first began, the pro-
ject has undergone rapid change. Beginning 
as a small pilot project, the network now in-
cludes over 500 schools with 400 000 stu-
dents, in 37 countries. A further 2 000 schools 
are linked to the network through national or 
regional arrangements. All EU Member States 
are now members of the ENHPS. The network 
provides a unique platform for cross-country 
exchanges, partnerships and commitments. 
The network is seen by the health and educa-
tion sectors as a consolidating initiative. With 
partnership as both method and goal, the 
network provides a flexible framework in 
which project schools can determine their 
needs and work to meet them in their own 
ways. Participating pilot schools commit 
themselves to promoting health in schools by 
making them safe and health-enhancing so-
cial and physical environments in which to 
live, work and learn. 
Management 
The network is not run by the international or-
ganizations but is supported by them, morally 
and technically, as well as financially. It is run 
by the participating schools with the primary 
objective of improving and protecting the 
physical and emotional health and welfare of 
pupils, teachers, non-teaching staff and the 
wider community. 
The network aims to be as decentralized as 
possible. The three sponsoring bodies (EC, 
Council, WHO/EURO) supporting the network 
have formed an International Planning Com-
mittee (IPC) with representatives from each of 
the organizations and a technical secretariat 
(hosted by the WHO Regional Office for 
Europe) as the technical supporting body. The 
IPC provides focus and ensures links and op-
portunities for all the parties in the network. 
These management arrangements have 
created a low bureaucracy and high result cul-
ture within the project. 
Each country with pilot schools has a nation-
al coordinator. The group of national coordi-
nators meets at least once a year to discuss ex-
periences, needs and challenges. The techni-
cal secretariat provides back-up for the na-
tional coordinators by keeping track of ENHPS 
developments, giving technical guidance in 
countries, assisting in the organization of 
workshops, giving presentations at interna-
tional and regional meetings, and arranging 
the annual business meetings for all national 
coordinators. The business meeting examines 
the future needs of members of the network. 
The technical secretariat also produces teach-
ing and training aids and other material use-
ful for the practical implementation and eval-
uation of the project. 
Several case studies emerging from the net-
work have now shown that through the com-
mitment and eagerness of the projects, a con-
siderable variety of programmes have been 
initiated. These have included: active collabo-
ration between pupils, staff, parents and the 
community in the implementation of the 
health-promoting school concept; environ-
mental improvements which have affected 
the ethos of the school; school policy devel-
opment in specific areas and the creation of a 
supportive atmosphere for teaching and 
learning. 
87 European dimension 
Europe is made up of many cultures. An im-
portant part of the education process and the 
upbringing of young people includes the op-
portunity of developing a common under-
standing and recognition of this cultural diver-
sity. Taking this into consideration, the project 
has from the very beginning aimed at includ-
ing a European dimension where twinning 
projects at both national and local level are 
ways of sharing experiences and improving 
international understanding and mutual re-
spect. 
Several twinning programmes have started al-
ready, involving the sharing of information 
and the development of parallel health pro-
motion activities with the help of tools such 
as electronic communication and video re-
cording, as well as the exchange of teachers 
and students. These are monitored on a reg-
ular basis and results are published in the form 
of newsletters, technical articles, case studies, 
analyses, etc. 
The role of the 
European Commission 
network of health-promoting schools, in 
cooperation with WHO/EURO and the Coun-
cil of Europe. The Commission's role has been 
instrumental in providing the added value 
which is much needed by such organizations 
and large-scale projects like the ENHPS. 
Impact assessment 
and value added 
The ENHPS is now a complex, large and truly 
European project. It has been hailed in docu-
mentation from the Commission, WHO/EURO 
and the Council as an exemplary model of col-
laboration between these three major Euro-
pean bodies and is now beginning to gather 
real evidence of success. 
Examples are given below. 
(i) The project has, from the outset, focused 
very strongly on the development of collabo-
ration for all partners involved. At national 
level, the formal agreement on a joint com-
mitment to the project from the Ministries of 
Health and Education has opened the way for 
a more effective approach to health promo-
tion and education. 
By adopting the programme of Community 
action on health promotion, information, ed-
ucation and training within the framework for 
action in the field of public health, the Com-
mission has created the environment for 
health promotion programmes up to the year 
2000. The health-promoting schools pro-
gramme is part of this programme and is 
aimed at the preparation and dissemination 
of school health education programmes and 
teaching materials and modules geared to dif-
ferent ages and different Member States; 
consultation between Member States (semi-
nars, conferences, studies, programme as-
sessments, etc.) with a view to including 
health education in school curricula; demon-
stration projects and innovative experiments 
aimed at promoting healthy lifestyles and re-
sponsible behaviour and involving the various 
partners concerned (children and young peo-
ple, teachers and instructors, parents, the 
community, etc.); supporting the European 
(ii) Several countries are already at the point 
of forming a national curriculum on health 
education based on the experience gained in 
the first phase of the project. 
(iii)The mobilization of resources to provide 
technical support through specific tools and 
training has been increasingly successful. 
(iv) Exchanges and cooperation between 
countries and schools have strengthened the 
network and brought about increased quality 
in health-promoting school-based initiatives. 
(v) The project is reported to have an increas-
ing impact on democratization in schools as 
well as in pre- and in-service teacher training. 
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on a regular basis, including one for the Ger-
man-speaking countries (Germany, Austria, 
Switzerland), where experience and good 
practice are exchanged. 
(ix) In several countries, networks are now ex-
panding to include more schools and thus the 
original idea of the pilot phase moving into 
the phase of dissemination and country-wide 
development is increasingly being fulfilled. 
(vii) An evaluation support system, funded by 
the EC, has just been completed. Its purpose 
is to provide appropriate tools for the evalua-
tion of the various elements of this complex 
project. Through the process of building up an 
evaluation support system for the ENHPS, a 
wide range of school health promotion eval-
uation expertise from within Europe and sev-
eral models of good practice in evaluation are 
now available. 
(viii) Some countries are even reporting that 
the project has had an impact on policy devel-
opment at national level. 
The funding for project activities demon-
strates the advantages of accessing various 
sources of funding for particular aspects of 
the project. The Technical Secretariat receives 
funding from the Commission for the coordi-
nation of project activities in EU Member 
States. The Technical Secretariat is also fund-
ed by WHO/EURO. The Commission also gives 
EU Member States funding for national sup-
port. Other countries within the network re-
ceive funding from WHO/EURO. Additional 
sources of funding have come from the Coun-
cil of Europe through the Demosthenes pro-
gramme. This programme provides funding  An important part of the 
education of young people 
includes the opportunity of 
developing a common under-
standing and recognition of 
the cultural diversity in 
Europe. 
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Europe. In some cases, funding has also been 
secured from the private sector. This has en-
abled the project to move forward at various 
levels, by pinpointing particular issues which 
have been prioritized by countries and have 
then attracted funding, by seeking support 
for countries in critical states of transition and 
by providing maintenance support funding 
for the development of long-term plans and 
strategies. Many countries also support pro-
ject activities by setting aside money from 
both the national health and education bud-
gets. National coordinators and project na-
tional support centres are frequently support-
ed in this way. 
The future 
Countries participating in the ENHPS recog-
nize that there is still a need for change. Na-
tional coordinators, and their respective part-
ners at national and local levels, carry substan-
tial responsibility in strategic planning, coor-
dinating activities and introducing changes 
into schools. It is essential, therefore, that they 
continue to be highly trained in all aspects of 
project management and innovation. How-
ever, particular problems are faced by nation-
al coordinators, trainers and teachers in intro-
ducing new methodologies and practices into 
education and health systems. Many class-
room teachers are not used to introducing 
new teaching methods and feel unsure about 
using them. Many school administrators lack 
confidence in introducing change into school 
management structures. Trainers, although 
eager to learn new methods, require substan-
tial training themselves, by competent group 
work experts. It is within this challenging con-
text that the cooperation offered jointly by the 
EC, the Council and WHO/EURO is greatly ap-
preciated by European countries. 
Changes on the scale requested by a health-
promoting school need skilful management in 
their introduction and adoption, and support 
in their final establishment as legitimate ele-
ments in school life. In the education environ-
ment which prevails in many European coun-
tries, the introduction and management of 
change is an enormously complex process. 
The opportunity to reflect upon and plan ap-
proaches to complex problems over an ex-
tended period of time is rare. The leaders of 
ENHPS national projects are now facing the 
most critical period in the project's life. The is-
sues to be addressed are now: maintaining 
momentum, creating the sustainability so vi-
tal for the long-term future of health promo-
tion in schools, and generating impact on lo-
cal and national policies. At both internation-
al and national levels, the project requires 
careful attention to be paid to how the ENHPS 
can tackle the changes necessary within the 
education and health promotion services, in 
order to guarantee success. 
The notion of whole school approaches to 
health promotion requires schools to con-
sider, introduce, adopt and develop new ap-
proaches and methodologies in education. 
Based upon the very encouraging results of its 
first phase of development, the ENHPS is 
ready to consolidate and increase its impact 
on the whole school and its organization. This 
includes: 
D the school environment 
D teaching and learning methodologies 
D the curriculum 
Π management practices 
D democracy in the classroom 
Π relationships with the community 
D research and evaluation. 
Each of these components is now operation-
ally taken into consideration in the develop-
ment plan for the second phase of project ac-
tivities. 
Priority areas for action up 
until the year 2000 
The first phase of ENHPS development high-
lighted the tremendous scope and potential 
for health promotion in schools. Able to ad-
dress key issues at personal, social and physi-
cal levels, schools constitute an ¡deal setting 
for health education, and signal the way 
ahead for the health promotion strategies of 
the future. 
Consequently, the network's original aim en-
abled schools to become more supportive, 
caring and healthier environments, integrat-
ing health promotion into the curriculum, in-
troducing health-enhancing programmes and 
practices into the schools' daily routine, gain-
90 ing a greater awareness of working condi-
tions, and fostering better relations within the 
schools themselves and a better rapport 
between the schools and their local commu-
nities. 
While the first phase of development has 
proved that these aims are still valid for the fu-
ture, the ENHPS is now ready to build and ex-
pand on them, tackling some new and ambi-
tious goals, goals which will meet the grow-
ing needs of schools and coordinators, and re-
spond to the new developments and changes 
within the project over the next four years. 
(November 1995), a new development plan 
including a working document setting out the 
strategy, aims and priorities for future devel-
opment of the European network of health-
promoting schools was endorsed by the three 
sponsoring bodies. 'The health-promoting 
school — an investment in education, health 
and democracy' is the title of the first inter-
national conference of the European network 
of health-promoting schools which took 
place in Greece in May 1997. A wide range of 
people, including key decision-makers and 
opinion formers working in the health and 
education sectors were invited. 
Future development will take into account the 
transition into an established long-term proj-
ect, allow for different approaches to project 
implementation, and recognize the need for 
an accurate means of measuring progress. 
In the next phase the development of the 
project will continue to foster a fresh and 
democratic approach. It will not simpiy aim to 
prevent illness by influencing individual be-
haviour. Rather, it will seek to improve the 
whole quality of the school setting with 
health promotion as a device, ensuring that 
the environment of pupils, teachers and all 
those involved in everyday school life is safe 
and health-enhancing. This push towards 
more structural changes within the school set-
tings will greatly facilitate the adoption of 
healthy lifestyles for the school population. 
It will also seek to reduce inequalities in health 
and education, with the introduction of care-
fully targeted activities aimed at vulnerable 
groups and specific areas such as disadvan-
taged inner cities and rural districts. 
At an international planning committee 
meeting, hosted by the EC in Luxembourg 
Evaluation at international, national and local 
level is also a major issue at a time when sev-
eral countries of the network are ending the 
initial phase of the project. Tools for evalua-
tion have been developed and an evaluation 
report from the Technical Secretariat will be 
available in the middle of 1997. The report 
will cover a selection of countries who are 
members of the ENHPS and it will focus on 
illustrating the character of project implemen-
tation in different national contexts, investi-
gating the support to the project at interna-
tional, national and local level and drawing 
lessons for improved support and the man-
agement of change. Included in the report 
will be an audit methodology, which will al-
low for the continued monitoring of national 
projects. 
The development of dissemination strategies 
has already started and the Technical Secretar-
iat sees it as a major task to offer continuous 
support to the national projects in this area. 
Europe deserves a stronger and ever-expand-
ing network of health-promoting schools. It is 
an investment for our future and for our 
Europe. 
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T
he European Commission, having acquired compe-
tence to take action in the field of public health, sub-
mitted a proposal for a health promotion action pro-
gramme to the European Parliament and the Council. This 
was adopted on 16 February 1996 as a five-year programme 
with an overall budget of ECU 35 million. The tightness of 
the budget virtually rules out the possibility of financial sup-
port for national policies to promote health: only the launch-
ing of funding in priority areas can be considered. Projects 
which are to be subsidized, extended or set up with funds 
from the European Union must be of prime importance for 
the Community as a whole and the Member States, must 
extend beyond national interests and policies and must have 
a clear European dimension in the sense that they offer ad-
ded value vis-à-vis national health promotion policies. 
Article 129 of the EU Treaty does not specify 
that the institutions of the EU are to develop 
their own plan for health promotion — in ad-
dition to the health policies of the Member 
States — which embraces the various nation-
al plans, later replaces them and is then imple-
mented as standard practice in the Member 
States. We can assume rather that the Mem-
ber States have, in accordance with the prin-
ciple of subsidiarity, long been operating com-
prehensive health policies catering for their 
own needs. These national programmes 
should remain in force, as in the past, and 
should be promoted only to the extent of be-
ing made known to the European public as 
well as to the regional or national population. 
This is precisely the aim pursued by Article 129 
of the Treaty on European Union, which sets 
the Community the task of promoting coop-
eration between the Member States and co-
ordinating Member State policies in liaison 
with the Commission. This means that any 
projects intended to achieve the aims of Arti-
cle 129 of the EU Treaty must have a European 
dimension or offer benefits for Europe. 
The place of work as a 
setting for health promotion 
Health promotion is a process in the course of 
which working and living conditions are 
changed and people are taught how to play 
an active part in enhancing their health. The 
key questions are the following. What keeps 
people healthy? What aspects of the material 
and social working and living environment 
serve as resources? What experiences and 
learning processes enable and motivate 
people to make an effort to stay healthy? 
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imum increase in well-being with higher life 
expectancy, especially for groups of the pop-
ulation which hitherto have been disadvan-
taged in terms of health. Health promotion at 
work is intended to help healthier practices 
and behaviour at work to become easier and 
more rewarding for all concerned. Under a 
corporate policy geared to promoting health, 
employees, in-house health experts, manag-
ers and work councils should together design 
working conditions which are conducive to 
health and which enable and encourage the 
workforce to adopt healthy working practices 
and lifestyles (behaviour). 
Primary prevention of specific diseases or haz-
ards, secondary prevention for early detec-
tion and tertiary prevention for rehabilitation 
all make vital contributions to a comprehen-
sive approach to health promotion. However, 
the key elements of a pol icy for health at work 
are as follows. 
(i) A corporate culture and philosophy which 
accords the workforce's health the same pri-
ority as the enterprise's economic goals 
creates a good atmosphere for a comprehen-
sive policy to promote health within the enter-
prise. In particular, this involves guidelines for 
cooperative and participative methods of 
management and management practice 
which accords high priority to the well-being 
of workers. 
(ii) A health and safety policy which places 
the emphasis on prevention and is refined to 
produce forward-looking, health-conscious 
job design provides a good platform for over-
all health promotion at work. This means that 
the enterprise's technology and organization 
are designed to give its workforce maximum 
control over their own working conditions, 
scope for exercising their own options and 
opportunities for mutual support between 
colleagues in, for example, group projects. 
Health promotion can also include in-house 
agreements on hard- and software ergonom-
ics and mixed tasking for people working on 
visual display units (VDUs). 
(¡ii) Personnel deployment and development 
strategies enable the potential offered by 
these technical and organizational aspects of 
work to be exploited to the full. Ergonomie 
improvements and increased scope for action 
only enhance employees' sense of well-being 
if they are able, qualified and motivated to 
take advantage of them. Recruiting people 
who meet the enterprise's requirements and 
The enterprise's social policy 
in the wider sense also in-
cludes providing healthy 
food in a canteen where the 
atmosphere is conducive to 
chatting with colleagues and 
relaxing. 
93 providing them with initial and further train-
ing thus make an important contribution to 
health promotion at work. 
(iv)The enterprise's social policy in the wider 
sense can also be conducive to health, irre-
spective of whether the employer introduces 
the following measures in the spirit of a be-
nevolent patriarch or at the suggestion of and 
in consultation with the representatives of the 
workers: cooperation with the health insu-
rance scheme on all matters of health protec-
tion; expert advice for people suffering from 
psychosocial stress and addiction problems; 
information and courses on coping with stress 
for specific target groups; widening the range 
of sports available at or through work; an in-
house agreement to protect non-smokers; 
tasty, cheap and healthy food in a canteen 
where the atmosphere is conducive to chat-
ting with colleagues and relaxing. 
(v) Arrangements on working hours which 
make it easier for people to reconcile family 
and working demands in accordance with 
their own inclinations and commitments help 
to avoid stress and can also reduce the effects 
on health of men's and women's different so-
cial roles. Important issues here are humane 
planning of shifts and arrangements to rein-
troduce normal working hours for shift work-
ers and especially night workers. 
(vi) Particularly health-conscious private enter-
prises or public services do not confine health 
promotion to internal matters. Environment-
and health-conscious production methods, 
products and services are part of the compre-
hensive health policy of such enterprises 
which seek to enhance their image locally and 
amongst customers and consumers. 
In the sense of the WHO'S Ottawa Charter, 
health promotion therefore means change — 
sometimes radical — in the structures and 
processes within an enterprise and its rela-
tions with its environment and, of course, as-
sumes that experts, management and the 
whole workforce measure their decisions and 
their conduct against the yardstick of health 
promotion and make adjustments, if necess-
ary. 
Fields of action and means 
of communication 
Health promotion concentrates on the factors 
which determine the health of the population 
and which an individual can alter at his own 
discretion. These factors mainly comprise diet, 
alcohol, tobacco, drugs, physical and mental 
health, and medication and its use. 
In the enterprise these factors are an integral 
part of both practical action which the enter-
prises can initiate themselves and health pro-
motion packages which public health institu-
tions such as health insurance bodies can of-
fer them. 
Information, education and training have 
proved to be useful health promotion tools 
for imparting the necessary information on 
the risks of specific factors or types of beha-
viour and for increasing the awareness and 
motivation of individuals with a view to alter-
ing attitudes and behaviour. These are de-
ployed in different ways in promoting health 
at work. 
(vii) Finally, a health-conscious enterprise also 
takes an active part in municipal and region-
al health promotion, providing, for example, 
advice, practical help with premises or tools or 
sponsorship for municipal social and sports 
facilities. 
94 The place of health 
promotion at work in the 
action programme 
Measures for promoting health pursue the 
following general objectives: to improve the 
standard of health in the community by in-
forming people about the factors which jeop-
ardize or promote health and by encouraging 
lifestyles and behaviour which are conducive 
to health, and to contribute to improving the 
socioeconomic conditions and environmental 
conditions which are a prerequisite for the 
health of the individual and the community. 
According to the Commission, health promo-
tion and health education can be regarded as 
general areas of activity which cover many 
lifestyle-induced diseases and accidents in a 
variety of environments (such as work) and 
seek to mitigate high-risk behaviour, es-
pecially by supporting measures to devise ap-
proaches and activities incorporating infor-
mation, education and training — the three 
main instruments of health promotion. 
The action programme sees the place of work 
as a suitable environment for a health educa-
tion drive. This can take the form of informa-
tion on diet as part of in-house catering, on 
prevention of excessive drinking and smoking 
and on stress factors and stress avoidance. 
The following measures are intended to con-
tribute to achieving the action programme's 
aims: 
(i) general health education measures at 
work, especially regarding diet and preven-
tion of excessive drinking and smoking; 
(ii) measures targeting specific groups such as 
young people, older workers and women; 
(iii) preparation and dissemination of teaching 
material, dissemination of 'model practices' 
arising from experiments, etc. Such initiatives 
complement action in other EU programmes. 
The action programme provides for more 
general measures in the field of health educa-
tion: information methods and techniques, 
exchanges of experience, cost-effectiveness 
analysis, preparation and assessment of cam-
paigns, and cross-border networks. 
The action programme states (point 104) that 
health promotion has an intersectoral dimen-
sion, which means that legal instruments in 
other areas of policy which also affect health 
can contribute to the promotion and protec-
tion of health. Working conditions are also 
mentioned in this context. This opens up the 
possibility of linking measures for safety and 
health with those for promoting health at the 
place of work. 
Successful workplace health 
promotion: an overview 
Once the reasons for a health drive at work 
have been clarified, the next question is how 
health promotion can be launched and imple-
mented successfully. The main conditions for 
this are: 
• cooperation within and between enter-
prises 
• analysis of the initial situation (health re-
port) 
• setting priorities and goals 
• involving workers 
• health-related communication 
• identifying and overcoming obstacles 
• observation and analysis of measures 
taken. 
95 Providing initial and further 
training for personnel makes 
an important contribution to 
health promotion at work. 
The foundations and key characteristics of 
health promotion at work can be summarized 
as follows: 
(i) Health promotion is a process in the 
course of which healthy and health-inducing 
practices and types of behaviour are made 
more rewarding for everyone in the enterprise. 
(ii) Health promotion combines strategies for 
work-orientated and behavioural prevention, 
organization and personnel development, 
healthy job design and reinforcement of per-
sonal responsibility for health. 
(¡ii) Health promotion is intended to reduce 
and eliminate disadvantages for individual 
groups of workers permanently. 
(iv) Humanitarian company aims and a partic-
ipatory management style create a positive at-
mosphere for promoting health. 
(v) Clear-cut areas of responsibility and ar-
rangements for interdisciplinary cooperation 
make it easier to cooperate on health. 
(vi) Weak points and needs must be analysed 
before priorities can be set. 
(vii) The aims of health promotion are to be 
set out in terms which are geared to action, 
i.e. are practical, target specific groups and 
promote an overall concept of health. 
(viii)The aims of health promotion in an enter-
prise become more focused and are more 
readily accepted when workers are actively in-
volved in all phases. 
(ix) Health promotion can be put into practice 
quickly once clear budget rules and agree-
ment on its goals have been established. 
(x) Health promotion benefits from timely 
and comprehensive information to all those 
involved and from attractive public relations 
work. 
(xi) Constant monitoring and regular assess-
ment of the costs and benefits of health pro-
motion provide arguments in favour of a per-
manent in-house health policy and efficient 
customization of individual measures. 
96 The more sophisticated these arrangements 
are in an enterprise, the higher the quality of 
health promotion will be in practice and the 
closer it will get to being a health-promoting 
enterprise in the sense of the WHO'S Ottawa 
Charter. 
Quality and health 
promotion 
Quality is a concept which is difficult to pin 
down, as it can be interpreted differently and 
is ultimately defined in terms of its goals. The 
formal definition in accordance with DIN ISO 
8402 is: 'All the properties of a product or a 
service which relate to the ability to meet var-
ious explicit or tacit requirements'. A better 
definition (Haist and Fromm) is: 'Compliance 
with the customer's requirements with re-
spect to function, price, delivery period, 
safety, reliability, environmental friendliness, 
value, cost, guidance, etc.'. 
The DIN ISO 9000 series of standards, which 
has been in existence since 1989, examines 
the need for enterprises to introduce methods 
and processes to prevent errors (quality assu-
rance systems). Such systems are understood 
to comprise conformity specifications, inter-
nal testing systems and design, operation and 
process documentation, which is kept in the 
enterprise's quality management file. 
An important requirement of ISO 9000 is for 
evidence of a quality assurance system, dem-
onstrating an enterprise's ability to develop, 
produce and deliver a product or a service 
(health promotion measures). 
Key features of quality assurance in organiz-
ing health promotion programmes are listed 
below. 
1. A basic consensus between all the par-
ties concerned 
Health promotion can only be implemented if 
all the parties concerned can agree on its 
aims. Ideally, health promotion at work ex-
presses the parties' conviction that goods and 
services may not be produced at the expense 
of human health. 
2. Organizational development 
Health promotion is a horizontal task which 
can affect all areas and ought to be incorpor-
ated in organization development projects. It 
can thus become part of the quality assurance 
system for total quality management and an 
instrument in change management. 
3. Participation of workers 
Health promotion must involve the employees 
and/or all parties concerned. Premises, time 
and training must be made available in order 
to secure their cooperation in achieving com-
mon health aims. The representation of inter-
est bodies are also called upon to support 
them. 
4. Work-related measures 
Measures to promote health at work should 
relate to general and individual working con-
ditions and should meet the needs of the 
workers. One of their tasks is therefore to 
identify pathogenic and health-promoting as-
pects of work. 
5. Interdisciplinarity 
An interdisciplinary approach to promoting 
health at work should be adopted in order to 
meet the specific requirements of this area of 
activity. Psychologists, sports teachers and nu-
tritional scientists, etc. must cooperate in this 
field to extend the traditional scope of health 
and safety at work. 
6. Long-term prospects and institutional-
ization 
Health promotion should be institutionalized 
as a long-term systematic process comprising 
analysis, planning, implementation and as-
sessment phases. This can be achieved with 
the help of a working party on health for one 
or more enterprises or an extended safety and 
health committee. 
7. Customization 
Health promotion at work is to be tailored to 
each enterprise, reflecting circumstances and 
the specific culture of each one; there is no 
one best way. 
Specific quality assurance elements are to be 
developed for the individual fields of activity. 
Individual plans (for Adipositas in Germany) 
already exist. 
97 The working of the network 
The network is designed to be an information 
network, in which the Bundesanstalt für Ar-
beitsschutz acts as an intermediary between 
the Commission and the 15 Member States. 
The tasks of the European coordination office 
include distributing the resources for the na-
tional contact points, gathering and circulat-
ing information on all significant activities 
undertaken in this field in Europe, ensuring 
the transfer of information, compiling the an-
nual European status report on the basis of 
the national status reports, and, through pub-
lic relations and publications, encouraging 
multilateral cooperation and circulating im-
portant findings. To this extent, the coordina-
tion office has an organizational role. 
The national contact points will be expected 
to conduct a stocktaking of all important ac-
tivities in the field of health promotion at 
work, organize and exchange information 
and experience, organize an information day 
in their own country, find new network part-
ners, help project groups to set up, and or-
ganize transfers of information, chiefly via 
electronic media. 
All 15 Member States have expressed an 
interest in participating in the network and in 
setting up national contact points. 
As far as the national stocktaking of activities 
in the field of health promotion at work is 
concerned, the Bundesanstalt für Arbeits-
schutz will produce a catalogue of specifica-
tions to help Member States in producing 
their status reports. Using summaries, the na-
tional reports should describe clearly the 
backgrounds to workplace health promotion 
and the different structures in place. Each na-
tional status report will be made available to 
all Member States. 
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101 Executive summary 
This communication sets out the Commission's pro­
posals for taking forward the Community's work on 
public health to meet the objective introduced by the 
Treaty on European Union that 'the Community shall 
contribute towards ensuring a high level of human 
health protection' (Article 129). It defines a frame­
work for action by the Community, and describes the 
role of the Community institutions and the Member 
States. It sets out a strategy for action, identifies the 
means available to the Community to accomplish its 
aims and establishes the procedures for evaluation, 
review and consultation. Finally, key areas of action 
are selected for the next five years. 
The communication is divided into two parts. The 
first part sets out the background to public health 
policy, and the second describes the European Com­
munity approach. 
Part A 
Background to public health policy 
Chapter I of the document provides an overview of 
the main health-related problems and challenges fac­
ing Member States today. These problems relate to: 
(i) the ageing population of the Community; 
(ii) increasing population mobility in the Community 
and between Member States; 
mortality and morbidity data. The figures show that 
in recent decades there has been a substantial 
improvement in overall health status, with people liv­
ing longer, and that cancer and cardiovascular diseas­
es, and for young people accidents, are the major 
causes of death in the Community. Other conditions 
producing significant morbidity and mortality are list­
ed. Annex V presents more detailed statistical data. 
Chapter III sets out the basis for Community action 
on public health. It describes the application of the 
principles of subsidiarity, transparency and propor­
tionality to this area, emphasizing that questions of 
the finance and delivery of care and treatment ser­
vices are for each Member State to determine. 
The legal bases for Community activities in health are 
outlined (the policies, programmes and instruments 
giving effect to them are set out in Annexes II and 
III). The provisions and significance of Article 129 
are then set out in detail. The main elements of this 
Article are the focus on prevention of diseases, par­
ticularly the 'major scourges', including drug abuse; 
the stress that health requirements must be consid­
ered in developing other Community policies, and the 
obligation on the Commission to liaise with the Mem­
ber States in the coordination of their policies and 
programmes. 
The chapter finally outlines the work undertaken by 
the European Council, the Council, the European 
Parliament and the Economic and Social Committee 
in the development of Community public health 
policy. 
(iii) changes in the environment and in the work set­
ting; 
(iv) rising expectations about what health services can 
and should deliver; and 
(v) the general socio-economic problems of the 
Community, notably social exclusion. 
As a result of these problems Member States have 
been facing increasing pressures on the provision of 
health services and these are likely to grow in the 
future. 
The scope of public health policy is then set out and 
how it involves activities aimed at individuals' imme­
diate environment and the more general context in 
which they live. 
Annex I to the communication summarizes the Mem­
ber States' prevention and health promotion policies. 
Chapter II presents a description of the major trends 
in health status in Member States based on available 
Part Β 
The European Community approach 
Chapter IV first sets out the scope of possible Com­
munity action in public health and the objectives of 
such Community action. It then describes the means 
of undertaking Community action in this field, includ­
ing the establishment of common objectives and of 
networks, exchange of information and personnel, 
improvement of data systems, financial support to 
programmes and projects, production of an annual 
Community health report, and assistance to cost 
reduction efforts. 
Principles for identifying diseases or health threats 
for Community action are given. The selection 
involves consideration of both diseases' effects on the 
health status of the Community population and 
whether preventive action can appropriately be taken 
at Community level (Annex IV lists important health 
scourges and their impact). 
102 On this basis cancer, cardiovascular diseases, acci-
dents. AIDS and communicable diseases, drug depen-
dence and rare diseases are deemed to be appropriate 
targets for action. 
Chapter V on causation of diseases makes the point 
that for effective disease prevention, it is vital that 
their underlying causes are addressed by a mixture of 
measures. Important causal factors, such as smoking 
and alcohol, are set out together with data on their 
trends in the Community. 
Chapter VI on the nature and extent of Community 
involvement explains the broad mechanisms that the 
Commission will use in taking forward the objectives 
of policy. It will give priority to large-scale, wide 
impact projects and will keep a 'health watch' on 
other Community programmes and policies as they 
develop. 
The kinds of general mechanisms to be used are 
described in detail. 
(i) Consultation and participation. Appropriate 
mechanisms will be set up to give advice to the 
Commission on formulating and implementing 
activities. 
defined in the fourth research and development 
framework programme, to ensure that the 
research needs of public health are met. to 
establish a strategy for public health research 
and to ensure that the results are properly dis-
seminated. 
(vi) Training of health professionals. To increase the 
effectiveness of health professionals' role in 
public health, existing courses will be evaluated, 
collaboration on new ones promoted, and 
exchanges of experiences and information on 
teaching and training will be fostered. 
Chapter VII on future action in the field of public 
health sets out, on the basis of the arguments in the 
preceding chapters, the priority areas for Community 
action in public health. The areas proposed cover 
'horizontal' activities and diseases — specific ones. 
They are: 
(i) health promotion, education, information and 
training; 
(ii) health data and indicators, and monitoring and 
surveillance of diseases; 
(ii) Promotion of programme and policy coordina-
tion. Comparisons and evaluations of preven-
tion policies and cost-effectiveness analyses will 
be made and networks to monitor diseases set 
up. 
(iii) cancer; 
(iv) drugs; 
(iii) Cooperation with international organizations 
and third countries. Existing cooperation with 
relevant international bodies such as WHO will 
be increased e.g. by commissioning specific 
work from them, conducting joint programmes 
or supporting their programmes. With regard to 
third countries, existing assistance schemes will 
be stepped up and consideration will be given to 
undertaking further cooperation with particular 
countries notably in Central and Eastern 
Europe. 
(iv) Information, education and health promotion. A 
coordinated programme of health education 
and promotion measures will be developed aim-
ing both at causal factors and specific diseases. 
This will take forward the work already being 
carried out in certain areas e.g. AIDS and can-
cer. 
(v) Research. Steps will be taken to strengthen links 
with the Community research programmes, as 
(v) AIDS and other communicable diseases; 
(vi) accidents and injuries; 
(vii) pollution-related diseases; 
(viii) rare diseases; 
(ix) other health threats (if circumstances re-
quire). 
This communication is only a first step towards a con-
tinuing effort of developing policies, programmes and 
individual actions designed to give full effect to Arti-
cle 129. and to other articles in the Treaties of rele-
vance to health protection. It would be followed by a 
series of programmes on each of the identified topics 
above. The Commission hopes that it will stimulate 
debate, help concentrate attention on health preven-
tion and promotion, as has been the case in Member 
103 States concerning health care and treatment, and mon endeavour to bring about a high level of health 
build lasting partnerships and networks in the com- protection in the European Community. 
104 Part A 
Background to public health policy 
I — Introduction 
1. This communication sets out the Commission's pro-
posals for a framework for action in the field of public 
health in the light of the ratification of the Treaty on 
European Union, which introduced Articles 3(0) and 
129, with explicit provisions on public health, in the 
Treaty establishing the European Community. 
2. In essence the communication does four things. First 
it sets out the major issues in relation to health which 
confront the Community. Second, it explains how pri-
orities for Community action can be established. Third, 
it describes the kinds of actions that are possible and 
how they fit together with what has been done so far on 
public health by the Community and by Member States 
and also with other Community programmes. Finally a 
number of specific programmes of actions are pro-
posed. 
3. The proposed framework set out in this communica-
tion is intended to build upon the important contribu-
tions made by the Council, the European Parliament, 
and the Economic and Social Committee in this area, as 
well as the work of the Commission. It takes full 
account of all the principles for Community action laid 
down in the Treaty on European Union and in the 
other Treaties. 
(a) Current health challenges in the Member States of 
the European Community 
4. The wide cultural, social and economic diversity of 
the European Community means that the different 
Member States are confronted with a variety of health 
protection problems. But there are also several impor-
tant common issues which bear on health matters 
across the Community as a whole. Such issues include 
the following. 
(i) Ageing population. The proportion of people of 60 
or over in the Community is rising. From only 
17.5% in 1980 one scenario depicts that it will reach 
24% by 2010. This increase will mean that progres-
sively there will be both larger numbers of elderly 
people who are disproportionate users of health 
services, and the burden of paying for them will fall 
on a relatively smaller working population. Thus 
the need for medical care threatens to outstrip 
society's ability or willingness to provide it. In addi-
tion, whether countries spend a larger or smaller 
amount on medical care, studies show that the 
impact of treatment on the population's mortality 
rates is outweighed by the power of the factors 
affecting the incidence of diseases such as cancers 
and cardiovascular diseases, and that the decline in 
old-age mortality is accompanied by a rise in the 
untreatable disabilities now common among the 
old. Studies also suggest that recently the average 
number of years that people spend disabled has 
grown faster than the number of years they spend 
healthy. 
(ii) Increasing population mobility. Migration into the 
European Community, the coming into effect of 
the single market and the general increase of travel 
and tourism are producing an ever-larger inter-
mingling of populations. The health implications of 
this trend include the propensity for spreading 
communicable diseases more rapidly, the potential 
for increased drug abuse and the potential difficul-
ties of providing for the specific needs of migrant 
communities. 
(iii)Diseases arising from environmental changes and 
workplace environments. A number of health prob-
lems are being produced by changes in the environ-
ment resulting from economic and technological 
developments. The increased levels of respiratory 
illnesses and certain forms of cancer can. for exam-
ple, be linked to such changes. Moreover, the intro-
duction of new working methods and modern 
machinery and computers into the workplace envi-
ronment can also lead to physical and psychological 
health problems. Conditions related to stress and 
musculoskeletal problems are also increasing signif-
icantly. 
(iv)Rising expectations concerning health. The factors 
above which are leading to growing demands for 
health services are accompanied by people's con-
comitant rising expectations of what the health ser-
vices can provide. The continuing development of 
powerful technologies for diagnosis and treatment 
has fostered this expectation of more and better 
provision and the desire of everyone, and especially 
the disadvantaged groups and poorer regions, to 
have access to it. The economic costs of this are 
increased by the fact that many new procedures rely 
on sophisticated and more costly drugs and equip-
ment. 
(v) Socio-economic problems, in particular social exclu-
sion. Slow economic growth and high levels of 
unemployment are leading Member States to apply 
tight constraints on public spending. This limits 
both the amount available for health services and 
what can be spent on social assistance. Moreover, 
unemployment, inequalities, discrimination, pov-
erty and social exclusion can themselves lead to 
health problems. 
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above which confront the Member States, their health 
spending has risen rapidly in the last two decades. As 
shown in Figure 1 (Annex V), during the 1970s and 
1980s, health expenditure increased significantly in 
relation to gross domestic product (GDP), partly 
reflecting the slowdown in the rate of economic 
growth. In the latter part of the 1980s, however, the 
figures for certain Member States stabilized and even 
declined as growth picked up. Nevertheless, cost con-
tainment remains a topic of major concern in the 
1990s especially in the context of the present reces-
sion and the budget constraints on public expenditure 
growth. Member States have been acting vigorously 
to contain costs, and cost containment has been 
achieved only by taking steps both to limit provision, 
as, for example, by controls on drug prescribing and 
medical recruitment, and to hold back demand, 
including the imposition of charges for drugs and 
tests. 
timable benefits both for the individual and for soci-
ety as a whole. 
(b) Scope of public health policy 
9. Against this backdrop the scope of public health 
activities can be delineated by a consideration of the 
risks to the health of the members of a community, and 
of the steps needed to protect individuals within the 
community from those risks and to increase the likeli-
hood of their living a full and healthy life. Apart from 
risks to health related to individual genetic, physical 
and mental make-up. risks to health derive both from 
one's chosen lifestyle and one's immediate surround-
ings, in particular at home and work, and from the local 
environment — the combination of social, economic 
and cultural conditions that provide the general context 
for people's lives. Thus the steps required to protect 
individuals' health must address both of these 'environ-
ments'. 
6. The underlying pressures on services have not dis-
appeared and are likely to intensify, despite the fact 
that there is little correlation between the main 
health indicators and health spending. Furthermore it 
has been established that lower service spending has 
disproportionate effects on the poor, sick and old. 
Hence there is a need for well-balanced responses to 
the inevitable pressures to adjust health spending, 
such as public health initiatives (e.g., smoking cessa-
tion, diet and exercise, air pollution controls, etc.), 
better structuring and financing of health systems to 
minimize costs, cutting out ineffective treatments and 
evaluating medical equipment and medicines in 
cost/benefit terms. 
7. The difficulties involved in taking the right deci-
sions in health protection under severe economic con-
straints prompted the Council to agree, inter alia, the 
Resolution concerning fundamental health policy 
choices of 11 November 1991 (OJ C 304, 23.11.1991). 
This Resolution, and indeed the Treaty on European 
Union, make it plain that Member States accept an 
obligation to ensure that their citizens enjoy a high 
standard of health. This ethical and legal obligation 
to protect the health of the public is reinforced by the 
economic benefits, for specific age groups and activity 
sectors (e.g. in perinatal care), of taking health pro-
motion, protection and preventive measures. 
8. By taking effective action, premature deaths 
among the productive population can be prevented, 
as can disablement and chronic illnesses with the con-
sequent effects of absenteeism and unfitness for 
work; health can be improved and demands upon 
health care and treatment services can be controlled. 
In short, the Community's productive capacity can be 
maximized and simultaneously the costs of ill health 
reduced. Finally, and most important, safeguarding 
health, as well as producing economic advantages can 
also improve the quality of life, which will have ines-
10. While the actions and programmes of the public 
authorities have dominated the development of pub-
lic health strategies, in the last three decades public 
health interest has focused increasingly on the 
responsibility of the individual for his own health and 
the modifications he can make to his own behaviour 
to prevent the onset of disease. Such considerations 
have been applied to diet, the taking of sufficient 
exercise, the avoidance of dangerous and toxic sub-
stances, including drug abuse, and the prevention of 
accidents. 
11. International control of disease first appeared in the 
form of national quarantine schemes in Europe and the 
Middle East to contain the spread of epidemic disease 
from one country to another. These efforts first demon-
strated the need for international cooperation for 
health protection. A permanent international health 
organization was established in Paris in 1907 to receive 
notification of serious communicable diseases from par-
ticipating nations, to transmit this information to the 
member nations, and to study and develop sanitary 
conventions and quarantine regulations on shipping 
and train travel. This organization was ultimately 
absorbed by the World Health Organization (WHO) in 
1948. 
12. The WHO undertakes both short- and long-term 
projects to control or eradicate diseases on a world 
scale and maintains close relationships with other Unit-
ed Nations specialized agencies, also dealing with 
health issues, particularly the United Nations 
Children's Fund (Unicef), the Food and Agriculture 
Organization (FAO), and the International Labour 
Organization (ILO). 
13. The Community has, from the outset, made health 
and well-being one of its primary goals: health concerns 
underlie the economic objectives of the EEC Treaty, 
the safety provisions of the ECSC Treaty and the pro-
tection requirements of the Euratom Treaty. It is for 
106 these reasons that the Treaty on European Union Community, and enjoins upon the Community and the 
(TEU) makes health protection one of the centrepieces Member States' Governments to contribute to the 
of the quest for ever closer union of the peoples of the attainment of a high level of health protection. 
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States 
(a) Mortality 
14. The last decades have been characterized by two 
major trends in the health status of the population in 
the European Community. First, on the basis of mortal-
ity indicators, there is clear evidence of a considerable 
and continuing improvement in overall health status. 
People are living longer and fewer infants are dying in 
all Member States. Between 1960 and 1989 life expec-
tancy for men across the 12 Member States rose from 
67.3 to 72.8 years, and for women, from 72.7 to 79.2 
years. Moreover, while the Member States with the 
best records have continued to improve, those with 
lower rates have been catching up. The range between 
the Member States has thus narrowed, halving between 
1970 and 1988. Even more striking, the lowest life 
expectancy figure in 1988 for the whole population of a 
Member State (74.3 years) was better than the best in 
1970 (73.8 years). 
15. A similar but even more dramatic picture emerges 
from the figures on infant mortality in the Community. 
This figure has dropped by a factor of more than four 
from 34.8 per 1 000 in 1960 to 8.2 in 1989. As with life 
expectancy there has been a substantial narrowing of 
the range between best and worst, and again the worst 
Member State in 1989 (12.18 per 1 000) was better than 
the best in 1970 (12.75 per 1 000). 
16. The second trend is that of a significant shift in the 
causes of death, with communicable diseases (AIDS 
excluded) decreasing considerably in importance 
thanks to better hygiene and living conditions, preven-
tive measures, such as vaccination programmes, and the 
availability of effective treatments. They have been 
replaced to a large extent by other diseases, notably 
cancer and cardiovascular diseases. Whereas just over 
one half of the 2.9 million deaths in the Community in 
1960 resulted from these latter diseases, by 1990 the 
proportion had risen to two thirds. Of the 3.3 million 
deaths, 1.4 million were from cardiovascular diseases 
and 0.8 million from cancer. These diseases are not 
only the primary cause of death among the over-65s, 
but also among the population between 35 and 65 years 
of age, thus contributing significantly to premature 
death, as do accidents for the 5 to 34-year-old group. 
The patterns of mortality are continuing to change, 
however. There is, for example, evidence of a recent 
decline in mortality from cardiovascular diseases and 
an increase in deaths from previously rare diseases such 
as Alzheimer's disease. Such developments reflect 
demographic changes, advances in therapy, and the 
launch of large-scale preventive programmes. 
(b) Morbidity 
17. Mortality rates provide only an incomplete picture 
of the overall health status of a population. For a full 
picture, information is also necessary on morbidity i.e. 
the numbers of people with a particular illness or other 
medical condition. Such information reveals not only 
which are the most prevalent illnesses in the popula-
tion, but it is also an indication of the demands made 
upon the health-care system. Unfortunately, although 
individual Member States have morbidity data, owing 
to substantial differences in collection methods and 
definitions, few comparable morbidity data exist at 
present for the Community as a whole. 
18. One notable exception is for traffic accidents where 
information is available both for deaths and for injuries 
Table 1 — Relative importance of different diseases measured by hospital admissions and bed days
1 
Injuries 
Digestive system disorders 
Cardiovascular 
Cancer 
Respiratory conditions 
Musculoskeletal conditions 
Other diseases 
1 Indicative data, provided by 
tion and periods of reference 
France (1985-
Admissions 
13.2 
12.7 
11.6 
10.2 
6.9 
6.3 
39.1 
the Ministries of Health 
87) 
Bed days 
11.7 
12.0 
15.5 
12.5 
5.8 
7.0 
35.5 
. not directly comparable 
* Danish figures for cancer include lung and breast cancers only. 
Denmark  (1990) 
Admissions 
7.7 
7.1 
24.9 
11.7 
10.4 
14.8 
23.4 
due to differences in 
Bed days 
13.9 
6.7 
21.9 
8.9* 
8.8 
15.5 
24.3 
definitions, classifica-
108 in the Community. Overall, these figures show a 
decline in the death rate in the Community from traf-
fic accidents in the period 1970 to 1990 and a smaller 
and patchier decline in the rate of injury. Younger 
age-groups are predominantly involved. In the light of 
the discussions on the White Paper on the develop-
ment of transport policy, the Commission has pub-
lished a communication on an action programme on 
road safety (COM(93) 246 of 9 June 1993) and a pro-
posal for a Council decision on the establishment of a 
database on road accidents (COM(593) of 23 July 
1993). Some information is also available on cardio-
vascular disease as seven Member States are partici-
pating in the Monica study run by WHO which col-
lects mortality and morbidity data in this field. The 
data indicate that just as cardiovascular diseases are 
the major cause of mortality in the Community, so 
they are a cause of serious morbidity in the middle-
and old-aged population. 
19. Comprehensive comparative data do not exist for 
other conditions. However, national statistics do pro-
vide pointers to the relative importance of the various 
diseases in terms of morbidity. Table 1 gives figures for 
the principal diseases in Denmark and France accord-
ing to their percentage of total hospital admissions and 
bed days. These show that despite some differences, the 
overall patterns in both countries are not dissimilar, 
with the same kinds of diseases being important in both 
countries. 
20. The data that exist confirm that cardiovascular dis-
eases are the most important contributions to Commu-
nity morbidity, just as they are to mortality, but they 
indicate that cancer is of less importance in morbidity 
than in mortality and that there are several non-fatal 
diseases which are of considerable significance in mor-
bidity, notably respiratory and musculoskeletal diseas-
es. Taken together the mortality figures and the infor-
mation available on morbidity make it possible to draw 
up a list of those diseases which produce high mortality 
and/or high morbidity. Table 2 gives those diseases 
which pose particularly serious health problems for the 
Community as a whole. 
21. In addition, some communicable diseases, which 
were in the past a major cause of mortality, are now 
once more on the increase. This is due in particular to 
the advent of AIDS and to the resurgence of certain 
important communicable diseases such as tuberculosis 
which had been thought no longer to represent a seri-
ous problem. They all have the potential to pose seri-
ous problems if no action is taken. Finally, the list must 
include drug dependence because of the substantial 
social and health problems to which it is linked, and the 
ever-increasing numbers of individuals involved in drug 
abuse. 
22. Together then these diseases account for most of 
the deaths, most of the illness and most of the demand 
for health services in the Member States of the Com-
munity. But it must be emphasized that the figures pre-
Table 2 — Diseases producing high mortality 
and/or morbidity 
Accidents 
Cardiovascular diseases 
Cancer 
Mental illness, including suicide 
Musculoskeletal conditions 
Respiratory diseases, including asthma 
sented above relate only to general trends. It is certain-
ly the case that in some ways the differences and the 
gaps between best and worst Community States are 
narrowing. However, comparing national figures can 
give a rather distorted picture, one reason for this being 
the different sizes of the Member States. Moreover, 
national figures themselves tend to disguise significant 
differences between the regions within each Member 
State. 
23. In the case, for example, of the mortality rate from 
lung and bronchial cancer, in 1988 the overall EC mor-
tality rate was 48.8 per 100 000. The UK had the high-
est rate (70.5) and Portugal had the lowest rate (20.6). 
But within the UK the rate varied nearly twofold 
between the north of England (92.4) and Northern Ire-
land (49.2). Italy's national rate (51.1) came closest to 
the Community average, but that masks the fact that 
the rate in northern Italy was three times as high as that 
in the south. Similar large variations within States can 
be identified for other major diseases. Such variations 
reflect cultural, social and economic differences 
between regions and also the significant impact that 
environmental factors such as air pollution can have on 
health. 
24. Similarly, studies have shown significant variations 
of morbidity and mortality between different socio-
economic groups within Member States. In 1987. for 
example, the perinatal and infant mortality rates in 
England were more than 50% higher for people with 
unskilled occupations than for professional groups, 
and in Denmark unemployed and unskilled men in 
poor accommodation had an 'excess mortality rate' of 
6.2% compared with the best ranked group. It is 
important, therefore, that full account is taken of the 
variations not only between but also within Member 
States as well as the general patterns for the whole 
Community when looking at the overall status and 
trends in the Community. 
25. Moreover, in considering specific diseases as pos-
sible targets for Community action, information about 
their mortality and morbidity is not by itself sufficient. 
It is also necessary to look at the key factors associated 
with their causation, at the more general social and eco-
nomic context which bears on health protection and 
109 policy choices and at the efforts already undertaken by Member States to prevent disease and promote health. 
Member States to respond to these health challenges. against the aforementioned background, is given in 
An overview of the policies and measures taken by the Annex I. 
110 III — The basis for Community action  determine or bring about the desired health out-
come. 
(a) Subsidiarity 
26. The manner in which these activities by the Com-
munity and the Member States have to be conducted is 
governed by the principle of subsidiarity. Subsidiarity, 
the attributes of which are laid down in Article 3b of 
the Treaty establishing the European Community, 
implies that in matters not under its exclusive compe-
tence, the Community intervenes when action, by rea-
son of its scale or effects, may better be carried out at 
Community level. Moreover, irrespective of whether a 
matter comes under its exclusive competence or not. 
action on it by the Community must be proportional to 
the objectives to be achieved. 
27. The following considerations apply in particular to 
the field of public health. 
(i) In coordinating policy, the Community's role is 
to forge constructive relationships at all levels, 
assist in closing identified gaps, formulate and 
improve strategies for effective implementation 
of policies and measures, and ensure that trans-
fers and flows of knowledge, expertise and mate-
rials occur to the mutual advantage of the parties 
concerned. 
(iv) The Member States in partnership with their 
health professionals and individuals involved are 
concerned with the financing and delivery of care 
and treatment. However, the Commission may 
assist the Member States in improving their col-
laboration on health-care matters, as for example 
on fundamental health choices,' and may provide 
assistance to them in actions designed to improve 
the quality of health care and treatment. 
(b) Legal bases 
28. Prior to the Treaty on European Union, there was 
no specific legal basis or competence vested in the 
Community in the field of public health. That is not 
to say that the Treaties did not contain provisions of 
direct relevance to the protection of health and wel-
fare. Thus, health and safety at work was given from 
the outset a prominent place in the EEC Treaty 
(Articles 117, 118 and Article 118A of the Single 
European Act) and in the ECSC Treaty, whereas the 
health protection provisions for both workers and 
members of the public contained in the Euratom 
Treaty (Articles 30 to 39) soon became the corner-
stone for regulatory action in this field in all Member 
States. 
(ii) In accordance with the principle of proportional-
ity, the Community intends to focus on the imple-
mentation of larger rather than smaller projects, 
which for the most part will involve more than one 
Member State. This will maximize impact and 
avoid becoming involved with narrow issues and 
concerns which may be perceived as an interfer-
ence with matters already dealt with by the author-
ities of the Member States, or as heavy-handed-
ness in resorting to means out of proportion to the 
objective being pursued. 
(iii) Diversity in and among the Member States in diet, 
culture, weather conditions, land use, and the type 
and concentration of economic activity, is such 
that, in general, no detailed prescription will be 
handed down from the Community, even regard-
ing problems which are identical or similar from 
Member State to Member State, region to region, 
locality to locality. In matters of health, it is up to 
the individual and the family to consider alterna-
tives and take decisions on matters that directly 
affect them; and up to society, through the demo-
cratic process, to create an environment conducive 
to the best decision being made by the individual, 
and to the right collective decisions being made in 
all matters where the individual cannot, alone. 
29. Other provisions in the EEC Treaty also directly 
or indirectly concern health: Article 2 sets out the 
duty of the Community to raise the standard of living; 
Article 36 allows restrictions on imports, and goods in 
transit, in order to protect the health and life of 
humans; Article 43 deals with agricultural policy 
which can have an impact on human health: Article 
48 ensures freedom of movement for persons, includ-
ing patients and health workers; Articles 52 to 58 are 
of relevance for the right of establishment, and in 
Article 59, the free movement of services, including 
health services, is guaranteed. Article 100A has a 
major impact on health since all proposals for direc-
tives establishing the internal market for products 
(e.g. blood products), services, capital and persons 
must have by virtue of this Article, a high level of 
health protection as a basis; Articles 130f to 130q 
cover research including health research. In addition, 
the protection of human health as the ultimate goal of 
environmental protection measures is enshrined in 
Articles 130r and 130s of the EEC Treaty as amended 
See paragraph 7 on page 106. 
Ill by the Single European Act. Finally. Article 155 
serves, inter alia, to issue recommendations also in 
matters related to health protection, and has been 
used in the past for issuing recommendations on a 
European list of occupational diseases, and Article 
235 for proposals for decisions and regulations for 
various health-related issues, such as information to 
the general public and training of members of the 
health professions in the framework of the Europe 
against cancer programme, the setting up of a Health 
and Safety at Work Agency, and the creation of the 
European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA). 
grammes, the Commission adopted a method which 
predated the principle of subsidiarity and involved a 
systematic attempt to generate Community added 
value, by promoting cooperation between the Mem-
ber States in the field of studies and research, and the 
spread throughout the Community of the most suc-
cessful national practices, in particular by bringing 
together the responsible partners in the Member 
States. The achievements of these programmes and 
the need for their continuation were underlined dur-
ing the recent evaluation of their effectiveness by the 
Council. 
30. The policies, programmes and instruments (see 
Annexes II and III) to give effect to these Articles 
played a determinant role in transforming the health 
scene of the Community and in raising the quality of 
life of its citizens. The Treaty on European Union not 
only maintained these provisions but also reinforced 
them. Consumer protection has been given a clear 
mandate to protect the health and safety of consumers 
in Article 129A. Article 130 on the environment 
requires the Community to contribute to the pursuit of 
the objective of protecting human health. In addition, 
in Article 126. the Community has been given the duty 
to contribute to the development of quality education, 
which plays an important role in health protection and 
promotion. Moreover under Article K.9 of the Treaty 
on European Union, the Council, acting unanimously 
on the initiative of the Commission or a Member State, 
may decide to undertake action aimed at combating 
drug addiction. 
31. Above all. public health has, by reason of Articles 
3(o) and 129, been accorded its own explicit provi-
sion. The Community has been given responsibility to 
contribute to the attainment of a high level of health 
protection with due regard to the principles estab-
lished by the European Council in Edinburgh (sub-
sidiarity, openness, transparency and proportional-
ity), and vested with powers to discharge this respon-
sibility in a manner that ensures respect and support 
for Member States' policies and activities, prevents 
unwarranted intrusion and interference, and leaves 
room for adjustment and choice of the means for 
their implementation. In doing this, the experience 
gained hitherto in public health actions carried out by 
the Community serves both as a guiding light and as a 
base on which to build. In particular, the Europe 
against cancer programme, launched in 1986 by the 
European Council, has demonstrated the value of 
identifying common objectives and goals. It has paved 
the way for the adoption by the Council of other pro-
grammes and initiatives dealing with AIDS, drug 
demand, alcohol abuse, and health education in 
schools, and has shown what can be achieved by part-
nership, cooperation, and use of instruments in other 
Community policies. In implementing the Europe 
against cancer and Europe against AIDS pro-
32. In initiating action under Article 129, the Commu-
nity has to address itself to preventing disease. Preven-
tion in all its facets thus becomes the focus of Commu-
nity action, whether primary, to ensure good health and 
to minimize exposure to risk factors implicated in the 
causation of diseases; secondary, to avert the onset of 
diseases in those so exposed, for example by screening, 
vaccination and preventive medication/prophylaxis: or 
tertiary, to avert the progression or recurrence of dis-
ease. Prevention can be distinguished from treatment 
as the latter may be described as an intervention to cor-
rect congenital defects, or to restore an individual to a 
previous (better) level of health. Treatment, as 
opposed to prevention, is therefore a matter of Mem-
ber States' cooperation and not an area in which the 
Commission can or should take initiatives on behalf of 
the Community. 
33. Preventive activity by the Community must 
address irseli to the question of major scourges. Major 
scourges or health threats may be determined in rela-
tion to a host of factors, both objective (health data 
and indicators) and subjective (perception, ethical, 
cultural and political questions). Consideration of 
these issues is to be found in Chapter IV. However, 
one point must be stressed here: Article 129 specifi-
cally requires public health action on the scourge 
of drugs. 
34. Article 129 implicitly recognizes the dichotomy 
between action addressed on the one hand to the indi-
vidual to enhance his/her potential for health gain, 
healthy lifestyle, and non-risk or low-risk behaviour, 
such as health information and education, and, on the 
other hand to societal action, involving research into 
the causes and transmission of disease. This research 
may be fundamental, and also behavioural, social, and 
environmental, and could concern the immediate, local, 
and even remote environment, over which the individ-
ual has little, if any, control. 
35. Of primary importance is the provision of Article 
129 that health protection requirements shall form a 
constituent part of the Community's other policies. In 
112 the future, elaboration of policies and measures with an 
impact on health must from the outset take account of. 
and be coherent with, public health policy. This means 
that other policies, despite their having different legal 
bases, will also serve the objectives of health protec-
tion. 
36. Central to the Commission's role in the implemen-
tation of Article 129 is the obligation to liaise with the 
Member States in the coordination of their policies and 
programmes concerning prevention, including drug 
prevention, investigation and analysis of causes and 
modes of transmission of health scourges, health infor-
mation and health education. The Commission will, in 
close collaboration with the Member States, take 
appropriate initiatives to promote such coordination, 
particularly in areas in which the Member States have 
already demonstrated a need to cooperate, notably dis-
ease surveillance and control, health data and indica-
tors, health information and health education, and in 
the fight against the major scourges of drugs, cancer 
and AIDS. 
(c) Past consideration of health matters by the 
Community institutions 
(i) European Council 
37. In 1986, the representatives of the Governments of 
the Member States, meeting within the Council, adopt-
ed a resolution on a programme of action of the Euro-
pean Communities against cancer (86/C184/05)
1 which 
set the objectives of this programme and listed the pri-
ority actions to be considered. It also agreed on declar-
ing 1989 as a year ofinformation on cancer. Moreover, 
it called upon the Member States to draw from their 
experience in the treatment and rehabilitation of drug 
addicts in order to collaborate in informing teachers, 
parents, and young people about the risks related to 
drug addiction and in preparing a report and recom-
mendations on measures that can be taken at Commu-
nity level. This serious preoccupation with drugs was 
reflected in the declarations of subsequent meetings of 
the European Council, notably in London in 1986, in 
Dublin and Rome in 1990. in Luxembourg and Maas-
tricht in 1991, and in Lisbon in 1992. The London 
meeting in 1986 also stressed the importance of coordi-
nating national campaigns against AIDS with a view to 
raising awareness and better informing the public on 
this disease. These resolutions and declarations by the 
European Council paved the way for the Community 
action against the scourges of cancer, drugs, and 
AIDS. 
(ii) Council 
38. Council and Ministers of Health's interest and 
debate concerning public health issues began in 1977 
and started to grow in the early 1980s. Efforts at set-
ting an agenda in this field at the Community level 
began to revive in 1982 when the European Parlia-
ment asked for a clarification of what exactly had 
been done in the public health field since 1978, the 
year in which a second research and development pro-
gramme was adopted by the Council in the sector of 
medical and public health research. The Commission's 
communication on Community-level cooperation on 
health-related problems finally initiated activities in 
1984. 
39. The informal meeting of Health Ministers in 
November 1984 discussed the increase of health spend-
ing, the combating of drug and tobacco addiction and 
health education for the young. The next (formal) 
meeting of the Health Council was held in May 1986. 
Resolutions and decisions were adopted on the action 
programme to fight cancer, on the introduction of a 
European emergency health card, on measures to fight 
against AIDS and on ways of decreasing the consump-
tion of tobacco and alcohol. This and subsequent meet-
ings of the Health Ministers, in which various health 
issues were discussed and important initiatives 
launched, raised hopes for a Community-wide health 
policy. 
40. The signing of the Treaty on European Union on 7 
February 1992 gave rise to heightened expectations 
concerning the potential for improving health protec-
tion in a Community where cooperation and coordina-
tion of policies and programmes, which had long been 
the dream of a few. could become a reality. This cul-
minated during the second half of 1992 in the exam-
ination by the Health Council of fundamental ques-
tions concerning the future course of Community 
action in the field of public health. Discussion took 
place on the need for breaking with the past and look-
ing forward to greater continuity, coherence, and pri-
oritization in public health work, and to constructing 
an appropriate framework comprising the successful 
Community programmes on cancer and AIDS and 
actions in specific areas, such as drugs and health edu-
cation in schools. In this, the Council was assisted by a 
Commission staff working paper, entitled 'Public 
health', which reviewed and took stock of the achieve-
ments of Community efforts so far. and acknowledged 
the need for a coherent approach based on preven-
tion, health promotion, health protection through 
other Community. policies, coordination between 
Member States, and cooperation with third countries 
and international organizations. 
OJC 184,23.7.1986. 
4L On 27 May 1993. the Council and the Ministers for 
Health meeting within the Council adopted an impor-
113 tant resolution on future action in the field of public 
health which dealt with all the main aspects of the pub-
lic health framework in which the Community will be 
working in the future. The resolution reaffirmed the 
need for close cooperation and for consideration of the 
weight to be given to health requirements in other pol-
icies; and set out a number of guidelines concerning 
the fundamental objectives of action, namely adding 
life to years and years to life, the need for multiannual 
planning to ensure coherence and continuity, the crite-
ria for selecting areas of activity with reference to 
amenability to preventive action, and complementarity 
with other policies with a health component, the meth-
ods of cooperation and consultation, and, finally, the 
relations with third countries and international organ-
izations. These guidelines have been studied carefully 
by the Commission and taken into account in this com-
munication. 
(Hi) European Parliament 
42. The European Parliament has been in favour of a 
Community health policy since the early 1980s and has 
put forward several resolutions in the field of health, 
notably: 
health policy in the European Community 
(OJ C 128,16.5.1983. p. 86) 
European charter of rights of hospital patients 
(OJ C 46,20.2.1984) 
Community programme of research into AIDS 
(OJ C 46,20.2.1984) 
children in hospital (OJ C 148,16.6.1986, p. 37) 
women in childbirth (OJ C 235,12.9.1988. p. 183). 
43. Members of the European Parliament have always 
shown a keen interest in health matters, as is evident 
from the very large number of Parliamentary ques-
tions raised on the subject. Its various committees, in 
particular the Committee on Environment, Public 
Health, and Consumer Protection, the special Com-
mittee on Drugs, and the Committee on Youth, Cul-
ture, Education, the Media and Sport, have prepared 
several reports on health-related subjects, including 
reports on AIDS, health education and drug abuse, 
bioethics, organ transplantation, and blood self-suf-
ficiency. 
44. A recent report of the Committee on Environment, 
Public Health and Consumer Protection, concerning 
public health policy after Maastricht (1993 — 
PE205.804), was prepared following a public hearing 
on 3 June 1993. The report lays particular stress on 
Article 129's call for coordination of Member States' 
policies and programmes and on integration of health 
requirements into other policy areas, and provides a 
comprehensive overview of current public health 
issues, including demography and health needs, com-
parable/compatible health data and indicators, health-
care costs, and research and health policy. The Com-
mittee made several proposals for Community action, 
including calls to the Commission to provide for wide-
scale consultation procedures; establish an epidemi-
ological investigation service; collect, analyse and dis-
seminate data on notifiable diseases; encourage 
exchange schemes for health professionals; develop 
the exchange of information between national health 
systems: report on the health status of the Community: 
investigate the feasibility of encouraging greater use of 
generic pharmaceuticals and coordinate the use of all 
pharmaceuticals; indicate the minimum levels of health 
care; develop and execute activities on health promo-
tion and education, including vaccinations and screen-
ing; and intensify its activities against cancer and 
AIDS, and with regard to the problems of the elderly. 
The report and a pertinent resolution will give an 
added impetus to the ongoing efforts to endow the 
Community with a much needed public health dimen-
sion. 
45. Reference should also be made to the important 
work carried out by the European Parliament's inter-
group on health, and to its STOA group (Science and 
technology option assessment). 
(iv) Economic and Social Committee 
46. During the past 10 years, the Economic and Social 
Committee has regularly given its opinions on health 
matters such as occupational medicine; dangerous sub-
stances and preparations: the Community system of 
information on accidents involving consumer products; 
occupational cancer; an action programme on toxicol-
ogy for health protection: prevention of asbestos pollu-
tion; cancer prevention action programme: and the 
transparency of medicinal product prices. More recent-
ly, the Committee approved Community initiatives in 
the social field, such as The European Year of Older 
People; the Europe against cancer programme and the 
Europe against AIDS programme, and the creation of 
the European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA). 
47. It is against a background of an expression of the 
will of the Community institutions, and also of the 
desires of numerous health professionals, medical 
and patient associations, interest groups and ordinary 
people in the Community, that the Commission, hav-
ing given thorough consideration to the timeliness 
and feasibility of action on the one hand, and the 
available means, on the other, seeks with this com-
114 munication to establish a coherent and comprehen- which will give expression to the new provisions in 
sive framework for Community public health action the Treaties. 
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The European Community approach 
IV — Selection of activities 
(a) Scope of possible activity 
48. The Council and the Member States have identified 
a large number of areas for possible action, at Commu­
nity level, which demonstrates the range and diversity 
of expectations, and underlines the need for the estab­
lishment of priorities in order to match resources to 
demands: 
the continuation of existing Community 
programmes on cancer and AIDS 
cardiovascular diseases 
communicable diseases 
mental diseases 
hereditary diseases 
asthma and allergies 
migration and health 
health and environment 
prevention of accidents and violence 
prevention of drug abuse 
improved data and their comparability 
nutrition 
tobacco 
alcohol 
exchanges of information on Member States' 
policies 
pilot projects in prevention and early diagnosis 
establishment of centres of excellence 
exchange visits for health personnel 
public health research 
cost containment 
fundamental health choices 
self-sufficiency of blood 
toxicology 
health and young persons 
use of pharmaceutical products 
renal dialysis 
emergency health card. 
49. Chapter II identified on the basis of information on 
mortality and morbidity those groups of diseases and 
conditions which currently or potentially pose the most 
serious threats to the Community. This chapter looks at 
these diseases separately in order to ascertain their suit­
ability for Community action. In order to do so it is 
necessary to establish broad objectives for Community 
action and operational criteria based on those objec­
tives for selecting diseases. 
50. There are essentially four interlinked objectives for 
Community action; 
(i) to prevent premature death which particularly 
affects the young and working population; 
(ii) to increase life expectancy without disability or 
sickness; 
(iii) to promote the quality of life by improving general 
health status and the avoidance of chronic and dis­
abling conditions: 
(iv) to promote the general well being of the popula­
tion particularly by minimizing the economic and 
social consequences of ill health. 
51. To attain these objectives and maximize the impact 
of its action, the Community needs to identify those 
diseases to be tackled as a matter of priority. Such iden­
tification starts with the examination of data which help 
to establish which are the major health threats, includ­
ing data.on mortality, morbidity, harm potential in the 
absence of intervention, amenability to preventative 
measures, perception by the public, and costs, both 
social and economic. On the basis of the Community 
criteria of subsidiarity and added value those major 
health threats for which it can be demonstrated that 
action by the Community is cost-effective, readily avail­
able and appropriate, can then be selected for Commu­
nity action. Moreover, other diseases, which cannot be 
considered major, can also be selected for Community 
action provided that it can be shown that the fight 
against them would benefit from the involvement of the 
Community. 
52. Action and measures by the Community, must be 
relevant, transparent, and explained in such a way that 
they can be understood by the Community citizens: 
they should be addressed, nevertheless, only to deci­
sion-takers and practitioners in several Member States. 
Otherwise, the risk is that the more visible the action of 
the Community becomes, the greater the risk of a frag­
mentation of effort and resources, and the less the asso­
ciated impact and degree of satisfaction. 
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53. Community action against diseases will in particular 
focus on encouraging cooperation between Member 
States, lending support to their action, promoting in 
close contact with the Member States coordination of 
their policies and programmes, and making better use 
of Community policies where these relate to public 
health. Particular attention has to be devoted to the fol-
lowing activities: health information, health promotion, 
health education, health training, cooperation with 
international organizations and third countries, and 
research. Action by the Community can take, in partic-
ular, the following forms. 
(1) Establishment of a general framework for support-
ing Member States' policies and programmes (net-
works, joint actions, information exchange systems). It 
is true that Member States already cooperate in certain 
areas, but this cooperation can now be strengthened. 
Increased cooperation could involve, for example: 
• establishment of common objectives, in particular 
areas, or for new health threats and problems: 
• programmes for exchange of experiences and of 
health professionals, and for dissemination of the 
most effective practices; 
(i) Selection criteria 
54. Based on the considerations above, the following 
criteria for identifying diseases (or health threats) for 
Community action can be set out: 
1. diseases that cause, or are likely to cause in the 
absence of intervention, significant premature 
death (years of life lost) and/or have overall 
high death rates; 
2. diseases that cause, or are likely to cause in the 
absence of intervention, significant ill health by 
having a high prevalence of morbidity or with 
the potential to cause high morbidity and/or 
serious disability (years of disability-free life 
lost); 
3. diseases having significant implications for the 
quality of life as well as major socio-economic 
effects, such as high health-care and treatment 
costs, or considerable absenteeism and unfitness 
for work: 
4. diseases for which practicable measures of pre-
vention exist: 
standardization and collection of comparable/com-
patible data on health, and the promotion of 
systems of health monitoring/surveillance; 
creation of information networks for the evaluation 
of different treatments and new technologies 
applied to health, inter alia, by disseminating the 
results of research carried out under the 
Community's framework programmes; 
compilation of an annual progress report on the 
health situation within the Community, based main-
ly on reports from each Member State, in order to 
evaluate activities undertaken and make decisions 
for the future: 
5. diseases for which there would be added value 
from the Community undertaking actions, par-
ticularly through economies of scale. 
55. Whereas application of criteria 1 and 2 may be rela-
tively straightforward, the importance and difficulties 
in using the third criterion must be stressed. In fact 
'quality of life' is a very subjective criterion used to pro-
vide descriptions of degrees of disability, distress or 
pain, or the capacity to carry out normal activities. Cer-
tain studies have suggested that people consider some 
health states as 'a fate worse than death', and such con-
cerns have been taken into account in valuations of the 
global burden of diseases by using concepts such as the 
quality-adjusted life year. 
• financial assistance for programmes and pilot proj-
ects; 
• assistance to the efforts of Member States to reduce 
health costs by reducing obstacles to free movement 
of patients between Member States, and by devel-
oping the health aspects of the use of medicinal 
products, whilst respecting the Member States' 
competences in these fields. 
(2) Better use of Community policies and instruments 
where these relate to public health. More attention will 
be paid in this respect to the implications for health 
protection and disease prevention when new Commu-
nity initiatives are introduced in areas other than 
health. 
56. The selection procedure involves two distinct steps. 
Firstly, by applying the first four criteria, diseases that 
are of major importance throughout the Community 
can be identified: these are not necessarily the major 
diseases which the Community should deal with. The 
latter can only be determined as a result of a second 
selection step involving the attainment of Community 
added value. Finally, those diseases, from among those 
identified following the two-step procedure, which 
should be tackled as a matter of priority, can be deter-
mined by seeking to maximize the Community added 
value in terms of health gain obtained by providing the 
necessary coherence and continuation with Community 
activities already undertaken against certain diseases, 
and by trying to aim, with a given action, at as many 
diseases as possible. 
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ination and analysis of the available data concerning a 
number of important diseases from those listed in the 
International Classification of Diseases. The table in 
Annex IV contains a list of diseases which have been 
evaluated according to the above criteria. Annex V 
contains statistical data used in the analysis and discus-
sion on trends that follow. The following paragraphs 
indicate those diseases, which on the basis of the crite-
ria should be the focus of Community action, and dis-
cuss trends. In addition, Community actions in the field 
of preventing drug dependence, already selected as a 
priority in Article 129, are described. 
(ii) Major health scourges other than drugs 
Cancer 
58. The major lifestyle-related cancer is cancer of the 
respiratory passages and of the lungs. Epidemiological 
evidence shows that this is linked mainly to smoking. In 
recent decades there has been an increase in cancers 
related to tobacco and alcohol (mainly upper respira-
tory and digestive tract and lungs). 
59. In Figure 2 of Annex V the trends towards a Com-
munity average prevalence of lifestyle-related health 
threats and a levelling out of prevalence between 
males and females (due to increasing female smoking) 
are clearly evident. The most rapid developments are 
shown in the cases of Denmark and the Netherlands 
but the trend is visible in all countries except Spain 
which, in contrast, has shown a fall in prevalence 
among females. As far as other forms of cancer are 
concerned, the trends are not quite so clear and, in 
some cases, do not follow the same pattern. This has to 
do with two factors: first, changes in lifestyle, and, sec-
ond, the improved capacity for making an early diag-
nosis and, thereby, early intervention. Improved 
capacity for making an early diagnosis (combined with 
improved sexual hygiene) means, in the case of cervi-
cal cancer, that a downward trend can be identified. 
However, for breast cancer, the opposite trend is evi-
dent: in almost all Member States the numbers are 
increasing. It is difficult to give a simple explanation 
for this development since breast cancer cannot be 
linked easily to lifestyle-related risk factors, although 
diet is suspected to play a role. There is similarly a rise 
in the overall number of cancers of the digestive 
organs. Here, however, a link to nutrition and changed 
eating habits is widely seen as a major explanation. 
This and the link between breast cancer and diet are 
being investigated by the Europe against cancer pro-
gramme, by means of a major survey of eating habits in 
seven Member States. 
Cardiovascular diseases 
60. There is a general trend towards a decrease in mor-
tality from cardiovascular diseases, though in Greece 
and Spain the figures are not so clear-cut as for the 
other Member States, for reasons possibly relating to 
changes in diet. No unequivocal explanation for this 
development has been produced so far, but there seems 
to be a certain correlation between reduced prevalence 
and changes in lifestyle. Generally speaking, mortality 
has dropped the most in countries with the biggest 
decline in the number of smokers, the best blood pres-
sure controls, decline in serum-cholesterol levels and 
the biggest increase in physical activity. Moreover, 
introduction of more efficient methods of treatment 
has had an influence on mortality as well. 
Accidents 
61. Since 1970 the overall death rate from all kinds of 
accidents (including poisoning) in the Community has 
declined. With regard to traffic accidents, there has 
been a significant fall in the death and injury rates in 
most Member States. For example, the mortality rate in 
France declined by one third between 1970 and 1990, 
that in Italy by one half and that in the Netherlands by 
two thirds. On the other hand, in Portugal the injury 
rate went up considerably after 1985, and in Spain the 
death and injury rates have both increased over the 
same period, though they are still at a relatively low 
level. Moreover, it must be stressed that traffic acci-
dents, as shown in Table 5 (Annex V), remain the lead-
ing cause of death for young people in the Community. 
Suicides 
62. The overall number of suicides in the Community 
has shown a rising trend over the last 20 years. A com-
parison between the first and the last years available 
(1970 and 1989) shows that Germany is the only coun-
try with a significant drop in the number of suicides. 
The other Member States show either a stable pattern 
or an increase. No definite explanation for these devel-
opments can be given although societal changes obvi-
ously play a role. But differences between political, cul-
tural and historical tradition tend to be of importance 
as borne out by the fact that suicide has generally been 
less common in southern Europe than in certain north-
ern European countries. 
AIDS and other communicable diseases 
63. Communicable diseases have to a large extent 
ceased to be a prevalent cause of death in the Commu-
nity, though they still cause significant morbidity. How-
ever, the advent of AIDS in the early 1980s has some-
what changed this picture. The last decade has seen a 
rapid increase in the number of people with this disease 
in the Community. In 1982, just 86 people were report-
ed as being diagnosed with AIDS. By 1990 this number 
had risen to just under 14 000. The numbers are still 
continuing to increase, though the rate of increase has 
slowed down. By 30 June 1992 over 69 000 cases had 
been reported and by 30 June 1993 the number had 
risen to nearly 89 000. Making allowances for delays in 
reporting cases, it is estimated that the cumulative total 
at the end of June 1993 was over 95 000. Although all 
Member States are affected, three, namely France. 
118 Spain and Italy, account for 71% of all Community 
cases. In northern Member States the largest number of 
AIDS cases are among homosexual men and in south-
ern States among injectable drug users. But the propor-
tion of AIDS cases among heterosexuals is continuing 
to increase throughout the Community. No precise fig-
ure is available for the number of people in the Com-
munity infected with HIV, the virus which leads to 
AIDS. But the WHO has estimated that about 500 000 
people are infected. 
64. The recent resurgence of tuberculosis, often asso-
ciated with AIDS, points also to the need to continue 
to take action against communicable diseases. 
Other important diseases 
65. As pointed out in Table 2 above, several other dis-
eases, notably mental illness, musculoskeletal condi-
tions and respiratory conditions, produce substantial 
morbidity in the Community. The ageing of popula-
tions is likely to increase the prevalence of these condi-
tions. Community action against these diseases, though 
not of the highest priority, will need to be kept under 
consideration in the future. 
(Hi) Drug dependence 
66. Drug dependence is the only health threat specifi-
cally mentioned in Article 129, making it automatically 
a priority for Community public health action. Action 
on drugs benefits already from coordination at Com-
munity level; the extent of this multifaceted problem, 
with its links to major social scourges such as social 
exclusion and unemployment, and the difficulties 
encountered by Member States in combating its severe 
effects on society, has led to a series of initiatives being 
taken at Community level over the past few years. The 
wide range of initiatives adopted by the Council and 
the European Parliament has demonstrated the great 
importance that they attach to this problem and their 
view that actions to tackle it are needed at the Commu-
nity level. This has been reinforced by the singling out 
of drugs in Article 129 as a major scourge to be given 
priority by Community public health action. 
67. Important initiatives on drugs include the Council 
Resolution of October 1986, and the European plan 
against drugs drawn up by the European Committee to 
combat drugs (CELAD) adopted by the European 
Council in December 1990 and prolonged by the Euro-
pean Council in December 1992. These documents set 
out a wide range of activities to be undertaken. More-
over, the Council adopted in February 1993 a regula-
tion setting up the EMCDDA, which is charged with 
data collection, analysis, comparison and evaluation in 
the field of drugs, with special emphasis, in its initial 
three-year work programme, on demand and reduction 
of demand for drugs. The Community will in the future 
be able to consolidate its achievements in the field of 
drug prevention, build on the work already carried out, 
and propose a forward-looking programme for public 
health action on drugs and drug dependence. 
(iv) Rare diseases 
68. By definition, rare diseases have less of an impact 
on society and are responsible for relatively little mor-
tality and morbidity. Nevertheless, experience shows 
that by the very fact of their rareness and the conse-
quent lack of information available about them, they 
can produce significant problems for individual coun-
tries. Legionnaires' disease, Creutzfeldt-Jakob disease 
and genetic disorders like haemophilia, are obvious 
examples. There could thus be benefits in Community 
initiatives aimed at such diseases to complement the 
efforts of Member States and maximize the exchange of 
information and experience, so that all Member States 
are assisted in taking appropriate action when con-
fronted with an unfamiliar threat. There are other dis-
eases which may be rare in some Member States but 
not in others. One typical example is thalassaemia, 
which is rife in the south of the Community. With 
regard to rare illnesses, therefore, the Community will 
have to cooperate closely with Member States to draw 
up initiatives likely to generate economies of scale and 
create solidarity between Member States. 
119 V — Causation of diseases 
69. The groups of diseases mentioned in the previous 
chapter are those to which Community measures 
should be directed. But for preventive action to be as 
effective as possible, it is not enough to direct it just at 
particular diseases and groups of diseases; it is even 
more important to aim it at their underlying causal fac-
tors. In considering, therefore, what kinds of measures 
might be appropriate and what priority to give them, it 
is necessary to look at the key factors associated in the 
aetiology of these conditions. 
72. It is clear from this table that, quite apart from 
genetic inheritance, there are a number of other com-
mon factors, both specific and more general, associated 
with these diseases. Of the specific factors, smoking and 
alcohol are implicated directly and nutrition also plays a 
role. More generally, environmental problems are 
directly implicated or to some extent are associated with 
all of them. Some factors are also associated with other 
significant conditions: nutritional problems, for exam-
ple, are a central factor in diabetes, rickets and osteo-
porosis; alcohol produces cirrhosis, and smoking by 
pregnant women increases the risk of infant mortality. 
70. Of course, as the significant variations of morbidity 
and mortality between different socio-economic groups 
within the Member States would indicate, adverse 
socio-economic conditions (e.g. poor housing, low 
access to health care, long-term unemployment) consti-
tute a threat to public health. This linkage has been rec-
ognized in the recently-launched programme on social 
exclusion (COM(93) 435) which seeks to assess through 
selected projects the impact of a range of socio-eco-
nomic conditions on social exclusion and promote soli-
darity. Combating these conditions, while at the centre 
of other Community policies, constitutes nevertheless 
one of the main preoccupations of the Community in 
pursuing its objective to contribute to preventing risks 
to certain groups, and in designing an effective strategy 
of health protection. 
71. Without attempting to be comprehensive, Table 3 
sets out major factors associated with the previously 
identified major health threats. 
73. In terms of designing an effective strategy of pre-
vention of disease and health protection, the fact that 
several key factors are common to a variety of condi-
tions has important consequences. It means, for 
instance, that measures aimed at preventing people ta-
king up smoking have a significant impact on the rates 
of morbidity and mortality from a range of different 
conditions, thus greatly enhancing their impact. 
74. Measures aimed at eliminating or reducing the 
impact of particular causal factors related to several 
diseases, employing for example actions in health infor-
mation, education, and promotion, addressing issues 
such as nutrition, tobacco and alcohol, and aimed at the 
general public or at particular groups such as children 
or the elderly, can play a key role in the overall strategy 
and help direct limited resources to maximum effect. 
Such 'horizontal' measures form a key part of the strat-
egy set out in Chapter VII. However, as well as 
addressing those factors which are implicated in several 
Table 3 — Factors implicated in disease causation 
Disease 
Accidents 
Cancer 
Cardiovascular diseases 
Communicable diseases, including AIDS 
Drug abuse 
Mental illness, including suicide 
Musculoskeletal conditions 
Respiratory diseases, including asthma 
Factors 
Drink-driving, unsafe behaviour, defective or 
poorly-designed products and services, environmental 
problems 
Smoking, alcohol abuse, nutrition, genetic factors, 
exposure to radiation and carcinogenic substances 
Smoking, alcohol abuse, nutrition, genetic factors, 
stress, lack of exercise 
Poor hygiene, unsafe water, unsafe sexual behaviour, 
drug abuse, nutrition, contaminated blood 
Socio-economic problems, psychological disorders, stress 
Socio-economic problems, genetic factors, stress 
Poor working environment, physical stress, nutrition, 
lack of exercise 
Environment problems, including pollutants, smoking 
genetic factors 
120 conditions, the specific features of each disease must 
not be overlooked. Generally speaking, it is difficult to 
be totally precise about the cause of many diseases. The 
evolution of microbiology has gradually enabled the 
identification of the micro-organisms responsible for 
most infectious diseases, but it will be necessary to wait 
for the mapping of the human genome to know which 
genes are responsible for certain clinical conditions. 
Moreover, the means of fighting against these illnesses 
will certainly adapt in the future as their precise causa-
tion is discovered. 
the trends in the northern and southern States. In the 
period 1976 to 1990. the total consumption decreased in 
six northern States by between 13.4% in Denmark 
(from 1 801 to 1 560 units per year) and 25.5% in the 
Netherlands (from 2 086 to 1 555 units per year), on the 
other hand there were considerable increases in the 
southern States with, for example, Spain showing a rise 
of 87.8% (from 1 122 to 2 109 units per year). This 
north-south divide tends to be borne out by Eurostat 
data on expenditure on tobacco as a proportion of total 
household expenditure. 
75. As is the case for the information on the prevalence 
and effects of the diseases themselves across the Com-
munity, so information on the major causal factors is 
also patchy. However, on three of the most important 
ones, nutrition, smoking and alcohol consumption, 
some information is available from WHO figures which 
provide a picture of trends across the Community. 
76. On nutrition, figures are available on the propor-
tions of fat and proteins in people's diets. In 1989, the 
amount of fat as a percentage of total energy intake 
ranged from 34% in Portugal to 47% in Belgium and 
that of protein from 10% in Greece to 14% in France. 
Of more significance, however, are the trends which 
show that while the percentage of protein in diets has 
not varied much since 1970. there has been a consider-
able rise in fat intake in several countries, notably 
France. Italy. Portugal and Spain. 
77. On smoking there are figures showing total cigar-
ette consumption per capita in the Member States on a 
yearly basis. These show a marked divergence between 
78. The trend of alcohol consumption is virtually a mir-
ror image of that for cigarette smoking. In the period 
between 1970 and 1988 the northern States saw a con-
siderable increase in alcohol consumption per head; for 
example, in Denmark there was an increase of 45.6% 
(from 6.8 to 9.9 litres of pure alcohol per capita per 
year) in the Netherlands of 46.4% (from 5.6 to 8.2) and 
in the UK of 43.4% (from 5.3 to 7.6). At the same time, 
in the southern States consumption was falling; in Italy 
it fell by 36.5% (from 13.7 to 8.7) and in France by 
21.6% (from 16.2 to 12.7). 
79. It must be emphasized that such data have to be 
interpreted very cautiously since the baselines for 
Member States vary considerably. The WHO data on 
alcohol as a percentage of total energy intake, for 
example, show that in 1989 there was a considerable 
range between Member States from 3% in Greece to 
8% in Germany. The main value of such figures is in 
indicating trends which in turn can reveal current and 
potential problems and highlight areas for intervention. 
121 VI — The nature and extent of Community 
involvement 
(a) General approach 
80. The health sector is a broad domain of organized 
activity, the workings and effects of which directly 
and profoundly influence one of the most cherished 
possessions of the individual, namely his or her 
health. Traditions, practices and the legal and admin-
istrative organization of public health services and 
systems are so varied as to render meaningless any 
talk of unification or harmonization of policies in this 
domain. 
(b) Consultation and participation mechanisms 
84. Article 129 provides for the consultation of the Eco-
nomic and Social Committee and of the Committee of 
the Regions. Moreover, Community instruments of 
binding character provide for consultation and partici-
pation mechanisms in relation to programmes and 
measures adopted by the Community in the field of 
public health. Apart from these mechanisms, the Com-
mission intends to obtain additional expertise in order 
to ensure that the best possible consultation and partic-
ipation machinery is available to give guidance and 
feedback as regards Community activity on health pro-
tection, whilst streamlining and consolidating the exist-
ing structure of committees and working groups. 
81. The role of the Community is to underpin the 
efforts of the Member States in the public health field, 
assist in the formulation and implementation of objec-
tives and strategies, and contribute to the continuity of 
health protection provision across the Community, set-
ting as a target the best results already obtained in a 
given area anywhere in the Community. 
82. Needs in the field of public health across the Com-
munity are vast and there is no question of the Commu-
nity seeking to meet them all. Rather, the Community 
will carry out actions that yield the highest possible 
added value from the limited resources available, using 
instruments and measures that are deemed to have the 
greatest impact. The Commission will seek to ensure 
that actions at the policy and strategy level, aiming at as 
many selected diseases as possible, are given top prior-
ity, sufficient means, and clear objectives. The Commis-
sion will accord priority to large-scale, wide-impact 
projects involving as much as possible governmental 
organizations and non-governmental organizations with 
a proven record in their respective fields. The Commis-
sion will also ensure that instruments in other policies 
are used for, or contribute to, health protection, and 
any adverse impact from other policies is eliminated by 
keeping a 'health watch' at all stages of drafting of per-
tinent instruments and programmes. Finally, the Com-
mission will be ready to respond to Member States' 
requests for contributions to cooperation between 
them, and will enlist, when it is appropriate, the aid of 
international organizations competent in health mat-
ters. 
83. Table 4 shows, in a matrix form, the kind of 
action that can be undertaken at Community level 
for a range of identified health threats expressed 
either as a disease or group of linked diseases or as a 
causal factor. Of special importance are activities to 
support Member States' actions and promotion of 
coordination of their policies and programmes, coop-
eration with international organizations and third 
countries, information, education, health promotion, 
training and research, which are further discussed 
below. 
85. The Commission will provide for the establishment 
of appropriate consultation and participation mecha-
nisms in the context of the implementation of this pub-
lic health framework. In this regard the respective roles 
of health professionals and non-governmental organ-
izations will be recognized. 
(c) Support to Member States' action and promotion of 
coordination 
86. The Commission intends to base its support for 
Member States on specific actions, which it alone is 
able to implement, in particular by promoting the 
exchange of experience and views and the preparation 
of actions that can be implemented through a variety of 
instruments in different sectors. 
87. With regard to areas of activity in which the Com-
mission believes there is value in launching new and 
innovative actions, the following considerations apply. 
(i) The comparison and evaluation of prevention poli-
cies against health threats though difficult, is essen-
tial in order to avoid an uncoordinated approach 
which can have an adverse impact on the choices 
and decisions of public health authorities. The 
Commission can play a decisive role in this respect 
by undertaking large-scale cost-effectiveness analy-
ses, based in particular on models and tools made 
available to it by epidemiological science, and by 
formulating proposals for measures and pro-
grammes aimed at strengthening the defences 
against diseases. 
(ii) The Commission will seek to assist Member States 
in improving standards of health promotion and 
disease prevention. Some Member States have 
undoubtedly attained a high level of protection in 
some areas, and since the aim is to achieve levels of 
protection at the best level existing in the Commu-
nity, the Commission should try to provide the 
information necessary to correct shortcomings, tak-
ing as its reference point those Member States' pol-
122 Table 4 — Possibilities for Community action 
Type of action 
Health 
threats and 
diseases 
Health data Surveillance, Health 
indicators monitoring of 
public 
Tobacco 
consumption 
Drug abuse 
Alcohol abuse 
Lack of exercise 
Poor diet 
Cancer 
Diseases of the 
circulatory system 
Respiratory diseases 
Congenital 
abnormalities 
Perinatal conditions 
Accidents 
Musculoskeletal 
problems 
Visual problems 
Auditory problems 
Mental disorders, 
suicides 
Nutrition-related 
disorders 
AIDS 
Other communi 
cable diseases 
Rare diseases 
Food borne diseases 
' = High  *** = Medium 
**** 
*** 
Information Health Training of Cooperation Policy Strategy Use of Financial Surveys, Cooperation Other 
on education/ health between coordination formulation instruments support studies with specific 
specific promotion professionals Member and imple- in other international preventive 
groups States mentation policies organizations actions 
and third 
countries 
*** 
*** 
Low 
*** 
*** 
*** 
** 
*** 
*** 
**** 
*** 
* = None 
**** 
**** 
*** 
**** 
*** 
** 
*** 
*** 
** 
**** **** 
*** 
*** icies and programmes which are the most advanced 
in this respect. A primary aim in this area will be 
the establishment of interconnected networks of 
competent centres for the monitoring and control 
of diseases, using appropriate data, criteria and 
methods. Efforts towards this goal are already 
under way concerning communicable diseases, and 
appropriate initiatives will be taken concerning 
other diseases, for example, cancer, building on 
systems and arrangements already existing. 
(iii) Member States' attitudes towards persons from 
non-member countries vary considerably with 
regard to health protection requirements and to 
the health protection afforded to them. Policies in 
this area need to be coordinated and the Commis-
sion intends to launch appropriate initiatives on 
this subject. In order to achieve these objectives 
there is a need for the greatest possible transpar-
ency and the Commission will need to have 
recourse to appropriate advice and to consult wide-
ly in order to plan effectively, to communicate its 
messages, and to promote dialogue on the issue of 
migrants and health. 
(d) Information, education and health promotion 
88. Activities directed towards the general public and 
specified sub-groups can be categorized as health infor-
mation, health education or health promotion. It has 
become clear over the years that the precise meaning of 
each of these terms varies according to the particular 
cultural and linguistic context. 
89. Health information involves the communication, 
often to the general public, but also to specified groups, 
of information on health-related matters. The content 
will normally be relatively general rather than personal, 
since it is unlikely that the recipients can be identified 
precisely. The medium may be paper (leaflets etc.), 
print (advertisements and articles), audiovisual (televi-
sion and radio) or, less often, personal (talks and lec-
tures by health experts, for example). 
90. Health education implies the provision of a body of 
knowledge concerning health to a defined target group, 
using learning opportunities. The process will include 
interaction with and feedback from the recipients and 
the process cannot be said to be completed until the 
target group has demonstrated a change in awareness 
which should include, and go beyond, the knowledge of 
a number of factual elements. The critical point is that 
the educator undertakes to deliver a certain set of 
information and knowledge, and will adopt various 
approaches to ensure that it is achieved. It should be 
noted that while this process is typically associated with 
school-based education of children, it is not confined to 
this group. Responsibility in this field depends on the 
administrative structures in the individual Member 
States: both health and education departments may be 
involved, and other ministries may also have a say. 
91. Health promotion has been described as applied 
health information. In other words, where health infor-
mation and health education attempt to provide the 
target with the information and tools necessary for a 
healthy lifestyle, health promotion will actively seek to 
modify attitudes, behaviour, and environments, to 
enable the pursuit of a healthy lifestyle. Techniques 
may include legislation, economic incentives, modifica-
tions in various ways of the environment of the target 
group in order to promote healthy lifestyles. Health 
promotion measures and those leading to the long-term 
improvement of social and economic conditions, have 
to go hand in hand, as health promotion is a complex 
task interwoven with the entire social and political situ-
ation. It is not sufficient to act unilaterally on health-
related problems, nor to limit efforts to people at high 
risk; rather, the whole community has to be involved in 
a joint effort that gives a continuing sense of collabora-
tion and participation to everybody and leads to the 
long-term improvement of general living conditions. 
92. Health promotion and health education can be con-
sidered as general subjects which are taking place in a 
large and diverse area (family, school, work, commu-
nity), cover many lifestyle-related diseases (cancer, 
AIDS, drugs, cardiovascular diseases, etc.) and acci-
dents, and aim to change risk behaviour (smoking, alco-
hol, nutrition, drug abuse, lack of physical exercise, 
etc.). The social and cultural differences between and 
within Member States have to be carefully assessed in 
undertaking Community health promotion and health 
education activities, particularly as regards nutrition 
and drug abuse. 
93. The different approaches needed in a diverse and 
complex society such as the European Community 
should, however, never lead to a scattered approach. 
On the contrary, the various approaches should rein-
force each other in order to ensure the maximum effec-
tiveness of all the health promotion and health educa-
tion actions. This can be done by linking the various 
approaches at the different levels (European, national, 
regional, and local). An effective organization and 
coordination of health promotion and health education 
actions at all levels, as well as careful planning and 
evaluation of the actions, within the context of an over-
all plan, is a prerequisite to ensure maximum benefits 
from the efforts expended in the promotion of health. 
The Commission, therefore, is reviewing existing pro-
grammes to ensure that where there are actions of a 
similar nature, such as health promotion and health 
education, these will be regrouped together so as to 
avoid duplication of effort and to improve efficiency. 
94. In implementing health promotion and health edu-
cation the role of the Commission will be to: 
(i) facilitate the exchange of information and models 
of good practice by networking, preparation of 
information packages, manuals, and workshops; 
(ii) lend support by providing appropriate incentives; 
124 (iii) initiate, generate, and coordinate, as necessary, 
activities at Community level. 
95. An appropriate use of the resources and expertise 
available in the Member States will be made in order to 
increase the effectiveness of health promotion and 
health education actions. 
(e) Research 
96. Apart from Articles 130f to 130q on 'research and 
technological development' which cover all research 
activities, Article 129 gives the Community a clear 
mandate for research in the field of disease causation 
and transmission. Actions under this public health 
framework should make full use of the results obtained 
under the Community's framework programmes for 
research. 
97. Research on biomedicine and health (Biomed) in 
the context of the current Community programme of 
research and technological development runs until 1994 
with a budget of over ECU 130 million. 
98. Current research covers four main areas: 
(i) coordination of research on prevention, care and 
health systems; 
(ii) major health problems and diseases with an 
important socio-economic impact; 
(iii) human genome analysis; 
(iv) medical ethics. 
99. AIDS figures prominently among the major health 
problems. The other major health problems covered by 
this programme are cancer, cardiovascular disease, 
mental illness and neurological disease and the ageing 
process and age-related health problems. In all these 
areas links with action-oriented activities are being 
strengthened. 
100. Discussions are currently under way concerning a 
fourth framework research programme on the basis of 
a formal Commission proposal (COM(93) 276). The 
Commission published on 6 October 1993 a working 
document (COM(93) 459) concerning the scientific and 
technological content of the specific programmes 
implementing the fourth framework programme. It is 
now being considered by the European Parliament and 
the Council, and it proposes the following headings for 
research in biomedicine and health during 1994-98: 
(i) AIDS, tuberculosis and other infectious diseases; 
(ii) cancer; 
(iii) pharmaceutical research: 
(iv) neurosciences and brain research; 
(v) prevention, occupational health, risk factors, and 
public health research; 
(vi) epidemiology of illnesses with a major socio-eco-
nomic impact: 
(vii) cardiovascular diseases; 
(viii) human genome analysis; 
(ix) health services research; 
(x) biomedical technology and engineering; 
(xi) biomedical ethics. 
101. Another area where significant developments in 
Community research over the next few years are ex-
pected is that of the telematics programme for health 
care (formerly AIM). The activities in AIM, with a 
budget of nearly ECU 100 million for the period 1991 
to 1994, are intended to improve the quality and cost-
effectiveness of health services through the use of 'tele-
matics', that is the combination of informatics and tele-
communications. 
102. In order to ensure that a coordinated effort is 
made and that existing and future Community research 
programmes cover adequately the subjects of health 
promotion and disease prevention, the following condi-
tions should be met: 
(i) the identification based on clear priorities agreed 
at Community level of those aspects of public 
health that need stimulus and promotion through 
research; 
(ii) coherence between public health actions and 
research activity; 
(iii), a clear strategy covering those matters relevant to 
public health topics; 
(iv) the step by step establishment of appropriate 
structures, for example, networks; 
(v) the proper dissemination of research results and 
their impact on decisions at Community level and 
Member State level. 
(f) Training of health professionals 
103. Health professionals in different settings (general 
practice, hospitals, schools, occupation, leisure) have a 
key function in the transmission of health education 
and health information messages to the Community. 
This has already been demonstrated in the case of the 
fight against cancer and AIDS, with important activities 
being undertaken in the framework of the relevant 
Community programmes. It is the intention of the 
Commission to pursue work in this area in order to: 
125 (i) increase the awareness of health professionals 
about the important role they can assume and 
about how they can contribute to the prevention of 
major diseases; 
(ii) increase their grasp of issues relevant to the pre-
vention of diseases with a multicultural dimension, 
for example, the role of nutrition, migration (for 
instance, related to thalassaemia and HIV), and 
their knowledge of conditions that are gaining in 
importance (for example, tuberculosis). 
104. To this end, taking into account both the 
Community's guidelines on education and training, as 
set out by the Commission in May 1993 (COM(93) 183) 
and the experience acquired through Community 
action programmes, such as Erasmus, FORCE and 
Comett, the Commission will undertake, where appro-
priate under these action programmes, the following: 
(i) promotion of exchange of information between 
Member States on current training courses and 
schemes notably in relation to toxicodependency, 
but also including alcohol and medicines, nutrition. 
and sexually transmitted diseases; 
(ii) coordination and recommendations on training 
programmes for health professionals, in close col-
laboration with the competent authorities, learned 
institutions, and the committees and associations 
concerned; 
(iii) encouragement of exchanges of experiences on 
teaching methods and didactic materials in relation 
to the prevention of major health scourges and on 
the evaluation of effectiveness of those teaching 
methods and materials; 
(iv) inventory and evaluation of existing methods and 
practical applications on how to improve accessibil-
ity and availability of information and materials 
aimed at health professionals, in relation to the 
prevention of major health scourges; 
(v) information and promotion of awareness of doc-
tors, nurses and social workers on specific condi-
tions uncommon in their respective Member 
States, but which, as a result of growing migration 
and travel, are becoming increasingly important in 
the Community, such as tuberculosis in migrants, 
HIV and STDs in tourists, and thalassaemia in 
people of Mediterranean origin. 
(g) Cooperation with international organizations and 
third countries 
105. Whilst cooperation with third countries and inter-
national organizations is specifically mentioned in rela-
tion to public health in Article 129, cooperation in gen-
eral has already been undertaken by virtue of Article 
228 of the EEC Treaty which provides for the conclu-
sion of agreements between the Community and one or 
more States or an international organization. The 
Treaty also states that the Commission has to ensure 
the maintenance of all appropriate relations with the 
organs of the United Nations, of its specialized agen-
cies, and shall also maintain such relations as are appro-
priate with all international organizations (Article 229). 
The EEC Treaty also provides in Article 230 for the 
establishment of all appropriate forms of cooperation 
with the Council of Europe and in Article 231 for coop-
eration with the Organization for Economic Coopera-
tion and Development (OECD). 
106. The Commission has already long-standing collab-
oration with third countries and with several interna-
tional organizations in the field of public health. In the 
future the onus must be on increasing the cooperation 
with them such that maximum benefit can be drawn for 
all the parties involved. To foster cooperation of the 
Community with third countries and international 
organizations in the field of public health it is necessary 
to have good knowledge of ongoing and planned coop-
eration between Member States and third countries 
and international organizations. This will help to avoid 
duplication of efforts and lend support to the actions 
undertaken by Member States. 
(i) International organizations 
107. A relatively large number of organizations, both 
governmental and non-governmental have health on 
their agenda. The main organizations concerned are 
WHO. the Council of Europe, the International Organ-
ization for Migration (IMO), Unesco, the International 
Atomic Energy Agency (IAEA), the Organization for 
Economic Cooperation and Development (OECD), 
the International Labour Organization (ILO), the Food 
and Agriculture Organization (FAO), the United 
Nations international drug control programme 
(UNDCP), the International Federation of Red Cross 
and Red Crescent Societies (IFRC), and the Interna-
tional Council on Alcohol and Addictions. 
108. Agreements in various forms have been estab-
lished with most international organizations, and in one 
instance the Community became a full member of an 
international organization (FAO, 1991). With the 
exception of WHO, whose activities encompass all 
health matters, other international organizations only 
deal with specific health issues as they relate to their 
objectives. However, in the case of the Council of 
Europe, which has links in many areas with the Com-
munity, there has been an expansion of its role in the 
public health field, particularly since a number of coun-
tries of Central and Eastern Europe have become 
members of that organization. 
109. The object of fostering cooperation is two-fold: 
(i) to strengthen the public health actions within the 
Community, as well as those undertaken outside 
the Community but which have an impact on it; 
126 (ii) to ensure that the Community plays an increased 
role in the public health field at the international 
level. 
WHO 
110. Cooperation with WHO is based on two exchang-
es of letters with the Commission (1972 and 1982). 
This cooperation covers the Organization as a whole, 
as well as its regional offices, and in particular the 
European office, and the International Agency for 
Research on Cancer (IARC). At operational level, 
intensive working relations have been developed 
between the Commission and WHO in different areas. 
These include the organization of joint activities in 
specific areas. Of particular importance is technical 
expertise provided by WHO to the Commission servic-
es, to help to reply to specific demands, such as devel-
opment assistance and the provision of humanitarian 
emergency aid. Cooperation in the cancer field with 
IARC is already extensive. A review of the current 
WHO-EC collaboration has been transmitted to the 
Council (COM(93) 224 final). It is the Commission's 
intention to arrange a further exchange of letters with 
WHO in order to update, improve and expand cooper-
ation on specific issues. 
Council of Europe 
111. With the Council of Europe, cooperation is based 
on the EEC Treaty and has been amplified by a 1987 
agreement. In the public health field, cooperation cov-
ers matters such as blood, organ transplantation, health 
education, youth and health promotion issues and 
health and sports, in particular, doping. There is also 
close involvement in the workings of the European 
Health Committee and the European pharmacopoeia 
and. especially, in action on drugs where close coopera-
tion exists between the Commission and the Pompidou 
Group and which will be further extended through the 
establishment of the EMCDDA. In addition, enhanced 
collaboration with the Council of Europe in the health 
field, appropriately directed, could promote coopera-
tion with Central and Eastern Europe thus contributing 
to the fulfilment of the objectives of paragraph 3 of 
Article 129. 
112. The Commission is carrying out an examination of 
its cooperation with the Council of Europe in public 
health, and will be making the results of this examina-
tion available in due course. Consideration will be 
given to proposing the introduction, into the draft 
Council of Europe conventions on health, of clauses 
permitting the European Community to become a 
party to these conventions, without the need for the 
negotiation and ratification of specific protocols. 
Other international organizations 
113. IOM: Cooperation is ongoing on the issue of 
migration and health. 
Unesco: AIDS and drug education are covered 
and will be further developed. 
ILO: Joint activities are being undertaken on 
drugs and alcohol at the workplace. Initiatives are 
being developed on smoking, health education 
and promotion also involving workers' families. 
FAO: A joint conference on nutrition and health 
has been organized and more joint activities are 
envisaged to implement its results. 
UNDCP: Cooperation on drug demand reduction 
is being stepped up. 
Red Cross: Humanitarian health assistance has 
been provided through the International Federa-
tion of Red Cross and Red Crescent Societies and 
will continue in the future on such issues as blood 
supply and quality, AIDS prevention, etc. 
OECD: Cooperation is ongoing in the field of the 
health aspects of the environment, (chemical safe-
ty in particular) and will be further developed on 
the subject of health statistics. 
IAEA: Close cooperation exists in the field of 
radiation protection. 
Nature of increased cooperation 
114. The nature of increased cooperation with interna-
tional and non-governmental international organiza-
tions could take three forms. 
(i) In matters of Community competence, the Com-
mission could ask international organizations to 
carry out specific tasks for the Commission in areas 
where these organizations have a mandate and 
proven expertise (joint projects). 
(ii) In areas reserved for cooperation between the 
Member States, the Commission can enlist the help 
of such organizations, in conducting joint pro-
grammes and actions which benefit some or all of 
the Member States. 
(iii) In areas where the international organizations con-
duct their own programmes or actions, which are 
not priority matters for the Commission or the 
Member States, the Commission may provide 
assistance, if such programmes and actions are of 
interest to the Community. 
(ii) Third countries 
115. Cooperation "with third countries will take into 
account the present and future links existing between 
these countries and the European Community. There 
are a number of countries having formal agreements 
with the Community, in some of these agreements 
health protection is specifically covered. It is intended 
127 to examine with these countries what emphasis will be 
accorded to health matters under these agreements. 
116. According to the conclusions of the European 
Council of Copenhagen (1993) Community programmes 
should be opened up to the countries of Central and 
Eastern Europe having association agreements with the 
Community. This should lead to the development of 
practical links with these countries to complement the 
assistance already provided by the Community. The 
possibility of opening action programmes for their par-
ticipation will be jointly considered with these countries. 
Similarly cooperation with countries that have applied 
for Community membership should permit the identifi-
cation of topics of mutual interest, and their gradual 
involvement in a number of ongoing activities. 
117. In the framework of its relations with develop-
ing countries, the Community participates in cooper-
ation programmes in the field of public health. 
Emphasis is placed on supporting, by means of vari-
ous financial instruments, health system reform and 
actions aimed at satisfying basic needs of the popula-
tions concerned, in particular the most vulnerable 
groups. Assistance is also extended to the fight 
against major endemic diseases, and in particular 
sexually transmitted diseases and AIDS. Collabora-
tion, in the context of public health programmes, 
present and future, will be stepped up in order to 
share experiences and adopt coherent strategies on 
health issues of importance both to the Community 
and the developing countries, such as AIDS and drug 
dependence. 
128 VII — Future action in the field of public health 
118. The strategy chosen for selecting health threats for 
action at Community level, in addition to what is and 
shall be undertaken in the research area, points to the 
pursuit by the Community of a mix of (i) actions of a 
general nature benefiting the fight against many diseas-
es, for persons of different age groups, socio-economic 
categories, sex, etc. such as health data and surveil-
lance, health information, education and promotion; 
(ii) actions that are disease-specific and need, for maxi-
mum efficacy, to be narrowly focused, ensuring at the 
same time a sensible continuation of major current pro-
grammes which have proved their worth and have 
brought together public authorities, many interest 
groups and individuals across the Community in the 
best demonstration of the principle of subsidiarity. 
119. Category (i) above directly responds to the chal-
lenge of undertaking action against all the major health 
scourges previously identified, in a way that promises 
to yield maximum health gain from the involvement of 
the Community, and stands to benefit both those who 
shape and take decisions, and the citizens of the Com-
munity. Category (ii) will help to facilitate the imput of 
interest groups and experts and better enlist and organ-
ize them in the fight against specific diseases. 
120. Annex IV shows for each identified health threat 
and disease what, in qualitative terms, is expected to be 
the impact of involvement by the Community. Commu-
nity programmes with actions of a general nature, list-
ed, among others, in Table 4, will not only yield added 
value in respect of these health threats and diseases, 
but also, in respect of other threats and diseases. This is 
the case, for example, of health information and nutri-
tion and on smoking in relation to cancer and to cardio-
vascular disease. Finally, specific actions in the context 
of programmes for particular threats and diseases will 
complement and reinforce the previous actions and will 
ensure that no opportunity is lost in tackling the select-
ed diseases in a comprehensive and coherent manner. 
Both disease specific and 'general action' programmes 
will be introduced by using the legal instruments fore-
seen by Article 129. and their aims will be furthered by 
measures based on Article 129, or indeed other appro-
priate articles of the Treaties. 
121. In terms of major health scourges, the above con-
siderations lead the Commission to conclude that a 
number of them can sufficiently be addressed at 
present by existing programmes and instruments, and 
by future actions of a general nature. These are cardio-
vascular and cerebrovascular disease, mental disease, 
congenital defects, perinatal conditions, and musculo-
skeletal disorders. The Commission intends to keep the 
situation as regards these diseases under review, so as 
to be able to undertake specific actions if this appears 
to be appropriate. Moreover, for those programmes 
and measures that have been selected, the Commission 
intends to introduce more systematic evaluation mech-
anisms, involving substantive as well as management 
measurements. The former will include estimation of 
decreases in the occurence of risk factors and alteration 
in risk behaviours and attitudes; the latter will enable 
the drawing up of conclusions on whether preset goals 
have been achieved and what modifications are needed, 
to identify the causes of success or failure, and to define 
ways by which goals can be achieved with minimum 
costs, and maximum results obtained with given 
resources. 
122. The areas singled out as a matter of priority for 
future Community action in the field of public health 
can now be determined. These areas may be the subject 
of Commission proposals for comprehensive multi-
annual programmes which set clear objectives and will 
respect the principles already outlined in this docu-
ment, including subsidiarity. These programmes would 
be introduced over a three-year period, and on the 
basis of experience gained, would last for five years. 
The programmes would be on the following topics: 
health promotion, education and training 
health data and indicators, and monitoring and sur-
veillance of diseases 
cancer 
drugs 
AIDS and other communicable diseases 
intentional and unintentional accidents and injuries 
pollution-related diseases 
rare diseases. 
In the light of experience and developments in the inci-
dence of diseases in the Community, the Commission 
may propose programmes on other health threats. 
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Overview of prevention and health promotion 
policies in the Member States 
1. Belgium 
(French community) 
Present priority areas are: AIDS, drugs, elderly people, 
immigrants and vulnerable groups. The preventive 
actions include health education, school health services, 
actions against drugs, AIDS and mental health prob-
lems. Moreover, long-existing programmes on vaccina-
tion, hygiene and sports injuries continue to be pursued. 
(Flemish community) 
A comprehensive health promotion and prevention 
strategy has been elaborated, the key elements of 
which are: 
(i) mid-term priority setting; 
(ii) coordination of local and regional initiatives 
which fit well with the overall, national and 
Community context; 
(iii) integration of sectoral approaches into a general 
health promotion frame, for example, school 
health, mental health, drug prevention, and 
child and family issues; 
(iv) implementation of legal provisions (e.g. early 
notification of diseases, vaccinations); 
(v) provision of adequate resources for specific pre-
ventive action, notably in the field of AIDS, 
cancer, cardiovascular diseases, perinatal mor-
tality, accidents, transmissible diseases and men-
tal health: 
(vi) action by the authorities assisted by other part-
ners such as the Flemish Health Promotion 
Institute which, since 1991, constitutes an 
important forum for all organizations concerned 
with health promotion and education; 
(vii) other coordination mechanisms have also been 
set up in specific fields, such as AIDS, tobacco 
prevention, alcohol and drugs, cancer, etc.: 
(viii) monitoring, surveillance and quality control 
work in public health including data collection 
and analysis of trends. 
2. Denmark 
Apart from a number of preventive services carried out 
by the established health-care system, the Danish pre-
vention policy is based on the document The health 
promotion programme of the Government of Denmark. 
This document, published in 1989, gave priority to pro-
grammes on cancer, cardiovascular disease, accidents, 
psychological problems and musculoskeletal diseases. 
In addition to these priorities. Denmark has specific 
programmes on drugs and AIDS as well as on asthma 
and allergic diseases. 
The Ministry of Health is the coordinator of all actions 
in this area taken by government agencies, and strives 
to integrate prevention considerations into other poli-
cies being implemented in Denmark. 
To this end, a number of coordinating bodies have been 
set up, all chaired by the Ministry of Health. 
As regards funding, preventive issues are financed from 
tax revenues. 
3. Germany 
Responsibility for health issues lies almost entirely with 
the Länder and apart from Federal programmes on 
cancer, AIDS, and drugs, all other health prevention 
actions as well as all other health-related activities are 
carried out in a decentralized manner by the Länder. In 
support of the above activities the Federal Government 
launched in 1993 a programme on health research 
called 'Health research to the year 2000'. This pro-
gramme deals with lifestyles, nutrition and the environ-
ment as well as care for groups at special risk namely 
children, young people, women and the elderly. 
A number of Federal advisory bodies have been set up 
to deal with health and prevention issues, foremost of 
which is the Bundesgesundheitsrat (Federal Health 
Council). The Council of professionals advises on con-
certed actions and the Federal Health Research Coun-
cil on research. Other advisory and expert groups exist 
for specific diseases. 
Preventive activities are financed from tax revenues at 
the federal, Länder, and municipality level, from health 
insurance contributions, as well as from contributions 
from companies and from various other sources. 
4. Greece 
Prevention policy in Greece follows the orientations of 
WHO's 'Health for all by the year 2000'. with emphasis 
being placed on the selection of priorities and on the 
130 involvement and cooperation of public and private 
bodies. Current areas of priority include cancer, AIDS, 
cardiovascular disease, blood and blood products sup­
plies, blood-related hereditary diseases, accidents, 
drugs, mental diseases, infectious diseases. 
Action on cancer, aided by the Community, focuses 
on nutrition, tobacco and screening programmes, and 
on developing a national cancer register. The fight 
against AIDS is carried out mainly through special 
programmes of information research and social assis­
tance. Particular efforts are made for encouraging vol­
untary blood donations, with compulsory controls 
being made on donated blood for hepatitis Β and C 
and for HIV, and on the prevention of thalassaemia 
and haemophilia. Increasing attention is directed 
towards the collection and utilization for prevention 
purposes of information on accidents on the road, 
home, and during leisure activities, and programmes 
of health education have been launched using in par­
ticular the concept of the health-promoting school. 
Action against infectious diseases includes systematic 
vaccination and compulsory notification, as well as ad 
hoc measures, for example on tuberculosis and malar­
ia. The elderly benefit from a range of health informa­
tion and education actions, and from measures 
designed to provide assistance at home. Finally, train­
ing of health professionals on prevention and on the 
problems of migrants is gaining importance. 
Policy is formulated by the Ministry of Health and 
Social Security, following advice from the Central 
Health Council which comprises experts from across 
the health professions. Specialized quasigovernmental 
agencies and bodies exist for the implementation of 
measures and programmes against certain diseases and 
health threats. 
Financing of action programmes and research is mostly 
provided by the Ministry of Health budget, but there 
are also contributions from tobacco taxation and 
nationwide donation campaigns. 
developing primary health care, special care, maternal 
and infant care, development of oral hygiene, mental 
health care and the rehabilitation and geriatric care 
systems. Specific disease prevention programmes 
include programmes on cardiovascular diseases, can­
cer. AIDS, accidents and zoonoses. In addition to 
these programmes, two horizontal programmes are 
being carried out on health promotion and health edu­
cation. 
Responsibility for the execution of prevention policies 
lies at all administrative levels: the national, regional 
and the local levels and a number of advisory bodies 
assist in the formulation and implementation of the var­
ious policies. Legal provisions regulate areas like vacci­
nations, notifiable diseases, food hygiene, atmospheric 
protection, protection against physical agents and pro­
tection against hazards at work. Additionally, a com­
prehensive set of legal instruments regulates tobacco: a 
ban on advertising, health warnings, nicotine and tar 
contents, a ban on sales to children and restrictions or 
bans on consumption. 
6. France 
The national prevention policy contains three elements: 
(i) action directed at all determinant issues affecting 
health; (ii) medical prevention (vaccination, screening 
and prophylaxis; and, (iii) action directed at specific 
target groups (school children, the old, pregnant 
women, the disabled, and young people with adapta­
tion difficulties). 
In 1991, a high-level committee on public health was 
established by the Minister for Health in order to give 
advice on public health questions and policy. This com­
mittee is at present reshaping public health policy on 
the basis of WHO's health for all strategy. Besides that 
committee, prevention and health promotion activities 
are carried out by specific advisory bodies and by local 
authorities. 
5. Spain 
The general health objectives fall into three categories: 
promotion of healthy lifestyles, prevention of environ­
mental risks to health and improvements to the health­
care system. 
Concerning the promotion of healthy lifestyles, public 
health measures are aimed at reducing tobacco con­
sumption and its harmful effects on health, encourag­
ing physical exercise, reducing the harmful effects of 
alcohol, reducing drug abuse and dependency on 
harmful substances and developing diets suited to indi­
vidual needs. The measures for the prevention of envi­
ronmental risks are aimed at reducing biological, phys­
ical and chemical risks as well as preventing hazards at 
work and accidents. Finally, improving the health-care 
system includes the extension of public health care. 
Legal obligations cover the following areas: vaccina­
tions; medical examinations before marriage, during 
pregnancy and post-natal for mother and child: drug 
use; tobacco and alcohol advertisements: and declara­
tion of communicable diseases. 
Prevention programmes on specific diseases and health 
threats concern AIDS, drugs and drug abuse, tobacco 
and alcohol, use of pharmaceuticals, STDs, cancer 
screening prevention and dental problems. General 
prevention programmes are directed towards elderly 
people, women, young people, the handicapped and 
also concern the integration of health aspects in urban 
development and schools. 
As regards funding, prevention activities are financed 
from a combination of tax revenues and health insu­
rance contributions. 
131 7. Ireland  9. Luxembourg 
The objectives of the national prevention policy 
include: prevention of infectious diseases, early detec-
tion of health defects in children, achieving significant 
improvements in the level of oral health, and reducing 
the incidence of disease attributable to smoking, alco-
hol abuse and other lifestyle-related factors. 
The Irish Government in 1988 adopted a policy aimed 
at health promotion, and established new health pro-
motion structures including a Cabinet sub-committee 
on health promotion to provide an effective mechanism 
whereby decision-making in areas of public policy with 
an impact on health can be made on the basis of a 
health perspective. Preventive actions in Ireland 
include immunization programmes, notification, diag-
nosis and hospital services for infectious diseases, moni-
toring of tuberculosis, cervical screening, maternity, 
infant care and child health, dental care, AIDS, drug 
abuse and tobacco. 
Since the 1970s, preventive action has been an integral 
part of the overall health policy in Luxembourg. This 
was reflected in the reorganization of the Government 
Health Department in 1980 whereby special divisions 
were set up for prevention. The most important pro-
grammes are the programmes on drugs, tobacco, alco-
hol, on cardiovascular diseases, and on cancer. In addi-
tion to this, a special programme has been launched to 
promote healthy nutrition and healthy lifestyles. 
Activities on prevention are coordinated by the Minis-
try of Health, with the other ministries taking part in 
the overall effort as well. Activities on prevention have 
since June 1992 been the object of the revised law on 
health insurance and the health sector. Apart from the 
provisions contained in this law, Luxembourg has not 
yet developed a separate and comprehensive pro-
gramme on prevention. 
Towards the end of 1993 the Ministry of Health pro-
posed a national health strategy which, in particular, 
included a strategic plan for health, promotion, mapped 
out the current Irish health status and set out national 
goals and targets for specific improvements, along with 
a strategy for achieving them. 
8. Italy 
Preventive activities in Italy are mainly concentrated 
on four issues. Environment and health, lifestyle-relat-
ed problems, health protection at work and the preven-
tion of infectious diseases. 
As regards environment and health, activities are in-
creasingly being carried out by the European Centre of 
Environment and Health which was set up by mutual 
agreement between the regional office for Europe of 
WHO and the Italian Government. On lifestyle-related 
diseases, Italian policy concentrates on nutrition, smok-
ing, drugs, and AIDS. Concerning health protection at 
work, the basic law (No 46 of 5 March 1990) governs 
health and safety at technical installations, equipment, 
substances and buildings, and has been supplemented 
by decrees transposing EC Directives based on Article 
118a of the EEC Treaty. For the prevention of infec-
tious diseases, Italy has over the last two years intro-
duced a new system for the prevention of and reporting 
on such diseases. The new system means that such dis-
eases can be identified better and more quickly ensur-
ing a rapid flow of information to and from the Minis-
try of Health so that, where appropriate, immediate 
action can be taken and information exchanged with 
international health organizations. 
Responsibility for the prevention activities lies with a 
number of institutions, notably the Ministry of Health, 
the National Health Service, local health authorities 
and the drugs addiction services. 
10. The Netherlands 
Prevention policy in the Netherlands is based on a 
number of programmes. Disease prevention consists of 
national vaccination programmes, screening pro-
grammes, cervical and breast cancer screening pro-
grammes, and counselling services for mothers and 
young children. Systematic training on prevention is 
currently being introduced notably for general practi-
tioners. Action on health promotion covers a wide 
range of activities such as national health education 
campaigns, school and workplace health education con-
ferences, mental health education especially for groups 
at risk, such as the elderly, divorced couples, children, 
etc. Health education also focuses on alcohol, tobacco 
and drugs. Intersectoral actions are carried out in the 
work environment, notably for safety and health at 
work, and so on. 
Preventive activities are carried out by national special-
ized institutions, municipal public health services, 
regional mental health services, regional addiction ser-
vices and primary health-care professionals. 
Disease prevention is financed by the insurance 
schemes. 
11. Portugal 
The medium-term objective for the Portuguese strategy 
on prevention is to improve the standard of public 
health by means of campaigns against cancer, drugs, 
AIDS and by the prevention of stroke and cardiovascu-
lar disease, the prevention of accidents in general, the 
prevention of suicide and by improving assistance to 
the elderly, to children and to young people. Moreover, 
the overall strategy seeks to improve conditions and the 
functioning of the health-care system by increasing the 
number of beds for the chronic sick, by improving or 
132 replacing facilities providing health care, and by taking 
steps to rationalize existing human resources and pro-
mote a better distribution of medical health-care per-
sonnel. The Ministry of Health is carrying out specific 
programmes on the control of diabetes mellitus and 
hypertension, vaccination, infant and juvenile health 
care, maternal health care, oral health, health at school, 
health education, a national cancer project, drug pre-
vention, and AIDS. 
The prevention policy in Portugal is coordinated by the 
Ministry of Health and is laid down in the Portuguese 
National Health Service Law. The Ministry of Health is 
advised by the National Health Council which compri-
ses representatives from all parties concerned with 
health protection. The National Health Council formu-
lates recommendations on the overall health strategy 
and in this work it is assisted by a large number of con-
sultative bodies. 
12. United Kingdom 
Prevention policy in the UK is made up of four parts. 
(i) Screening and immunization programmes 
include breast and cervical cancer screening, 
and immunization of all children for diphtheria, 
tetanus, whooping cough, polio, measles, 
mumps, rubella. BCG and HIB. 
(ii) Specific health initiatives exist, such as the 
'Health of the nation' initiative for England 
launched in July 1992 which identified five 
national priorities and set 27 targets. The prior-
ity areas concern coronary heart disease and 
strokes, cancers, mental illness, accidents, and 
HIV/AIDS and sexual health (including family 
planning). The implementation of this initiative 
is to be based on the commitment of all Govern-
ment departments, on building health alliances 
at national and local level, on acting through 
appropriate settings, and on improved health 
monitoring and impact evaluation. 
(iii) Health promotion and education activities are 
another part. For England, under the 'Health of 
the nation' strategy, priorities were established 
for activity by the Health Education Authority, 
both at national and local level, for health pro-
motion as an explicit element in general 
practitioners' contracts and for widespread 
health promotion throughout the health service. 
Other preventive actions specifically concern 
smoking, alcohol, drug misuse, nutrition, family 
planning and dental health. 
(iv) Environmental health and public health actions 
include actions on the safety of medicines, consu-
mer products and the environment, promotion of 
food hygiene at national and local level, and finally 
control and surveillance of communicable diseases. 
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Community policies and instruments of direct 
relevance to health protection 
1. Overview of activities 
Health and the environment 
The close link between the environmental aspects of 
public health and the necessity of governmental inter-
vention was well established throughout Europe by the 
end of the last century and by then international activ-
ity had already begun. The efforts of the European 
Community 'to preserve, protect and improve the qual-
ity of the environment' and thus 'to contribute towards 
protecting human health' are a continuation of this 
international activity made more influential and effec-
tive by EC powers to legislate and EC funds to assist 
implementation. The latest comprehensive expression 
of the Community's environmental activities is to be 
found in 'Towards sustainability'. a European Commu-
nity programme of policy and action in relation to the 
environment and sustainable development (COM(92) 
23 final, Volume II) adopted by the Council on 1 Feb-
ruary 1993. This programme contains further proposals 
for improving the quality of water, air and soil, for con-
trolling dangerous substances and industrial activities, 
and for monitoring radiation and controlling pollution 
and the disposal of waste. 
Health and safety at work 
The adoption of the Single European Act (1986) and 
inclusion of Article 118a gave a great boost to the 
Community's efforts to improve the health and safety of 
workers and reduce the risks from carcinogens and 
other dangerous substances and accidents at work. The 
Community's involvement in this area originated in the 
concern to improve working conditions in the Treaty 
establishing the Coal and Steel Community (April 
1951), reinforced by the social provisions (Title HI) of 
the EEC Treaty and the health protection measures in 
the Euratom Treaty. Important measures were adopted 
from 1977 onwards, notably in 1980, but a significant 
step in Community involvement was taken in 1989 when 
a framework Directive (89/391/EEC) was adopted on 
the improvement of the safety and health of workers at 
work. A large number of subsequent Community meas-
ures have been adopted within this framework, estab-
lishing the Community as the driving force in occupa-
tional safety and health matters. Some of these measures 
are closely linked with the Community's public health 
measures in the field of toxicology and poison centres.
1 
A healthy population requires healthy food 
The need for food products to be safe, uncontaminated. 
and wholesome led to phytosanitary and veterinary 
controls, as well as to requirements for the composition 
of foodstuffs, the use of preservatives, additives, etc. 
and for informative labelling requirements. These mat-
ters are the subject of a number of internal market 
measures in the Community dating back as far as 1962. 
More recently (mid-1980s onwards) interest has been 
growing in the nutritional value of foodstuffs and addi-
tives for the promotion of health. Current public health 
concerns are to avoid foodstuffs which have an associa-
tion with major diseases such as cancer and cardiovas-
cular disease and to help people to choose sensibly 
what to eat through health education and by clear 
labelling of the components of food products. To this 
end, the Commission has instituted a major nutritional 
study under the Europe against cancer programme.
2 
Consumer protection 
The population also needs protection from other prod-
ucts and from the potentially harmful effects of some 
services. The products include not only medical prod-
ucts such as pharmaceuticals
3 and medical devices
4 but 
also the whole range of potentially dangerous items 
available on the market. The Community's internal 
market measures to ensure a high level of health pro-
tection in these matters include 'new approach' direc-
tives relating to medical devices, personal protective 
equipment, machinery, toys,
5 etc., as well as directives 
and measures relating to consumer information general 
product safety and the monitoring of accidents.
6 
Research and information technology 
Basic to developments in public health policy are the 
findings of research into the causes and transmission of 
diseases and ways to prevent them, including the use of 
modern techniques of information technology. The 
Community's successive medical and health research 
programmes have, since their start in 1978, contained 
Resolution of the Council and Ministers for Health of the 
Member States on improving the prevention and treat-
ment of acute human poisoning (90/C 329) of 3 December 
1992. 
European prospective investigation of cancer, nutrition 
and health (EPIC) 1998. 
Council Directives 65/65, 75/318 and subsequent legisla-
tion. 
Council Directive 90/385/EEC of 20.6.1990 (OJ L 189, 
20.7.1990) and Council Directive 93/42/EEC of 14.6.1993 
(OJ L 169, 12.7.1993). 
Council Directive 88/378 of 3.5.1988 (OJ L 187,16.7.1988). 
Council Directive 92/59. 
134 an important element concerned with the prevention of 
disease. The current Biomed programme contains simi-
lar provisions. Community information technology and 
telematics programmes and pilot schemes, often carried 
out in cooperation with WHO and the Council of 
Europe, have included elements concerned with the 
monitoring of congenital disease, the use of informatics 
in medicine (AIM), care systems (statistics, early warn-
ing, food safety and pharmacovigilance). and epidemi-
ology. 
Social security 
The coordination of social security systems gives 
insured people access under certain circumstances to 
health care in all other countries of the Community by 
means of Regulation (EEC) No 1408/71 and form Elll. 
The recognition of a right to benefit from systems for 
protection of human health regardless of personal 
resources is laid down in Council recommendation 
92/442/EEC on the convergence of social protection 
objectives and policies. Access to systems for the pro-
tection of human health, regardless of an individual's 
resources, can be guaranteed either through a system of 
health insurance, which is open to persons of all income 
levels irrespective of their individual risk profile, or 
through the free provision of health care and preven-
tion within a public health service. 
The health professions 
The health professions and staff of governmental and 
non-governmental organizations responsible for the 
provision of health services have a key role to play in 
the provision of advice and information for the promo-
tion of public health and the prevention of disease. 
The Community's measures for the mutual recognition 
of professional qualifications between the Member 
States and for the development of cooperation and 
training in higher education and training institutions 
make an important contribution in this context. Ele-
ments of the Community's programmes to combat can-
cer and AIDS are designed to promote improved 
training for health staff involved in the fight against 
those diseases. 
Disease prevention and health promotion 
The Community's public health activities since the mid-
1980s have gone beyond control of and protection from 
environmental and workplace health hazards to the 
encouragement and coordination of measures to com-
bat major diseases and to promote health in a positive 
way. 
The Community's programme to combat cancer 
(1987-89) was the first major disease prevention pro-
gramme. The Europe against cancer programme 
focused on actions in particular areas such as tobacco 
and alcohol consumption, dietary habits, exposure to 
carcinogens and to the sun. It encouraged appropri-
ate screening programmes and information on early 
detection and promoted a 10-point European code 
against cancer for the general public. The Commu-
nity, using internal market provisions, adopted legis-
lative measures on tobacco to improve and control 
the labelling of tobacco products and the tar content 
of cigarettes. A recommendation on smoking in pub-
lic places was adopted and a proposal for a directive 
to ban the advertising of tobacco products is current-
ly under consideration. A further programme to 
combat cancer was adopted to continue the activity 
from 1990 to 1994, which demonstrated its value and 
effectiveness, its power in agenda setting, and its 
impact, through its partners at all levels, on raising 
awareness. 
Other major public health programmes soon followed 
as political pressure and health developments demand-
ed Community action. The Europe against AIDS pro-
gramme (1991—93) has 10 main action areas. As with 
cancer, some actions concerned the raising of public 
awareness, improved health education and cooperation 
with the Community's research programme. Other new 
elements were also introduced to suit the particular 
nature of the disease, including social support and 
counselling, estimates of the costs of managing HIV 
infection and efforts to combat discrimination against 
HIV-positive persons. Following the evaluation by the 
Council of the action under the programme, and in 
anticipation of the coming into force of the Treaty on 
European Union, the Council and the Ministers for 
Health have sought to prolong the programme to the 
end of 1994. 
The European plan to combat the abuse of drugs has a 
particular element concerned with public health actions 
to reduce the demand for drugs. Information exchang-
es, the raising of public awareness, and assistance for 
pilot projects on prevention are features of the plan. A 
European drug prevention week is an important means 
of fostering cooperation and raising awareness. 
For the public to know about and respond to such 
guidelines as the European code against cancer, a sus-
tained programme of health promotion and education 
and the provision of relevant information is necessary. 
The WHO's programme 'Health for all by the year 
2000' stressed this approach and the Community's 
initiatives on health education, instituted by both the 
Education and the Health Ministers, are concerned 
with the subject. Campaigns to persuade people to 
change their behaviour have also been launched in the 
context of the Community's programmes to combat 
cancer and AIDS and actions on drug abuse. 
Other aspects 
There are. of course, other aspects of the Com-
munity's public health activities. Actions to promote 
135 the attainment of self-sufficiency in human blood or 
plasma derived from voluntary non-remunerated 
donations and to develop the production of blood 
products coming from these donations are a good 
example. There have also been actions in the field of 
toxicology for health protection, on improving the 
prevention and treatment of acute human poisoning, 
in the development of the European emergency 
health card and in a number of other areas, not only in 
the sphere of public health, but also as part of other 
Community policies. 
2. List of Community instruments of direct rele-
vance to health protection 
EEC Treaty 
(1951—57): implicit recognition of public health con-
cepts by reference to 'accelerated raising of the stan-
dard of living* — many articles indirectly relevant to 
health protection. 
Euratom Treaty 
(1957): provides for: 
(i) basic safety standards to be laid down within the 
Community for the protection of the health of 
workers and the general public against the dan-
gers from ionizing radiations (chapter III); 
(ii) safeguard inspections and training of inspectors 
(chapter VII); 
(iii) conclusion of agreements or conventions with 
international organizations, third countries (chap-
ter X). 
With the adoption of the Single Act 
(1986): a specific legal basis concerning health, safety, 
environmental protection and consumer protection was 
established: Article 100a(3); Article 118a (protection of 
workers' health and safety); environment (Articles 
130r, 130s, 130t). 
Health and safety at work 
(1977—78): adoption of the first Council Directive 
concerning safety signs and the Direc-
tive concerning vinylchloride mono-
mer (based on Article 100 of the EEC 
Treaty). 
1980: Council Directive concerning the protec-
tion of workers against chemical, physical 
and biological agents (Article 100). 
1989: adoption of the framework Directive 
89/391/EEC concerning main apsects of 
health and safety at work (Article 118a) 
and 12 other directives on particular 
aspects of occupational safety and health. 
Environment 
EEC Treaty (Articles lOOr, 100s, lOOt) 
(1) Dangerous substances, 
ogy. Examples include: 
industrial risk, biotechnol-
1967: Council Directive 67/548/EEC relating to 
classification, packaging and labelling of dan-
gerous products (OJ L196,16.8.1967, p. 1); 
1976: Council Directive relating to restrictions on 
the marketing and the use of certain danger-
ous substances and preparations (OJ L 262 
27.9.1976, p. 201); 
1982: Council Directive on the major accident haz-
ards of certain industrial activities (OJ L 230. 
5.8.1982, p. 1); 
799.?: Council Directive on principles for assess-
ment of risks to man and the environment of 
substances. 
(2) Air. Examples include: 
1970: Council Directive concerning air pollution by 
emissions from motor vehicles (OJ L 76. 
6.4.1970, p. 1): 
1982: Council Directive on a limit value for lead in 
the air (OJ L 378, 31.12.1982, p. 15); 
1985: Council Directive on air quality standards for 
nitrogen dioxide (OJ L 87,27.3.1985, p. 1). 
(3) Directives on waste (OJ L 194, 25.7.1975. p. 39), 
waste water treatment (OJ L 135, 30.5.1991, p. 40), 
waste prevention of air pollution from waste incin-
eration plants (OJ L 163,14.6.1989, p. 32; OJ L 203, 
15.7.1989, p. 50). 
(4) Noise (motor vehicles, aircraft, construction plants, 
household appliances, etc.) (OJ L 42, 23.2.1970, p. 
16). 
(5) Water (drinking water quality, bathing water) (OJ 
L 347,17.12.1973, p. 1). 
Consumer protection 
Foodstuffs 
Since 1962 Council Directives concerning additives 
used in foodstuffs intended for human consumption 
136 have been adopted (based on Article 100 of the EEC 
Treaty). In 1969 a Standing Committee for Foodstuffs 
was set up. The Scientific Committee for Food which 
sets up lists of additives and the conditions for their use 
was set up in 1974. 
1985: 
1989: 
1990: 
Other 
1989: 
1988: 
1991: 
1992: 
Council Directive concerning certain sub-
stances having hormonal action. 
Council Directive on the official control of 
foodstuffs and Council Directive on the 
approximation of laws of the Member States 
relating to foodstuffs for particular nutrition-
al uses (based on Article 100a (3) of the EEC 
Treaty). 
Council Directive related to quick-frozen 
foodstuffs for human consumption. 
Council Directive on nutrition labelling for 
foodstuffs. 
Council Directive relating to plastic materials 
intended to come into contact with food-
stuffs. 
Council Decision on a Community system for 
the rapid exchange of information and the 
dangers arising from the use of consumer 
products (Article 235). 
Council Directive concerning safety of toys. 
Council Directive on control and acquisition 
of weapons. 
Council Directive on general product 
safety. 
Pharmaceuticals 
In 1965. the Council adopted the first Directive on the 
approximation of the provisions relating to proprietary 
medicinal products, based on Article 100 of the EEC 
Treaty. 
1975: Setting up of a pharmaceutical committee: 
the Committee for Proprietary Medicinal 
Products, Council Directive relating to stan-
dards and protocols in respect of the testing 
of proprietary medicinal products. 
1987: Council Directive concerning the approxi-
mation of national measures relating to the 
placing on the market of high-technology 
medicinal products, and Council Directive 
concerning tests relating to the placing on 
the market of proprietary medicinal prod-
ucts. 
1989: Council Directives 89/342/EEC on vaccines, 
89/343/EEC on radiopharmaceuticals. 
89/381/EEC on blood derivatives, and 
89/105/EEC on the transparency of the pric-
ing and reimbursement of medicinal prod-
ucts for human use (Article 100a). 
1991: Commission Directives on pharmaceutical 
goods manufacturing practice (91/356/EEC) 
and on testing requirements for medicinal 
products (91/507/EEC). 
1992: Council directives on wholesale distribution, 
legal classification for the supply, labelling 
and advertising of medicinal products for 
human use (Article 100a). 
1993: Council Regulation (EEC) No 2309/93 (Arti-
cle 235 of the EEC Treaty) and Council 
Directives 93/39/EEC and 93/40/EEC (Arti-
cle 100a) creating a European Agency for the 
Evaluation of Medicinal Products and estab-
lishing new Community procedures for the 
registration of medical products for human 
and veterinary use. 
Free circulation of persons 
1964: Council Directive 64/221/EEC on the coordi-
nation of special measures for foreign nation-
als on grounds of public order, public secur-
ity or public health, concerning their move-
ment and residence (Article 56(2) of the 
EEC Treaty). 
Medical and paramedical activities 
1975: Setting up of a committee of senior officials 
on public health concerned with the: 
Directive on the mutual recognition of 
diplomas of doctors (Articles 49. 57 and 66 
of the EEC Treaty); 
Directive on the coordination of provi-
sions in respect of activities of doctors 
(Articles 49, 57, 66 and 235 of the EEC 
Treaty). 
Followed by the: 
Council Directive concerning the mutual 
recognition of diplomas of nurses (1977); of 
dentists (1978); of midwives (1980); of phar-
macists (1985) and of general practitioners 
(1986). 
Medical devices 
The Council has adopted several directives concerning 
protection of health and safety of persons with regard 
to placing medical devices on the market: 
137 Directive 84/539/EEC on electro-medical equip- Directive 90/385/EEC on active implantable devices: 
ment used in human or in veterinary medicine; Directive 93/42/EEC on medical devices. 
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Health protection requirements as a constituent 
part of other Community policies 
Cooperation in the fields of law and internal 
affairs 
Control of persons at external frontiers, immigration, 
drugs, and European Monitoring Centre for Drugs and 
Drug Addiction. 
Citizens' rights 
Accession to the European Convention on Human 
Rights. 
Protection of personal data. 
External affairs 
PHARE and TACIS; UN drugs. 
Relations with international organizations: Council of 
Europe, WHO, FAO, OECD, IOM, Unesco, UNDCP, 
IAEA, UN. 
Acceptance of the European Pharmacopoeia. 
Cooperation with third countries: EFTA. CEEC, Medi-
terranean countries, Latin America, North America, 
etc. 
Negotiations with ASEAN on the illicit manufacture of 
drugs and psychotropic drugs. 
Monitoring of intra-Community and international traf-
fic in drugs and psychotropic drugs. 
Internal market 
Quality, safety and hygiene of food products, warning 
system, labelling, additives, colouring agents, contam-
inants, interaction between diet and health, packag-
ing. 
Medical equipment standardization, e.g. in vitro diag-
nosis, pharmaceutical products, cosmetic products, 
drugs and precursors. 
Substances and dangerous preparations, classification 
and labelling; fertilizers, biocides. 
Regulation of qualifications of (health) personnel. 
Competition 
Price of medicinal products; social security systems. 
Social affairs 
Women and health, social protection, disabled persons, 
the elderly, migrants, poverty, health protection of 
workers, European Social Fund. 
Education and training 
Erasmus, activities intended for young people and 
health professionals. 
Agriculture 
Quality and health of plants, animals and specialized 
crop species (fruits and vegetables, wine, alcohol, 
tobacco, etc.); hygiene related to fish, shellfish, milk, 
dairy products. 
Promotion of consumption of olive oil, dairy products, 
fruits and vegetables. 
Veterinary and phytosanitary controls within and out-
side the Community. 
Fisheries 
Quality of products from fishing and aquaculture. 
Promotion of consumption of products from fishing 
and aquaculture. 
Promotion of sanitary conditions of production, con-
sumption and commercialization of products from fish-
ing and aquaculture. 
Transport 
Transport safety; prevention of accidents, in particular 
road accidents associated with alcohol, accident data-
base. 
Development 
Cooperation actions concerning health systems reform, 
and programmes and projects of support to the devel-
opment of health. 
Campaign against AIDS. 
R&D programme in the field of science and technol-
ogy for development, subprogramme on medicine, 
health and nutrition in tropical and sub-tropical 
areas. 
139 Culture communication and information 
People's Europe: activities aimed at young people, in 
the fields of drugs, AIDS, sport, for example. 
Environment 
Nuclear safety and health protection (Euratom; protec-
tion against other physical agents: noise, low frequency 
electromagnetic waves). 
Control of dangerous chemical substances and prepara-
tions; dangers associated with biotechnology and gene-
tically modified organisms. 
Control of emissions from industrial installations; waste 
management. 
Quality of the air, soil, water, drinking water. 
Civil protection. 
Research 
Community Reference Bureau. 
Nuclear safety; radiation biological and health effects; 
assessment of risks of natural and medical radiation. 
Biotechnology: neurosciences. 
Biomed I: human genome analysis; biomedical ethics, 
research on health services and technologies and dis-
eases associated with lifestyle: AIDS, cancer, drugs, 
ageing, quality control. Fourth R&TD programme: pre-
ventive and epidemiological research on diseases with 
major socioeconomic impact and genetic diseases. 
Research on health systems, on evaluation of needs. 
and on education and information on health matters. 
European brain research. 
Telecommunications and telematics programme 
Telematics programme for health care (AIM), 
improved quality assurance and effectiveness of thera-
peutic and social measures and primary health services, 
resource management medical images, health records, 
rehabilitation patient data cards, etc. via results of sev-
eral specific projects, concerted action and accompany-
ing measures: RACE, Esprit, Impact, TIDE. 
Telematics programme for administration (ENS) 
CARE project: rapid, efficient access to health statis-
tics; pharmacovigilance, etc. 
Legal protection of data (Council of Europe recom-
mendations). 
Indirect taxation 
Distilled and fermented beverages, processed tobacco. 
Tourism 
Consumer protection 
General safety of products and services and liability; 
Ehlass project; system for the rapid exchange of infor-
mation; consumer information and education. 
ECHO 
Emergency humanitarian aid for non-member coun-
tries. 
Social and health statistics 
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I tl en t i fica t io n of major health scourges 
in the European Community 
Disease I 
health problem 
Cancer 
Cancer of colon 
Lung cancer 
Digestive organs 
Breast cancer 
Prostate cancer 
Diseases of the circulatory system 
Hypertensive disease 
Acute myocardial infarction 
Cerebrovascular 
Ischaemic heart disease 
Respiratory diseases 
Bronchitis, emphysema, asthma 
Congenital abnormalities 
Perinatal conditions 
Accidents (including poisoning) 
Motor vehicle accidents 
Drug and alcohol abuse 
Musculo skeletal problems 
Visual problems 
Auditory problems 
Mental disorders 
Suicides 
Nutrition-related disorders, 
including diabetes, 
dental caries 
AIDS 
Other communicable diseases, e.g. 
sexually-transmitted diseases and 
tuberculosis 
Childhood infections, e.g. 
Measles 
Rubella 
Other childhood infections 
Rare diseases, e.g. 
Thalassaemia, sickle-cell anaemia, 
rickets 
Food borne diseases, e.g. 
Salmonella poisoning 
·*·* = High 
Standardized 
death rates per 
100 000 or 
incidences per 
100 000 (estimates) 
337 
29 
42 
62 
33 
19 
338 
16 
90 
90 
137 
17 
5 
5 
51 
15 
13 
2.41 (incidence) 
51 (incidence) 
26 (incidence) 
*** = Medium 
Costs for 
health services 
(and other 
costs, e g. 
absenteeism) 
*** 
**** 
*** 
*** 
*** 
**+* 
*** 
**** 
** 
**** 
*** 
*** 
*** 
** 
* 
** 
** = Low 
Practical 
possibilities 
or 
prevention 
*** 
*** 
*** 
**** 
**** 
**** 
**** 
*** 
** 
** 
** 
*** 
**** 
**** 
**** 
*** 
**** 
* = None 
Community 
added value 
(opportunities 
for 
intervention) 
**** 
**** 
*** 
**** 
**** 
*** 
* 
*** 
**** 
**** 
**** 
*** 
**** 
Major scourge 
(major 
health 
problems) 
**** 
**** 
*** 
* 
**** 
**** 
*** 
* 
** 
*** 
*** 
* 
** 
*** 
Previous 
Community 
health 
action 
**** 
** 
** 
** 
*** 
** 
* 
* 
*** 
*** 
*** 
* 
* 
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Statistical data 
Figure 1 — Total and public expenditure on health care in relation to national expenditure in the 
Community, 1970,1980 and 1991 
Percentage of national expenditure (GDP less exports plus imports) 
to 
6 -
Total expenditure □ Public expenditure 
I 
10 
EL  UK DK IRL B 1 NL 
Public expenditure in 1990 for EL. L, P. 
142 Figure 2 — Temporal distribution of causes of death (EUR 12) 
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143 Figure 3 — Causes of death by age group (EUR 12) in 1989' 
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Belgium 1986: Spain 1987; Italy 1988. 
In this year group nearly all accidents are traffic-related. 
Infectious and parasitic diseases, diseases of the digestive system, of the genito-urinary system, of 
the nervous system, of the blood, skin. etc. 
145 Leading causes of death by age and sex 
in the European Community 
Age in years 
under 1 
1-^1 
5—9 
10—14 
20—24 
28—29 
30—34 
35—39 
40^4 
45—49 
50—54 
55—59 
60—64 
65—69 
70—74 
74—79 
80—84 
over 85 
Source: World Health Organization. 
Males 
Hypoxia, birth asphyxia 
and other respiratory conditions 
Motor vehicle accidents 
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Motor vehicle accidents 
Motor vehicle accidents 
Suicide 
Acute myocardial infarction 
Acute myocardial infarction 
Acute myocardial infarction 
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Acute myocardial infarction 
Acute myocardial infarction 
Acute myocardial infarction 
Diseases of pulmonary circulatory 
and other cardiopathies 
Females 
Hypoxia, birth asphyxia 
and other respiratory conditions 
Congenital anomalies of heart 
and circulatory system 
Motor vehicle accidents 
Motor vehicle accidents 
Motor vehicle accidents 
Motor vehicle accidents 
Suicide 
Breast cancer 
Breast cancer 
Breast cancer 
Breast cancer 
Breast cancer 
Breast cancer 
Acute myocardial infarction 
Acute myocardial infarction 
Acute myocardial infarction 
Acute cerebrovascular disease 
Diseases of pulmonary circulatory 
and other cardiopathies 
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(Information) 
COUNCIL 
COMMON POSITION (EC) No 1/96 
adopted by the Council on 20 December 1995 
with a view to adopting Decision 96/. . ./EC of the European Parliament and of the Council, of 
.. ., adopting a programme of Community action on the prevention of drug dependence within 
the framework for action in the field of public health (1996 to 2000) 
(96/C 37/01) 
THE EUROPEAN PARLIAMENT AND THE COUNCIL OF 
THE EUROPEAN UNION, 
Having regard to the Treaty establishing the European 
Community, and in particular Article 129 thereof, 
Having regard to the proposal from the Commission ('), 
Having regard to the opinion of the Economic and Social 
Committee (
2), 
Having regard to the opinion of the Committee of the 
Regions (
3), 
Whereas in its resolutions (
s) concerning this problem the 
European Parliament formulated a series of proposals 
with a view, in particular, to Community action on the 
prevention of drug dependence; 
Whereas the European Council, at its meeting in Dublin 
on 25 and 26 June 1990, stressed that it was the 
responsibility of each Member State to develop an 
appropriate drug demand reduction programme and 
considered that effective action by each Member State, 
supported by joint action of the Twelve and the 
Community, should be a main priority over the coming 
years; 
Acting in accordance with the procedure laid down in 
Article 189b of the Treaty (
4), 
Whereas drug dependence has grown alarmingly in the 
Member States and has serious implications for the 
health of individuals and the welfare of the general 
public; 
Whereas, in creating in 1985 a Committee of Inquiry 
into the problem of drugs in the Member States of 
the European Community, the European Parliament 
demonstrated its desire to study in depth the factors 
which trigger drug demand and enable drugs to continue 
being produced and distributed; 
(') OJ No C 257, 14. 9. 1994, p. 4. 
(
2) OJ No C 110, 2. 5. 1995, p. 8. 
(
3) OJ No C 210, 14. 8. 1995, p. 88. 
C) Opinion of the European Parliament of 20 September 1995 
(not yet published in the Official Journal), Council common 
position of . . . (not yet published in the Official Journal) and 
Decision of the European Parliament of ... (not yet 
published in the Official Journal). 
Whereas the actions undertaken at Community level on 
the basis of Council resolutions, declarations and 
conclusions relating to the prevention of drug 
dependence, and in particular subsequent to the adoption 
by the European Council, meeting in Rome on 13 and 
14 December 1990, of the European Plan to Combat 
Drugs, have helped to sustain the Member States' 
efforts; 
Whereas the Council, in its resolution of 2 June 1994 (
6), 
in response to the Commission communication of 
24 November 1993 on a framework for action in the 
field of public health, included drug dependence among 
the priority areas for Community action for which the 
Commission was invited to bring forward proposals for 
action; 
(
5) OJ No C 172, 2. 7. 1984, p. 130. 
OJ No C 283, 10. 11. 1986, p. 79. 
OJ No C 47, 27. 2. 1989, p. 51. 
OJ No C 150, 15. 6. 1992, p. 42. 
(
6) OJ No C 165, 17. 6. 1994, p. 1. 
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Whereas Regulation (EEC) No 302/93 (') established a 
European Monitoring Centre for Drugs and Drug 
Addiction to provide the Community and the Member 
States with reliable and comparable information 
concerning drugs and drug addiction; 
Whereas there is a need to improve knowledge of the 
phenomenon of drugs and drug dependence and their 
consequences, and of the ways and means of preventing 
drug addiction and the associated risks; 
Whereas the declaration on the occasion of the entry into 
force of the Treaty on European Union adopted by the 
European Council, meeting in Brussels on 29 October 
1993, emphasized that the Treaty provides 'a structured 
institutional framework, so that in particular greater 
control can be achieved over those of society's problems 
that run across frontiers, such as drugs (. . .)'; 
Whereas the problems associated with the drugs 
phenomenon are such that they require a fully 
coordinated and global strategy, as stated by the 
European Council, meeting in Brussels on 10 and 
11 December 1993; 
Whereas drug dependence is the only scourge expressly 
mentioned in the provisions of the Treaty dealing with 
public health and is therefore a priority for Community 
action within the framework for action in the field of 
public health set out by the Commission; 
Whereas this programme is one of the essential 
components of the Commission communication to the 
European Parliament and the Council of 23 June 1994 
on a European Union action plan to combat drugs (1995 
to 1999), on which the Council commented in its 
conclusions of 2 June 1995; 
Whereas, by reason of its scale and effects, Community 
action to encourage support for the prevention of drug 
dependence will make a better contribution to achieving 
the desired objectives, which come within the framework 
of Article 129 of the Treaty, in particular the second 
subparagraph of paragraph 1 thereof; 
Whereas cooperation with the competent international 
organizations and with non-member countries should be 
strengthened; 
Whereas a multiannual programme should be launched 
with clear objectives for Community action, and priority 
actions selected with a view to preventing drug 
dependence and the associated problems, as well as 
appropriate evaluation mechanisms; 
Whereas the programme should have as its objective to 
help combat drug dependence by preventing dependence 
linked to the use of narcotics and psychotropic 
substances and associated use of other products for the 
purposes of drug addiction; 
Whereas there is a need both for general preventive 
action and for preventive measures focusing on specific 
target groups, particularly the young and marginal 
groups, while avoiding stereotypes of drug users; 
Whereas it is important that the Commission ensures that 
this programme is implemented in close cooperation with 
the Member States; whereas, to that end, provision must 
be made for a procedure to ensure that Member States 
are fully involved in implementing the programme; 
Whereas agreement on a modus vivendi (
2) between the 
European Parliament, the Council and the Commission 
concerning measures implementing acts adopted in 
accordance with the procedure laid down in Article 189b 
of the Treaty was reached on 20 December 1994; 
Whereas, from the operational point of view, the 
investment made in previous years should be safeguarded 
and developed; 
Whereas, however, possible duplication of effort should 
be avoided by the promotion of exchanges of experience 
and by the joint development of basic information 
modules for the general public, for health education and 
for training members of the health professions, which 
may be targeted on specific groups; 
Whereas the objectives of this programme and of the 
measures carried out for its implementation form part of 
the health protection requirements referred to in 
Article 129 (1), third paragraph, of the Treaty and are 
thus a component of other Community policies; 
Whereas, in order to increase the value and impact of the 
programme, a continuous assessment of the measures 
undertaken should be carried out, with particular regard 
to their effectiveness and the achievement of objectives 
both at national level and at Community level, and, 
where appropriate, the necessary adjustments made; 
Whereas this Decision lays down, for the entire duration 
of the programme, a financial framework constituting the 
principal point of reference, within the meaning of point 
1 of the Declaration by the European Parliament, the 
Council and Commission of 6 March 1995, for the 
budgetary authority during the annual budgetary 
procedure; 
(') OJ No L 36, 12. 2. 1993, p. 1.  ') OJ No C 293, 8. 11. 1995, p. 1. 
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Whereas this programme should be of five-year duration 
in order to give sufficient implementation time to allow 
actions to achieve the objectives set, 
2. The annual appropriations shall be authorized by 
the budgetary authority within the limits of the financial 
perspective. 
HAVE DECIDED AS FOLLOWS:  Article 4 
Article 1 
Establishment of the programme 
1. A programme of Community action on the 
prevention of drug dependence, hereinafter referred to as 
'this programme', shall be adopted for the period 
1 January 1996 to 31 December 2000 within the 
framework for action in the field of public health. 
2. The objective of this programme shall be to help in 
combating drug dependence, in particular by encouraging 
cooperation between Member States, supporting their 
action and promoting cooperation between their policies 
and programmes with a view to preventing dependence 
linked to the use of narcotics and psychotropic 
substances and associated use of other products for the 
purposes of drug addiction. 
3. The actions to be implemented under this 
programme and their specific objectives are set out in the 
Annex under the following headings: 
A. Data, research, evaluation 
B. Information, health education and training. 
Consistency and complementarity 
1. The Commission and the Member States shall 
ensure that there is consistency and complementarity 
between actions to be implemented under this 
programme and other relevant Community programmes 
and initiatives, including the 'Socrates', 'Leonardo da 
Vinci' and 'Youth for Europe (III)' programmes and the 
biomedical and health research programme under the 
Community's framework programme for research. 
2. The Commission shall also ensure that in the 
activities undertaken account is also taken of the work of 
the European Monitoring Centre for Drugs and Drug 
Addiction (EDMC). It shall also ensure, together with the 
Member States, that the Community's priorities and 
needs are taken into due account in the EDMC's 
programmes. 
3. The Commission and the Member States shall 
ensure consistency with the European Union's action plan 
to combat drugs. 
Article S 
Article 2 
Implementation 
1. The Commission shall ensure the implementation, 
in close cooperation with the Member States, of the 
actions set out in the Annex, in accordance with 
Article 5. 
2. The Commission shall cooperate with the 
institutions and organizations which are active in the 
field of drug demand reduction. 
3. The Member States are called upon to take the 
measures they judge necessary to coordinate and organize 
the implementation of this programme at national level. 
Article 3 
Budget 
1. The total appropriation for the implementation of 
this programme for the period referred to in Article 1 
shall be ECU 27 million. 
Committee 
1. The Commission shall be assisted by a committee 
consisting of two members designated by each Member 
State and chaired by the representative of the 
Commission. 
2. The representative of the Commission shall submit 
to the committee draft measures concerning: 
(a) the committee's rules of procedure; 
(b) an annual work programme indicating the priorities 
for action; 
(c) the arrangements, criteria and procedures for 
selecting and financing projects under this 
programme, including those involving cooperation 
with international organizations competent in the 
field of public health and participation of the 
countries mentioned in Article 6 (2); 
(d) the evaluation procedure; 
(e) the arrangements for dissemination and transfer of 
results; 
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(f) the arrangements for cooperating with the 
institutions and organizations referred to in 
Article 2 (2). 
the consistency and complementarity referred to in 
Article 4. 
The committee shall deliver its opinion on the draft 
measures referred to above within a time limit which the 
chairman may lay down according to the urgency of the 
matter. The opinion shall be delivered by the majority 
laid down in Article 148 (2) of the Treaty in the case of 
decisions which the Council is required to adopt on a 
proposal from the Commission. The votes of the 
representatives of the Member States within the 
committee shall be weighted in the manner set out in that 
Article. The chairman shall not vote. 
The Commission shall adopt measures which shall apply 
immediately. However, if these measures are not in 
accordance with the opinion of the committee, they shall 
be communicated by the Commission to the Council 
forthwith. In that event, the Commission shall defer 
application of the measures which it has decided upon 
for a period of two months from the date of such 
communication. 
The Council, acting by a qualified majority, may take a 
different decision within the time limit referred to in the 
previous subparagraph. 
3. In addition, the Commission may consult the 
committee on any other matter concerning the 
implementation of this programme. 
The representative of the Commission shall submit to the 
committee a draft of the measures to be taken. The 
committee shall deliver its opinion on the draft within a 
time limit which the chairman may lay down according 
to the urgency of the matter, if necessary by taking a 
vote. 
The opinion shall be recorded in the minutes; in addition, 
each Member State shall have the right to ask to have its 
opinion recorded in the minutes. 
The Commission shall take the utmost account of the 
opinion delivered by the committee. It shall inform the 
committee of the manner in which its opinion has been 
taken into account. 
4. The Commission representative shall keep the 
committee systematically informed about: 
— financial assistance granted under this programme 
(amounts, duration, breakdown and beneficiaries), 
— Commission proposals or Community initiatives and 
the implementation of programmes in other areas 
which are directly relevant to the achievement of the 
objectives of this programme, with a view to ensuring 
Article 6 
International cooperation 
1. In the course of implementing this programme, 
cooperation with non-member countries and with 
international organizations active in the field of public 
health shall be encouraged and implemented in 
accordance with the procedure laid down in Article 5. 
In particular, the Commission shall cooperate with the 
Council of Europe's Pompidou Group, with international 
intergovernmental organizations such as the World 
Health Organization (WHO), the United Nations 
Educational, Scientific and Cultural Organization 
(UNESCO), the International Labour Organization (ILO) 
and with the United Nations International Drug Control 
Programme (UNDCP). 
2. This programme shall be open to the participation 
of the associated countries of Central and Eastern Europe 
(ACCEE) in accordance with the conditions agreed to in 
the additional Protocols to the Association Agreements, 
to be concluded with those countries, concerning 
participation in Community programmes. This 
programme shall be open to the participation of Cyprus 
and Malta on the basis of additional appropriations in 
accordance with the same rules as apply to the EFTA 
countries following procedures to be agreed with the 
countries in question. 
Article 7 
Monitoring and evaluation 
1. The Commission, taking into account the reports 
drawn up by the Member States and with the 
participation, where necessary, of independent experts, 
shall ensure that an evaluation is made of the actions 
undertaken. 
2. The Commission shall submit to the European 
Parliament and the Council an interim report halfway 
through this programme and a final report on its 
completion. The Commission shall incorporate the results 
of the evaluations into these reports. It shall also send 
them to the Economic and Social Committee and the 
Committee of the Regions. 
Done at . . . 
For the European Parliament 
The President 
For the Council 
The President 
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ANNEX 
PROGRAMME OF COMMUNITY ACTION ON THE PREVENTION OF DRUG DEPENDENCE 
A. DATA, RESEARCH, EVALUATION 
Objective 
To improve knowledge of the phenomenon of drugs and drug dependence and its consequences and of 
means and methods of prevention of drug dependence and the risks relating thereto, in particular by 
using the information supplied by the EDMC and the possibilities offered by existing Community 
programmes and instruments. 
Actions 
1. Help identify the data to be collected, analysed and disseminated for the purposes of this 
programme, including data on polysubstance dependence. 
2. Exploit the most useful data for implementing this programme, on the basis in particular of a 
regular communication of the work of the EDMC. 
3. Help develop a strategy for research on the prevention of drug dependence, in particular for 
improving knowledge as regards the impact in the public health sphere of policies targeting drug 
users and on the effects of drugs and the use of appropriate techniques for preventive purposes. 
4. Support studies and pilot projects on the socioeconomic, sociocultural and psychosociological 
factors associated with drug dependence, including those in target groups. 
5. Support studies and actions and promote the exchange of experience on ways and means of 
preventing the risks associated with drug dependence, in particular with a view to: 
— preventing, in drug-dependent pregnant women, the effects of drugs on the foetus and the risks 
of transmitting infections to the child, 
— reducing the risks associated with the injection of drugs, 
— making an assessment of accompanying health measures, in particular substitution 
programmes, 
— evaluating methods and programmes for prevention and risk reduction in the management of 
drug-dependent prisoners. 
6. Encourage the exchange of information and experience on preventing drug addiction relapses, 
including the rehabilitation of drug users. 
B. INFORMATION, HEALTH EDUCATION AND TRAINING 
Objective 
Contribute to improving information, education and training aimed at preventing drug dependence and 
the associated risks, in particular for young people and particularly vulnerable groups. 
(a) Information and health education 
Actions: 
7. Support schemes to evaluate the effectiveness of information and health education campaigns 
and carry out regular public opinion surveys via Eurobarometer to monitor changes in 
Europeans' attitudes towards drugs. 
8. Organize further European Drug Preventive Weeks on the basis of previous experience. 
9. Help identify, test and develop the best information and educational tools and methods for 
target groups, and in particular: 
— encourage the use of information tailored to particular environments or circles, taking 
account of changes in patterns of use, and products used, and of the phenomenon of 
polysubstance dependence; 
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— support schemes to adapt messages to the needs and specific features of particularly 
vulnerable groups; 
— support the development of telephone helpline services and consider the feasibility of 
introducing a single telephone number for such services in all Member States. 
10. Help to define drug prevention guidelines and support the selection and use of teaching 
methods and materials, in particular within the context of the European network of 
health-promoting schools, in order to develop attitudes in young people which will enable 
them to avoid drugs and drug addiction; support integrated projects, programmes and other 
drug prevention initiatives in places frequented by children and young people, with the 
participation wherever possible of parents and those concerned. 
11. Encourage exchanges of experience on initiatives aimed at improving cooperation between all 
those involved in the provision of education. 
12. Support schemes for advising teachers, families and those responsible for young people on the 
early detection of the use of drugs and the action to take. 
13. In cooperation with the EDMC and the Council of Europe, if need be, encourage the 
extension of the European network of 'test towns', so as to promote technical cooperation on 
the ways and means used by these towns to reduce drug demand. 
14. Support for exchanges of experience, particularly on a regional cross-border basis, concerning 
local prevention initiatives. Exchanges of experience on prevention models and practices 
involving towns in different Member States which are particulatly affected by the problem of 
drugs. 
(b) Training 
15. Promote initiatives to improve the drug prevention aspect of vocational training programmes 
for teachers and those responsible for young people and encourage exchanges of students 
training for the social and health professions, including exchanges under other Community 
programmes. 
16. Support the development of further training programmes, teaching materials and modules for 
those likely to come into contact with drug users and groups at risk, including in particular 
social work, health, police and other law-enforcement professionals. 
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STATEMENT OF THE COUNCIL'S REASONS 
I. INTRODUCTION 
1. On 22 August 1994 the Commission submitted a proposal, based on Article 129 of the 
Treaty, for a Decision adopting a programme of Community action on the prevention 
of drug dependence within the framework for action in the field of public health. 
2. The European Parliament, the Economic and Social Committee and the Committee of 
the Regions delivered their opinions, respectively, on 20 September 1995 ('), 
22 February 1995 (
2) and 16 November 1994 (
3). 
3. In the light of those opinions, the Commission submitted an amended proposal (
4). 
4. On 20 December 1995, the Council adopted its common position in accordance with 
Article 189b of the Treaty. 
II. OBJECTIVE OF THE PROPOSAL 
The programme proposed, which is regarded by both the Commission and the Council as 
one of the priorities for action in the field of public health for the next five years, is at the 
same time one of the essential components of the European Union action plan to combat 
drugs, for which the guidelines were approved by the Cannes European Council. 
The general provisions of the programme are similar to those proposed in respect of other 
programmes presented in the same context (combating cancer, preventing AIDS and other 
communicable diseases, improving health). 
The activities originally presented in the framework of this programme (Annex), worded in 
fairly general terms, were grouped under three main headings: 
— improving public awareness in particular by means of coordinated transnational 
actions, 
— using opportunities provided in other Community policies, programmes and 
instruments, when appropriate to prevent and combat drug dependence, 
— initiatives and actions relating to young people of school age in relevant environments 
— home, leisure and school — and the promotion of best practices in this regard. 
In its amended proposal, the Commission sets them out in more detail and extends them 
to: 
— groups at risk, 
— improving knowledge, 
— improving training and cooperation for the purposes of prevention. 
III. ANALYSIS OF THE COMMON POSITION 
1. General comments 
As regards the general features of the programme (Articles), the Council has 
introduced, in accordance with an approach similar to that followed in other cases in 
this field, amendments which it felt were necessary to clarify and strengthen the 
(') Not yet published in the Official Journal. 
(
2) OJ No C 110, 2. 5. 1995, p. 8. 
(
3) OJ No C 210, 14. 8. 1995, p. 88. 
(
4) COM(95) 579 final, COD 94/0135. 
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structures and conditions for implementing the programme, and in particular for 
cooperation between the Commission and the Member States. 
As regards the content of the programme (Annex), the Council has adopted a range of 
actions which is significantly more developed and specific than that originally 
proposed by the Commission, in agreement with the elements contained in the 
communication accompanying the Commission proposal, and which are in line with 
its amended proposal. 
2. Specific comments 
2.1. Amendments made by the Council to the Commission's amended 
proposal 
The main amendments to the proposal are, as regards the programme's general 
features, similar to those adopted in the Council's common position for the other 
programmes proposed in the health field (') and reflect the considerations set out 
below. They concern the following aspects. 
(a) Establishment of the programme (Article 1) 
The aim of the amendments made is to clarify the programme's general objective 
(paragraph 2) and its structure (paragraph 3). 
(b) Implementation (Article 2) and Committee procedure (Article 5 — former 
Article 4) 
The adjustments made to the provisions and procedures for implementing the 
programme are aimed mainly at: 
— identifying more accurately the respective roles and contributions of the 
various players participating in the implementation of the programme 
(Article 2), 
— reconciling the requirement for flexibility in the management of the 
programme with the need to involve the Member States more actively in 
certain important decisions, by a mixed procedure, namely: the management 
committee procedure for the latter and, for the others, the advisory committee 
procedure (Article 5 (2) and (3) — in accordance with the interinstitutional 
modus vivendi referred to in recital 17). 
In addition, the systematic provision of information about financial assistance 
granted and activities in other areas which are directly relevant to the 
achievement of the objectives of the plan, which is provided for in paragraph 4, 
meets the need for transparency and effectiveness (in relation particularly with the 
provision in Article 4). 
(c) Total appropriation (Article 3 (1)) 
The amount adopted — ECU 27 million — which is only very slightly lower than 
the amount provided for by the Commission, constitutes a balance between the 
requirement for implementing and monitoring the programme's actions and the 
need to take account of budgetary discipline. 
NB: The relevant provisions (Article 3 and recital 22) comply with the text of 
the Declaration by the three institutions of 6 March 1995. 
(d) Consistency and complementarity (Article 4 — new) 
This Article brings together the requirements imposed on the Commission and, 
where appropriate, the Member States, in the implementation of the programme 
in connection with: 
— the other related programmes and initiatives, 
— the European Monitoring Centre for Drugs and Drug Addiction, 
— the European Union's action plan to combat drugs. 
(') The amendments were, moreover, agreed to in most cases by the European Parliament at second 
reading. 
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(e) International cooperation (Article 6) 
The Council restricted itself to adjustments (see Article 5 of the proposal) 
intended to ensure consistency between these provisions and the provision of 
Article 5 (2) (f) (1) and existing agreements or agreements to be negotiated with 
the countries concerned (2). 
(f) Monitoring and evaluation (Article 7) 
The aim of the amendments made to the text (Article 6) is to clarify the 
conditions for monitoring in general and evaluation in particular. 
(g) Annex 
While keeping as close as possible to the field of action specified by the 
Commission in its amended proposal, the Council has adopted a more closely 
knit structure, more similar to the one adopted for the other programmes 
mentioned above, concentrating on two major areas of action — and listing their 
specific objectives — as indicated in Article 1 (3), and, where appropriate, in 
subheadings, under which the actions are grouped together. 
2.2. European Parliament amendments 
(a) Amendments agreed to by the Commission 
The Commission agreed in full or in part to 20 of the 56 (') amendments. 
In accordance with the structure adopted or with an approach which is less 
detailed in places, the Council has embodied, in some cases in part, most of the 
amendments which the Commission agreed to in full or to some extent. 
It follows that while the field of action of the programme resulting from the 
Council's common position is very close to that adopted most recently by the 
Commission, the presentation and wording differ from those of the European 
Parliament and the Commission in various respects, in particular: 
— as regards amendments 11 to 40 (recitals and Article 2), where the main 
elements contained in the Commission proposal are included in the Annex to 
the Decision (specific objectives and actions), in particular: 
— amendment 28: see objective Β 
— amendments 32, 33: see action 5 
— amendments 35, 36: see actions 3, 4 
— amendment 38: see action 14 
while the programme's general objective and the description of the 
programme's general areas are set out in Article 1 (paragraphs 2 and 3). 
The multidimensional nature of the drug problem (see amendment 21 in 
particular) is affirmed in particular emphasis in recital 9 of the common 
position. 
Some other elements are covered, in substance, as more general 
implementation aspects: 
— amendment 30 (cooperation with the plan) by Article 4 (3); 
— amendment 40: both by Article 4 (2) (EDMC) and by Article 2 (2) 
(NGOs). 
In doing this the Council has followed a layout which is closer to that 
adopted in the framework of other programmes in this area, while avoiding 
any duplication which might detract from the clarity and applicability of the 
text; 
(') Amendments 15, 22, 31 and 32, in full, and 11, 21, 23, 26, 28, 30, 33, 35, 36, 38, 40, 41, 49, 51, 52 
and 61, in part. 
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— as regards the amendments to the Annex to the Decision proper, some aspects 
— which deal with ways of operating or implementing methods — are also 
covered in a general way by the provisions of Articles 2, 4 and 6. 
The more specific elements of the content are included, as regards their 
substance, in less detailed form, or in part, as follows: 
amendment 49 
amendment 61 
amendment 51 
amendment 52 
amendment 53 
actions 7 to 9 
actions 13 to 16 and 3 and 4 
actions 4 to 6 and 9 to 11 
actions 4 to 5 
action 10. 
(b) Amendments not agreed to by the Commission 
In general the Council went along with the considerations which resulted in the 
Commission not agreeing to some of the European Parliament's amendments, 
either because they went beyond the framework of the programme (3, 4, 7, 17, 
37, 39, 55 in part, 60) or the field of Community powers under which they come 
(1, 5, 8, 10, 13, 14, 24, 56 in part, 57), or introduced wording or elements which 
were too specific and could be included in another way, elsewhere or implicitly in 
the framework adopted. 
However, among the amendments which the Commission said in its amended 
proposal that it could not agree to, the following are covered by the text of the 
Council's common position either in part or in another form: 
— amendment 42 (the committee procedure) which, in general, is contained in 
Article 5 (2) and (3), 
— amendment 48, by Article 5 (2) (b), 
— amendments 55 and 56, partially covered by actions 3 and 5. 
IV. CONCLUSIONS 
Although the Council has not agreed to all the amendments submitted by the European 
Parliament in detailed and specific form, it has adopted a text which, as regards the content 
of the programme, covers a field of action very close to that adopted by the Commission on 
the basis of the European Parliament's opinion. As in the case of other similar programmes, 
it has also endeavoured to clarify presentation and to strengthen its conditions in order to 
ensure maximum transparency and effectiveness in implementing and monitoring the 
programme. 
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(Acts whose publication is obligatory) 
DECISION No 645/96/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL 
of 29 March 1996 
adopting a programme of Community action on health promotion, information, education and 
training within the framework for action in the field of public health (1996 to 2000) 
THE EUROPEAN PARLIAMENT AND THE COUNCIL OF 
THE EUROPEAN UNION, 
Having regard to the Treaty establishing the European 
Community, and in particular Article 129 thereof, 
Having regard to the proposal from the Commission ('), 
Having regard to the opinion of the Economic and Social 
Committee (
2), 
Having regard to the opinion of the Committee of the 
Regions (
3), 
(2) Whereas the actions to be carried out must be 
undertaken within the framework for action in the 
field of public health set out by the Commission 
and take into account, as the Council requested in 
its Resolution of 27 May 1993 (
5), other actions 
undertaken by the Community in the field of public 
health or having an impact on public health; 
(3) Whereas the Council, in its Resolution of 2 June 
1994 (6 j ¡n response to the Commission 
communication of 24 November 1993 on the 
framework for action in the field of public health, 
included health promotion, education and training 
among the priority areas for action for which the 
Commission was invited to bring forward 
proposals for action; 
Acting in accordance with the procedure laid down in 
Article 189b of the TreatyC) in the light of the joint text 
approved on 31 January 1996 by the Conciliation 
Committee, 
(1) Whereas, pursuant to Article 3 (o) of the Treaty, 
Community action must include a contribution 
towards the attainment of a high level of health 
protection; whereas Article 129 of the Treaty 
expressly provides for Community competence in 
this field insofar as the Community contributes to 
it by encouraging cooperation between Member 
States and, if necessary, by lending support to their 
action; 
(■) OJ No C 252, 9. 9. 1994, p. 3, and OJ No C 135, 2. 6. 
1995, p. 2. 
(
2) OJ No C 102, 24. 4. 1995, p. 15. 
(
3) OJ No C 210, 14. 8. 1995, p. 81. 
(
4) Opinion of the European Parliament of 15 March 1995, (OJ 
No C 89, 10. 4. 1995, p. 72), Council Common Position of 
2 June 1995 (OJ No C 216, 21. 8. 1995, p. 21) and Decision 
of the European Parliament of 25 October 1995 (OJ No 
C 308, 20. 11. 1995). Decision of the European Parliament 
of 15 February 1996 (OJ No C 65, 4. 3. 1996) and Council 
Decision of 16 February 1996. 
(4) Whereas, in their Resolution of 23 November 1988 
concerning health education in schools (
7), the 
Council and the Ministers for Education meeting 
within the Council emphasized that certain eating 
habits, the uncontrolled use of some chemical 
substances and medicines, drug abuse, smoking and 
environmental pollution have a harmful effect on 
health, also bearing in mind the problems of safety 
and accident prevention; 
(5) Whereas, in their Resolution of 3 December 1990 
concerning an action programme on nutrition and 
health (
8), the Council and the Representatives of 
the Governments of the Member States meeting 
within the Council underlined that the promotion 
of a healthy lifestyle as regards nutrition is vitally 
important to enable people to make the necessary 
choices for ensuring appropriate nutrition in 
keeping with individual needs; 
(
5) OJ No C 174, 25. 6. 1993, p. 1. 
(
6) OJ No C 165, 17. 6. 1994, p. 1. 
(
7) OJ No C 3, 5. 1. 1989, p. 1. 
(
8) OJ No C 329, 31. 12. 1990, p. 1. 
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(6) Whereas, in their Conclusions of 13 November 
1992 ('), in response to the Commission 
communication to the Council of 11 May 1992 on 
health education in schools, the Council and the 
Ministers for Health of the Member States meeting 
within the Council identified school as a vital 
setting for systematically developing a healthy 
lifestyle at an early age that would enable sickness 
and accidents to be reduced; whereas they 
considered that there were a variety of other 
settings such as local communities, homes, 
workplaces and hospitals, in which health 
education had a central role; whereas they invited 
the Commission to strengthen cooperation between 
Member States in implementing effective health 
education measures in the various settings; 
enables the objectives envisaged to be more 
effectively achieved; 
(13) Whereas cooperation with the competent 
international organizations and with non-member 
countries should be strengthened; 
(14) Whereas a multiannual programme should be 
launched with clear objectives for Community 
action, and priority measures should be selected, as 
well as appropriate mechanisms for the evaluation 
of such action, with a view to promoting the health 
of all the citizens of the Community; 
(7)  Whereas in its resolution of 19 November 1993 
on public health policy after Maastricht (
2) the 
European Parliament formulated a series of 
proposals for Community action in the field 
of accident prevention and prevention of 
cardiovascular diseases which are not currently the 
subject of Community programmes; 
(8) 
(9) 
June 1994 
the Council 
Whereas, in its Resolution of 2 
concerning cardiovascular diseases (
3), 
invited the Commission to examine actions to 
encourage their prevention and further study of the 
risk factors for such diseases; 
Whereas the results of the integrated approach 
adopted in the joint World Health Organization — 
Council of Europe — European Community Project 
entitled 'The European Network of Health-
Promoting Schools' are encouraging with respect to 
ways of implementing health promotion in 
particular settings; 
(10) Whereas it is recognized that socio-economic 
conditions such as urbanization, housing, 
unemployment and social exclusion have to be 
taken into consideration in the promotion of 
health, particularly for those living in deprived 
areas; 
(11) Whereas health education and information arc 
expressly mentioned in the provisions of the Treaty 
dealing with public health, and constitute a priority 
for Community action in public health; 
(12) Whereas, by reason of its scale and effects, 
Community action in support of health promotion 
(15) Whereas this programme must contribute to raising 
awareness of health determinants and risk factors 
and encourage the development of an integrated 
approach to health promotion; 
(16) Whereas, from an operational point of view, 
the activities undertaken in the past in terms of 
both the establishment of Community networks 
of non-governmental organizations and of the 
mobilization of all those involved in health 
promotion and education should be safeguarded 
and developed; 
(17) Whereas the programme must take account of past 
and current measures implemented in the Member 
States either by the competent authorities or by 
other parties involved in health policy; 
(18) Whereas, however, possible duplication of effort 
should be avoided by the promotion of the 
exchange of experience and by the joint 
development of basic information modules for the 
general public, for health education and for training 
members of the health-care professions; 
(19) Whereas the objectives of this programme and the 
actions undertaken to implement it form part of the 
health protection requirements referred to in the 
third subparagraph of Article 129 (1) of the Treaty 
and as such form a constituent part of the 
Community's other policies; 
(20) Whereas it is important that the Commission 
ensures implementation of this programme in close 
cooperation with the Member States; whereas, to 
that end, provision should be made for a procedure 
to ensure that Member States are fully involved in 
implementing the plan; 
(') OJ No C 326, 11. 12. 1992, p. 2. 
(
2) OJ No C 329, 6. 12. 1993, p. 375. 
(
3) OJ No C 165, 17. 6. 1994, p. 3. 
(21) Whereas a modus vivendi between the European 
Parliament, the Council and the Commission 
concerning the implementing measures for acts 
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adopted in accordance with the procedure laid 
down in Article 189b of the Treaty was concluded 
on 20 December 1994; 
(22) Whereas this Decision lays down, for the entire 
duration of this programme, a financial framework 
constituting the principal point of reference, within 
the meaning of point 1 of the Declaration by the 
European Parliament, the Council and Commission 
of 6 March 1995, for the budgetary authority 
during the annual budgetary procedure; 
(23) Whereas this programme should run for five years 
in order to allow sufficient time for actions to be 
implemented to achieve the objectives set; 
(24) Whereas, in order to increase the value and impact 
of the action programme, a continuous assessment 
of the measures undertaken should be carried out, 
with particular regard to their effectiveness and the 
achievement of objectives at both national and 
Community level and, where appropriate, the 
necessary adjustments should be made; 
(25) Whereas responsibility for measures concerning sex 
education in general, especially measures designed 
to further integrate such education within schools, 
lies with the Member States, with due regard to 
their structures, especially schools, 
— encouraging intersectoral and multidisciplinary 
approaches to health promotion, taking account 
of the socio-economic factors and the physical 
environment necessary for the health of the individual 
and the community, especially for disadvantaged 
groups. 
3. The actions to be implemented under the 
programme and their specific objectives are set out in the 
Annex under the following headings: 
A. Health promotion strategies and structures 
B. Specific prevention and health promotion measures 
C. Health information 
D. Health education 
E. Vocational training in public health and health 
promotion. 
Article 2 
Implementation 
1. The Commission shall ensure the implementation, 
in close cooperation with the Member States, of the 
actions set out in the Annex, in accordance with 
Article 5. 
HAVE DECIDED AS FOLLOWS: 
Article 1 
2. The Commission shall cooperate with the 
institutions and organizations which are active in the 
field of health promotion, information, education and 
training. 
Establishment of the programme 
1. A programme of Community action on health 
promotion, information, education and training, 
hereinafter referred to as 'the programme', shall be 
adopted for the period 1 January 1996 to 31 December 
2000 within the framework for action in the field of 
public health. 
2. The objective of the programme shall be to 
contribute towards ensuring a high level of health 
protection and shall comprise actions aimed at: 
— encouraging the 'health promotion' approach in 
Member States' health policies by lending support 
to various cooperation measures (exchanges of 
experience, pilot projects, networks, etc.), 
— encouraging the adoption of healthy lifestyles and 
behaviour, 
— promoting awareness of risk factors and 
health-enhancing aspects, 
Article 3 
Budget 
1. The financial framework for implementation of the 
programme for the period referred to in Article 1 shall be 
ECU 35 million. 
2. The annual appropriations shall be authorized by 
the budgetary authority within the limits of the financial 
perspective. 
Article 4 
Consistency and complementarity 
The Commission shall ensure that there is consistency 
and complementarity between actions to be implemented 
under the programme and the other relevant Community 
programmes and initiatives, as part of public health 
action or the fields of education and vocational training 
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(Socrates and Leonardo da Vinci programmes), research 
(Biomed II) and health and safety at work. 
3. In addition, the Commission may consult the 
Committee on any other matter concerning the 
implementation of the programme. 
Article 5 
Committee 
1. The Commission shall be assisted by a Committee 
consisting of two members designated by each Member 
State and chaired by a representative of the 
Commission. 
2. The representative of the Commission shall submit 
to the Committee a draft of the measures to be taken 
concerning: 
(a) the Committee's rules of procedure; 
(b) an annual work programme indicating the priorities 
for action; 
(c) the arrangements, criteria and procedures for 
selecting and financing projects under the 
programme, including those involving cooperation 
with international organizations competent in the 
field of public health and participation of the 
countries referred to in Article 6 (2); 
(d) the evaluation procedure; 
(e) the arrangements for dissemination and transfer of 
results; 
(f) the arrangements for cooperating with the 
institutions and organizations referred to in 
Article 2 (2). 
The representative of the Commission shall submit to the 
Committee a draft of the measures to be taken. The 
Committee shall deliver its opinion on the draft within a 
time limit which the Chairman may lay down according 
to the urgency of the matter, if necessary by taking a 
vote. 
The opinion shall be recorded in the minutes; in addition, 
each Member State shall have the right to ask to have its 
opinion recorded in the minutes. 
The Commission shall take the utmost account of the 
opinion delivered by the Committee. It shall inform the 
Committee of the manner in which its opinion has been 
taken into account. 
4. The representative of the Commission shall keep the 
Committee regularly informed of: 
— financial assistance granted under the programme 
(amount, duration, breakdown and beneficiaries), 
— Commission proposals or Community initiatives and 
the implementation of programmes in other areas 
which are of direct relevance to achievement of the 
objectives of the programme, with a view to ensuring 
the consistency and complementarity referred to in 
Article 4. 
Article 6 
The Committee shall deliver its opinion on the draft 
measures referred to above within a time limit which the 
Chairman may lay down according to the urgency of the 
matter. The opinion shall be delivered by the majority 
laid down in Article 148 (2) of the Treaty in the case of 
decisions which the Council is required to adopt on a 
proposal from the Commission. The votes of the 
representatives of the Member States within the 
Committee shall be weighted in the manner set out in 
that Article. The Chairman shall not vote. 
The Commission shall adopt measures which shall apply 
immediately. However, if these measures are not in 
accordance with the opinion of the Committee, they shall 
forthwith be communicated by the Commission to the 
Council. In that event: 
— the Commission shall defer application of the 
measures which it has decided upon for a period of 
two months from the date of such communication; 
— the Council, acting by a qualified majority, may take 
a different decision within the time limit laid down in 
the first indent. 
International cooperation 
1. In the course of implementing the programme, 
cooperation with non-member countries and with 
international organizations competent in the field of 
public health, in particular the World Health 
Organization and the Council of Europe as well as 
non-governmental organizations active in the areas 
covered by this programme, will be encouraged and 
implemented in accordance with the procedure laid down 
in Article 5. 
2. The programme shall be open to participation by 
the associated countries of Central and Eastern Europe 
(Accee) in accordance with the conditions laid down in 
the Additional Protocols to the Association Agreements 
relating to participation in Community programmes, to 
be concluded with those countries. The programme shall 
be open to participation by Cyprus and Malta on the 
basis of additional appropriations in accordance with the 
same rules as those applied to the EFTA countries, in 
accordance with procedures to be agreed with those 
countries. 
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Article 7 
Monitoring and evaluation 
1. The Commission, taking into account the reports 
drawn up by the Member States and with the 
participation, where necessary, of independent experts, 
shall ensure that an evaluation is made of the actions 
undertaken. 
2. The Commission shall submit to the European 
Parliament and the Council an interim report halfway 
through the programme and a final report on completion 
thereof. The Commission shall incorporate into these 
reports the results of the evaluations. It shall also send 
the reports to the Economic and Social Committee and 
the Committee of the Regions. 
Done at Brussels, 29 March 1996. 
For the European Parliament 
The President 
K. HÄNSCH 
For the Council 
The President 
T. TREU 
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ANNEX 
COMMUNITY ACTION PROGRAMME ON HEALTH PROMOTION (1996 to 2000) 
A. HEALTH PROMOTION STRATEGIES AND STRUCTURES 
Objective 
To encourage the evaluation of the impact of health promotion policies and instruments and the 
development of a health promotion approach in the Member States by promoting the devising and 
assessment of health promotion strategies and dissemination of the best practices. 
Actions 
1. Surveys and comparative analyses of the impact of Community and national health promotion 
policies and instruments and of health promotion structures and strategies and the assessment of 
the latter; activities to encourage and support cooperation between Member States on various 
strategic aspects of public health and health promotion. 
2. Support for transnational networks of national, regional or local health promotion bodies, 
adopting an integrated approach (i.e. an approach covering the various determinants, contexts and 
population groups) and promotion of joint activities and projects. 
B. SPECIFIC PREVENTION AND HEALTH PROMOTION MEASURES 
Objective 
To improve knowledge, particularly in conjunction with measures under the Biomed programme, of the 
situation and the problem of health promotion in relation to certain risk factors and health 
determinants and to certain disadvantaged social groups. To promote intersectoral and multidisciplinary 
approaches to health promotion directed at vulnerable or disadvantaged groups. 
Measures 
3. Support for integrated health promotion measures and projects relating more specifically to groups 
which are disadvantaged as a result of their vulnerability or social exclusion, of social and cultural 
differences or of living in unfavourable areas or environments, together with measures to combat 
exclusion and precarious situations. 
4. Examination of the role of nutrition and other life-style factors in the etiology of diseases and 
information to the public to improve understanding of basic nutritional principles and of new 
techniques and methods of presenting and preparing foodstuffs. 
5. Promotion of analysis, evaluation and exchange of experience and information and support for 
actions in respect of innovative measures for the prevention of cardiovascular and cerebrovascular 
diseases, taking account of the risk factors for such diseases. 
6. Support for exchanges of experience and information concerning the rational use of medicines, in 
particular generic medicines and self-medication, in cooperation with general practitioners and 
pharmacists. Exchange of experience on providing the public with information on the use of 
medicines, in particular medicines available without prescription. 
7. Promotion of examination, assessment and exchanges of experience and support for actions 
concerning measures to prevent alcohol abuse and the health and social consequences thereof. 
8. Support for measures to promote regular physical activity and to reach sound physical and mental 
hygiene practices. 
9. Support for studies on ageing populations in the European Union and promotion of exchanges of 
experience and information on the prevention of age-related illnesses in conjunction with the other 
specific programmes. 
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C. HEALTH INFORMATION 
Objective 
To improve knowledge of mechanisms for devising health messages and assessing health information 
methods and encourage an exchange of information and documentation between professionals and 
those responsible for public health and health promotion policies. 
Measures 
10. Support for and coordination of work in the Member States to improve knowledge of the 
psychological, sociological and cultural mechanisms and the economic factors involved and of 
information methods to encourage the adoption of healthy lifestyles; support for the assessment of 
results and for dissemination of the best practices. 
11. Surveys of public opinion on various aspects of health promotion (Eurobarometer survey) and 
support for the preparation and assessment of specific information campaigns including those 
coordinated at Community level or in several Member States. 
12. Support for the development of a European infrastructure, for example in the form of 
transnational networks, reference centres containing information and documentation on public 
health and health promotion for use by professionals, administrators and decision-makers in the 
field of public health, and dissemination to interested parties of information on the Community's 
activities in this field. 
D. HEALTH EDUCATION 
Objective 
To encourage greater integration of health education in schools, including sex education; to foster the 
development and dissemination of the best health education experiments and methods tailored to 
different contexts (e.g. school, work and leisure) and different target groups (e.g. children, adolescents 
and young adults, and workers). 
Measures 
13. Exchanges of experience between Member States concerning the development and distribution of 
appropriate health education programmes, teaching materials and modules. Support for 
information campaigns, demonstration projects and innovative experiments aimed at promoting 
healthy lifestyles and responsible behaviour including support for the European Network of 
Health-Promoting Schools in cooperation with the WHO and the Council of Europe. 
14. Support for, coordination and evaluation of health education projects which are aimed at young 
persons and adolescents who have left the school system and are devised and implemented either 
by official bodies or by private associations and non-governmental organizations in settings such as 
sport and leisure activities and socio-cultural activity centtes. 
15. Support for innovative means of providing continuing structured health education, involving 
distance teaching and information technologies, for adults and the elderly. 
16. Support for health education measures in the workplace, particularly in relation to nutrition and 
the risks involved in tobacco and alcohol consumption, as well as mental health factors, including 
prevention of stress-related risks. 
E. VOCATIONAL TRAINING IN PUBLIC HEALTH AND HEALTH PROMOTION 
Objective 
To help to familiarize the various categories of health staff, those who decide on and administer health 
policy or action and those in the front line of health promotion (e.g. teachers, educators, social workers) 
with knowledge, ideas and methods relating to public health, prevention, health promotion, information 
and health education. 
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Measures 
17. Review and assessment of existing structures and training schemes in public health and health 
promotion and compilation of a European directory. Support for cooperation between schools of 
public health, universities and bodies providing training in this area with a view to the 
development of common training courses and exchanges of students and teaching staff in 
conjunction with existing education and training schemes. 
18. Promotion of cooperation beween Member States on the content of training courses and training 
activities in the fields of public health and health promotion for professionals, administrators and 
decision-makers, emphasizing interdisciplinary approaches (including social, economic, 
psychological and environmental aspects). 
19. Support for training activities relating to health education in schools aimed at teachers, instructors 
and other staff concerned including development of modules, teaching aids and educational 
materials. 
20. Encouragement and support for exchanges of experience relating to the training of health 
professionals in health promotion and the early detection and prevention of diseases, including 
cardiovascular diseases, and in identifying and controlling risk factors and situations, including 
those linked to alcohol abuse. 
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DECISION No 646/96/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL 
of 29 March 1996 
adopting an action plan to combat cancer within the framework for action in the field of public 
health (1996 to 2000) 
THE EUROPEAN PARLIAMENT AND THE COUNCIL OF 
THE EUROPEAN UNION, 
Having regard to the Treaty establishing the European 
Community, and in particular Article 129 thereof, 
Having regard to the proposal from the Commissioni
1), 
Having regard to the opinion of the Economic and Social 
Committee)
2), 
Having regard to the opinion of the Committee of the 
Regions)
3), 
Acting in accordance with the procedure laid down in 
Article 189b of the Treaty (
4) in the light of the joint text 
approved on 31 January 1996 by the Conciliation 
Committee, 
(1) Whereas, at its meetings in Milan in June 1985 and 
in Luxembourg in December 1985, the European 
Council underlined the advantages of launching a 
European programme against cancer; 
(2) Whereas the Council and the Representatives of the 
Governments of the Member States meeting within 
the Council adopted on 7 July 1986 a Resolution 
on a programme of action of the European 
Communities against cancer (
5) and on 17 May 
1990 Decision 90/238/Euratom, ECSC, EEC 
adopting a 1990 to 1994 action plan in the context 
of the 'Europe against Cancer' programme)
6); 
(3) Whereas in its resolution of 19 November 1993 on 
public health policy after Maastricht (
7) the 
European Parliament asked that activities against 
cancer be intensified; 
(4) Whereas in its Resolution of 13 December 1993 (
8) 
the Council invited the Commission to submit in 
due course a draft third action plan, taking into 
(') 
(
2) 
(
3) 
OJ No C 139, 21. 5. 1994, p. 12, and OJ No C 143, 9. 6. 
1995, p. 16. 
OJ No C 393, 31. 12. 1994, p. 8. 
OJ No C 210, 14. 8. 1995, p. 55. 
Opinion of the European Parliament of 1 March 1995 (OJ 
No C 68, 20. 3. 1995, p. 17), Council common position of 
2 June 1995 (OJ No C 216, 21. 8. 1995, p. 1) and Decision 
of the European Parliament of 25 October 1995 (OJ No 
C 308, 20. 11. 1995). Decision of the European Parliament 
of 15 February 1996 (OJ No C 65, 4. 3. 1996) and Council 
Decision of 16 February 1996. 
OJ No C 184, 23. 7. 1986, p. 19. 
OJ No L 137, 30. 5. 1990, p. 31. 
OJ No C 329, 6. 12. 1993, p. 375. 
OJ No C 15, 18. 1. 1994, p. 1. 
account the Council Resolution of 27 May 1993 on 
future action in the field of public health as well as 
the objectives and improvements set out in the 
Annex to that Resolution (
9); 
(5) Whereas the Council, in its Resolution of 2 June 
1994 (
1C), in response to the Commission 
communication of 24 November 1993 on the 
framework for action in the field of public health, 
included cancer among the priority areas for action 
for which the Commission was invited to bring 
forward proposals for action; 
(6) Whereas, by reason of its scale and effects, 
Community action in support of cancer prevention 
enables the desired objectives to be attained more 
effectively; 
(7) Whereas policies and programmes formulated and 
implemented at Community level should be 
compatible with the targets and objectives of 
Community action on cancer prevention; whereas, 
in particular, implementation of actions under the 
Community's biomedical and health research 
programme should be closely coordinated with the 
implementation of Community actions on cancer 
prevention; 
(8) Whereas cooperation with the competent 
international organizations and with non-member 
countries should be strengthened; 
(9) Whereas cancer is a major disease associated with 
lifestyles; whereas the risk factots inherent in 
them need to be reduced, especially tobacco 
consumption, which will also have an effect 
on combating other diseases, in particular 
cardiovascular diseases; 
(10) Whereas, by ensuring wider dissemination of 
knowledge of the causes of cancer and of its 
prevention, by ensuring improved comparability 
and dissemination of information on these subjects, 
and by developing complementary actions especially 
in health education, this plan will contribute to the 
achievement of the Community objectives set out in 
Article 129 of the Treaty; 
(11) Whereas measures must be adopted to combat 
promotion in the media of habits which may lead 
(') OJ No C 174, 25. 6. 1993, p. 1. 
(
10) OJ No C 165, 17. 6. 1994, p. 1. 
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to cancer, such as poor dietary habits and 
smoking; 
(12) Whereas it is important that the Commission 
ensures implementation of this plan in close 
cooperation with the Member States; whereas, to 
that end, provision should be made for a procedure 
to ensure that Member States are fully involved in 
implementing the plan; 
(13) Whereas a modus vivendi between the European 
Parliament, the Council and the Commission 
concerning the implementing measures for acts 
adopted in accordance with the procedure laid 
down in Article 189b of the Treaty was concluded 
on 20 December 1994; 
(14) Whereas moreover, in order to have available to it 
all the necessary scientific information, the 
Commission cooperates with a high-level committee 
of scientific experts appointed by the Member 
States; 
protection requirements referred to in the third 
subparagraph of Article 129 (1) of the Treaty and 
as such form a constituent part of the Community's 
other policies, such as those on the environment, 
the protection of workers, consumer protection, 
nutrition, agriculture and the internal market; 
(21) Whereas this Decision lays down, for the entire 
duration of the action plan, a financial framework 
constituting the principal point of reference, within 
the meaning of point 1 of the Declaration by the 
European Parliament, the Council and Commission 
of 6 March 1995, for the budgetary authority 
during the annual budgetary procedure; 
(22) Whereas this plan should run for five years in order 
to allow sufficient time for actions to be 
implemented to achieve the objectives set, 
HAVE DECIDED AS FOLLOWS: 
(15) Whereas, from an operational point of view, the 
investment made under the preceding action plans 
in terms of both the European pilot networks and 
the mobilization of all those involved in combating 
cancer should be safeguarded and developed; 
(16) Whereas this plan must take account of past and 
current measures implemented in the Member 
States either by the competent authorities or by 
other parties involved in health policy; 
(17) Whereas, however, possible duplication of effort 
should be avoided by the promotion of exchanges 
of experience and by the joint development of basic 
information modules for the general public, for 
health education and for training members of the 
health-care professions, which may be targeted on 
specific groups, including children; 
(18) Whereas a Community strategy to contribute to 
combating cancer includes all aspects of primary, 
secondary and tertiary prevention, including 
exchange of experience on quality control in early 
detection of the disease and prevention of its 
development, and taking into account psycho-social 
aspects, with particular emphasis on the quality of 
life; 
(19) Whereas, in order to increase the value and impact 
of this plan, a continuous assessment of the 
measures undertaken should be carried out, with 
particular regard to their effectiveness and the 
achievement of objectives at both national and 
Community level and, where appropriate, the 
necessary adjustments should be made; 
Article 1 
Establishment of the plan 
1. A Community plan of action against cancer entitled 
'Europe against Cancer', hereinafter referred to as 'this 
plan', shall be adopted for the period 1 January 1996 to 
31 December 2000 within the framework for action in 
the field of public health. 
2. The objective of this plan shall be to contribute 
towards ensuring a high level of health protection and 
shall comprise actions aimed at: 
— preventing premature deaths due to cancer, 
— reducing mortality and morbidity due to cancer, 
— promoting the quality of life by improving the general 
health situation, 
— promoting the general well-being of the population, 
particularly by minimizing the economic and social 
consequences of cancer. 
3. The actions to be implemented under this plan and 
their specific objectives are set out in the Annex under 
the following headings: 
A. Data collection and research 
B. Information and health education 
C. Early detection and screening 
D. Training and quality control and guarantees. 
(20) Whereas the objectives of this plan and the actions 
undertaken to implement it form part of the health 
4. The actions to be undertaken shall include in 
particular: 
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— the establishment of common objectives, 
— the standardization and collection of comparable and 
compatible data on health, including the development 
and strengthening of the European network of cancer 
registers, 
— programmes for exchange of experience and of health 
professionals and for the dissemination of the most 
effective practices, 
— the creation of information networks, 
— European-scale studies and dissemination of the 
results, including support for epidemiological studies 
focused on prevention, 
— implementation of pilot programmes and pilot 
projects, 
— compilation of reports, especially to monitor the 
measures taken, 
— early detection and screening, 
— exchanges of experience on quality control of the 
early detection of the disease and the ptevention of its 
development, including palliative methods, and 
contributions for selecting priorities in cancer research 
and transfer of results of basic research into clinical 
trials. 
Article 2 
Implementation 
1. The Commission shall ensure the implementation, 
in close cooperation with the Member States, of the 
actions set out in the Annex, in accordance with the 
procedure laid down in Article 5. 
2. The Commission shall cooperate with the 
institutions and organizations which are active in 
combating cancer. 
undet this plan and the other relevant Community 
programmes and initiatives, including the biomedical and 
health research programme under the Community's 
framework programme for research and the programmes 
introducing an integrated information network 
(information technology in areas of general interest). 
Article 5 
Committee 
1. The Commission shall be assisted by a Committee 
consisting of two members designated by each Member 
State and chaired by a representative of the 
Commission. 
2. The representative of the Commission shall submit 
to the Committee a draft of the measures to be taken 
concerning: 
(a) the Committee's rules of procedure; 
(b) an annual work programme indicating the priorities 
for action; 
(c) the simplification and improvement of this plan's 
basic administrative procedures, which shall be duly 
published; 
(d) the arrangements, criteria and procedures for 
selecting and financing projects under this plan, 
including those involving cooperation with 
international organizations competent in the field of 
public health and participation of the countries 
referred to in Article 6 (2); 
(e) the evaluation procedure; 
(f) the arrangements for dissemination and transfer of 
results; 
(g) the arrangements for cooperating with the 
institutions and organizations referred to in 
Article 2 (2). 
Article 3 
Budget 
1. The financial framework for implementation of this 
plan for the period referred to in Article 1 shall be set at 
ECU 64 million. 
2. The annual apptopriations shall be authorized by 
the budgetary authority within the limits of the financial 
perspective. 
Article 4 
Consistency and complementarity 
The Commission shall ensure that thete is consistency 
and complementarity between actions to be implemented 
The Committee shall deliver its opinion on the dtaft 
measures referred to above within a time limit which the 
Chairman may lay down according to the urgency of the 
matter. The opinion shall be delivered by the majority 
laid down in Article 148 (2) of the Tteaty in the case of 
decisions which the Council is required to adopt on a 
proposal from the Commission. The votes of the 
representatives of the Member States within the 
Committee shall be weighted in the manner set out in 
that Article. The Chairman shall not vote. 
The Commission shall adopt measures which shall apply 
immediately. However, if these measures are not in 
accordance with the opinion of the Committee, they shall 
forthwith be communicated by the Commission to the 
Council. In that event: 
— the Commission shall defer application of the 
measures which it has decided upon for a period of 
two months from the date of such communication, 
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— the Council, acting by a qualified majority, may take 
a different decision within the time limit laid down in 
the previous subparagraph. 
3. In addition, the Commission may consult the 
Committee on any other matter concerning the 
implementation of this plan. 
The representative of the Commission shall submit to the 
Committee a draft of the measures to be taken. The 
Committee shall deliver its opinion on the draft within a 
time limit which the Chairman may lay down according 
to the urgency of the matter, if necessary by taking a 
vote. 
The opinion shall be recorded in the minutes; in addition, 
each Member State shall have the right to ask to have its 
opinion recorded in the minutes. 
The Commission shall take the utmost account of the 
opinion delivered by the Committee. It shall inform the 
Committee of the manner in which its opinion has been 
taken into account. 
4. The representative of the Commission shall keep the 
Committee regularly informed about: 
— financial assistance granted under this plan (amounts, 
duration, breakdown, beneficiaries), 
— Commission proposals or Community initiatives and 
the implementation of programmes in other areas 
which are of direct relevance to achievement of the 
objectives of this plan, with a view to ensuring the 
consistency and complementarity referred to in 
Article 4. 
public health, in particular the World Health 
Organization and the International Agency for Research 
on Cancer, will be encouraged and implemented in 
accordance with the procedure laid down in Article 5. 
2. This plan shall be open to participation by the 
associated countries of Central and Eastern Europe 
(Accee), in accordance with the conditions laid down in 
Additional Protocols to the Association Agreements 
relating to participation in Community programmes, to 
be concluded with those countries. This plan shall be 
open to participation by Cyprus and Malta on the basis 
of additional appropriations in accordance with the same 
rules as those applied to the EFTA countries, in 
accordance with procedures to be agreed with those 
countries. 
Article 7 
Monitoring and evaluation 
1. The Commission, taking into account the reports 
drawn up by the Member States and with the 
participation, where necessary, of independent experts, 
shall ensure that an evaluation is made of the actions 
undertaken. 
2. The Commission shall submit to the European 
Parliament and the Council an interim report halfway 
through the programme and a final report on completion 
thereof. The reports shall highlight, in particular, 
the complementarity between this plan and the other 
actions mentioned in Article 4. The Commission shall 
incorporate into these reports the results of the 
evaluations. It shall also send the reports to the Economic 
and Social Committee and the Committee of the 
Regions. 
Article 6 
International cooperation 
1. In the course of implementing this plan, 
cooperation with non-member countries and with 
international organizations competent in the field of 
Done at Brussels, 29 March 1996. 
For the European Parliament For the Council 
The President The President 
K. HÄNSCH T. TREU 
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ANNEX 
SPECIFIC OBJECTIVES AND ACTIONS 
A. DATA COLLECTION AND RESEARCH 
Objective 
To extend and improve knowledge of the causes, prevention and treatment of cancer and to facilitate 
the collection of reliable and comparable data on the incidence of cancer, including data on paediatric 
oncology, in particular to identify trends and to devise European-scale epidemiological studies. 
Actions 
1. Support for exchanges of information and experience relating to the collection and dissemination 
of reliable and comparable data for cancer registers (prevalence, incidence, mortality, survival rates 
and age groups). Development and strengthening of a European network in cooperation with the 
International Agency for Research on Cancer (IARC). 
2. Support for the carrying out of epidemiological studies at European level and for the dissemination 
of their conclusions with regard to the identification of carcinogens (physical, chemical and 
biological), with special attention to environmental factors and related conditions at work, the 
risks arising from exposure to them (types of exposure and population subgroups affected), 
methods of prevention and the introduction of programmes for objectively assessing survival rates 
on the basis of specific criteria (age, sex, position of the tumour, stage of development, histological 
type, etc.) and for assessing sources of disparities in those rates. On the basis of these conclusions, 
support for the drawing up and dissemination of recommendations. Cohort studies on cancer, diet 
and health (EPIC network), support for epidemiological studies based on research into nutrition as 
a potential preventive factor (identification of protective agents, modification of specific dietary 
factors) and, where appropriate, preventive chemical agents. 
3. Contribution to the selection of priorities for cancer research to be carried out under the 
Community's framework programmes for research, and specifically the biomedical and health 
research programme, which includes basic and clinical cancer research, and promotion of research 
methods aimed at early, accurate and reliable diagnosis by means of laboratory diagnosis 
techniques, in particular based on immunology and genetics. Support for the establishment of an 
inventory of European basic and clinical cancer research measures; help with the transfer to clinical 
trials of the results of basic research; setting up and/or development of information exchange 
networks for clinical trials in progress, and help with the launching of multiple-centre and 
multinational clinical testing in order to speed up the assessment of new methods of care. 
B. INFORMATION AND HEALTH EDUCATION 
Objectives 
— To help to improve knowledge of cancer risks and cancer prevention among European citizens and 
encourage them to adopt healthy lifestyles; 
— to promote and assess policies and measures related to cancer causes and risks. 
Actions 
4. Establishment of an annual 'Europe against Cancer' week. 
5. Improving the dissemination and effectiveness of cancer prevention messages, in particular the 
recommendations of the European Code against Cancer, by supporting targeted measures (for 
teachers, general practitioners, etc.) and pilot projects, studies and analyses of health promotion 
techniques and assessments of action in this field. 
6. Supporting and extending pilot action networks for providing information and exchanges with 
regard to cancer prevention, taking into account the recommendations of the European Code 
against Cancer, in order to contribute to the highlighting and dissemination of best practice. 
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7. Promoting information and awareness-raising campaigns for specific population groups on health 
promotion and cancer prevention, particularly in public places and at work. 
8. Encouraging projects with a European dimension relating to the prevention of tobacco 
consumption; assessment of the implementation of recommendations on tobacco consumption in 
public places, particularly on public transport and in education establishments. Promotion of 
strategies aimed at protecting the most vulnerable groups, in particular pregnant women and 
children, from the risk of passive smoking. Assessment of the effect of measures taken in the 
Member States to reduce tobacco consumption, for example the banning or control of direct or 
indirect advertising, taxation measures and the exclusion of tobacco from the price index, and 
dissemination of knowledge acquired from the assessment process. Support and assessment of pilot 
measures for preventing tobacco consumption as part of the exchange networks between Member 
States, for example networks of no-smoking towns, no-smoking hospitals and youth clubs in 
cooperation with healthcare workers and teachers. 
9. Selection at European level and dissemination of the best methods of overcoming addiction to 
smoking, and evaluation of their impact as part of pilot measures to implement these methods in 
liaison with opinion formers and healthcare workers in the Member States. Launching, among the 
pilot projects in the media, of a project to combat passive smoking. Continuing classification of 
dangerous substances and preparations with the aim of improving packaging and labelling. 
10. Contributing to the formulation and implementation of integrated health education programmes in 
different life contexts, with cancer prevention given a particularly important role. Definition and 
implementation of supplementary cancer prevention projects for specific groups in different 
contexts (town planners, environmental specialists, architects, radiologists). 
Evaluation, in the context of pilot Community networks, of health education initiatives, with 
priority being given to making individuals more aware of their responsibility for their own health, 
to discouraging smoking and excessive alcohol consumption, to promoting a healthy diet, 
especially increased consumption of fruit and vegetables, to appropriate media campaigns 
promoting a healthy diet and to making people aware of the risks associated with excessive 
exposure of the skin to ultraviolet radiation, targeted at young people. 
11. Support for exchanges of experience under the integrated health education programmes with the 
aim of improving initial and continuing training for teachers and project supervisors in the field of 
cancer prevention, taking account of the experience gained in the framework of programmes such 
as Erasmus and the supporting actions of the Commission in the education field. 
12. Support for the production and dissemination of Community teaching materials relating to cancer 
prevention, particularly those tested in the pilot networks, and for the evaluation of the impact of 
such materials. 
13. Implementation of studies and dissemination of their conclusions, making it possible to improve 
the level of knowledge of the perceptions of young people with regard to cancer, tobacco, diet and 
the risks associated with excessive exposure of the skin to ultraviolet radiation. Carrying out 
analyses with the aim of increasing the effectiveness of preventive programmes among children and 
young people. 
C. EARLY DETECTION AND SCREENING 
Objective 
To help improve and increase the possibilities of early detection, in particular through the development 
and dissemination of effective screening programmes and appropriate practices. 
Actions 
14. Support for the introduction and evaluation of European pilot project networks in the field of 
mass screening for breast and cervical cancer, on the basis of recommendations established at 
European level with regard to ensuring the quality of scteening, and support for the organization 
of meetings to examine the feasibility of extending pilot projects to national and regional levels. 
15. Support for the preparation and dissemination at European level of a common terminology and 
classification in order to improve the quality of anatomical and cytopathological interpretation, 
particularly of suspect growths in the breast and uterus, in particular for anatomists and 
cytopathologists in the Community. 
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16. Support for European feasibility studies on mass screening for other cancers (of the ovary, prostate, 
skin, colon/rectum and mouth), taking particular account of the medical, psychological, social and 
economic aspects. 
D. TRAINING AND QUALITY CONTROL 
Objective 
To help improve cancer-related training for healthcare workers, including training in paediatric 
oncology, and quality control methods. 
Actions 
17. Furthet implementation of the Commission Recommendation of 8 November 1989 concerning the 
training of health personnel in the matter of cancer; assistance with the introduction of periodic 
assessment of the impact of the European pilot networks on initial and continuing training in the 
matter of cancer for the medical, nursing and dentistry professions, in particular for health 
personnel working in paediatric oncology. 
18. Support for the mobility of the health professions (particularly trainers), in order to improve 
theoretical and practical knowledge of cancer (in particular primary prevention, early diagnosis, 
mass screening, particularly for cervical and breast cancer, and quality assurance), between those 
specialized centres in Member States offering training of a high quality, where such mobility is not 
ensured under existing Community programmes such as Comett II or Force. 
19. Support for exchanges of experience and the drawing up and dissemination of conference 
recommendations for a consensus on good practice in the field of combating cancer and of 
recommendations by groups of experts, in order to speed up the dissemination and implementation 
of the results of controlled studies. 
20. Preparation of teaching materials of European interest, aimed at improving training for healthcare 
workers in the matter of cancer, particularly through the use of interactive computer programmes; 
assessment of the impact of those materials in the pilot networks. In particular, support for the 
development, implementation and evaluation of prevention modules intended for the health 
professions, and of models to assist in diagnosis and in making decisions on measures to prevent 
the development of the disease and risks of relapse. 
21. Promotion of initiatives and support for European studies and dissemination of their conclusions, 
particularly in the context of European-level meetings and exchanges of experience, in order to 
gain a better understanding of the quality control methods for measures aimed at correct early 
detection of the disease and prevention of its development, risks of relapse and associated 
syndromes and improving the effectiveness of those methods, taking into account the psychological 
and social aspects, in particular the quality of life of patients, including palliative methods. 
22. Support for pilot projects in the area of quality assurance, including dissemination and evaluation 
of the results, with particular reference to practices connected with checks on radiotherapy 
installations and the training of health personnel. 
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DECISION No 647/96/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL 
of 29 March 1996 
adopting a programme of Community action on the prevention of AIDS and certain other 
communicable diseases within the framework for action in the field of public health 
(1996 to 2000) 
THE EUROPEAN PARLIAMENT AND THE COUNCIL OF 
THE EUROPEAN UNION, 
Having regard to the Treaty establishing the European 
Community, and in particular Article 129 thereof, 
Having regard to the proposal from the Commission^), 
Having regard to the opinion of the Economic and Social 
Committee (
2), 
Having regard to the opinion of the Committee of the 
Regions (
3), 
Acting in accordance with the procedure laid down in 
Article 189b of the Treaty (
4) in the light of the joint text 
approved on 31 January 1996 by the Conciliation 
Committee, 
(1) Whereas the Council, in its Resolution of 2 June 
1994 (
5), in response to the Commission 
communication of 24 November 1993 on a 
framework for action in the field of public health, 
included AIDS and other communicable diseases 
among the priority areas for Community action for 
which the Commission was invited to bring 
forward proposals for action; 
(2) Whereas AIDS is at present an incurable disease 
regarded as a major scourge, to combat which 
coordinated action is required in the areas both of 
research and of prevention; 
(3) Whereas it is important to promote the utilization 
and proper use of condoms as a means of 
preventing transmission of the HIV virus and other 
sexually-transmissible diseases; 
(4) Whereas AIDS is a phenomenon that poses a 
dilemma not only for those parts of human 
relationships of most intimate concern to 
(') OJ No C 333, 29. 11. 1994, p. 34, and OJ No C 228, 2. 9. 
1995, p. 6. 
(
2) OJ No C 133, 31. 5. 1995, p. 23. 
(
5) OJ No C 100, 2. 4. 1996, p. 28. 
(
4) Opinion of the European Parliament of 27 April 1995 (OJ 
No C 126, 22. 5. 1995, p. 74), Council Common Position of 
2 June 1995 (OJ No C 216, 21. 8. 1995, p. 11) and Decision 
of the European Parliament of 25 October 1995 (OJ No 
C 308, 20. 11. 1995). Decision of the European Parliament 
of 15 February 1996 (OJ No C 65, 4. 3. 1996) and Council 
Decision of 16 February 1996. 
(
5) OJ No C 165, 17. 6. 1994, p. 1. 
individuals, but also for modes of collective 
behaviour; whereas its implications extend to law 
and the economy, to politics, public health, 
education and culture, as well as to medicine, 
sociology and research; 
(5) Whereas the plan of action adopted by Decision 
91/317/EEC of the Council and the Ministers for 
Health of the Member States, meeting within the 
Council (
6), in the framework of the 'Europe against 
AIDS' programme expired at the end of 1993; 
(6) Whereas the 'Europe against AIDS' programme was 
extended until the end of 1995 by Decision 
No 1729/95/EC of the European Parliament and of 
the Council (
7); 
(7) Whereas the Council in its conclusions of 
13 December 1993 on the setting up of an 
epidemiological network in the Community)
8) and 
the European Parliament in its resolutions of 
26 May 1989)'), 15 May 1991 (
,0) and 
19 November 1993 (") took the view that it was 
essential to acquire a better knowledge of diseases 
on the basis of their causes and their 
epidemiological context; whereas, accordingly, the 
two institutions have called on the Commission to 
submit proposals for the setting up of an 
epidemiological network in the Community; 
(8) Whereas the European Parliament and the Council 
emphasized that the smooth running of a network 
for gathering epidemiological data requires that the 
comparability and compatibility of data be ensured 
and that theoretical training in epidemiology and 
practical preparation in epidemiology in the field be 
developed for the teams participating in the 
network; 
(9) Whereas the Community is in a position to make a 
major contribution towards the organization of 
exchanges of experience and the dissemination of 
information with regard to the specific training of 
health professionals and the information of all the 
social players involved, such as teachers, families, 
authorities and heads of undertakings; 
(10) Whereas, in their Resolution of 13 November 
1992 C
2), the Council and the Ministers for 
(
6) OJ No L 175, 4. 7. 1991, p. 26. 
(
7) OJ No L 168, 18. 7. 1995, p. 1. 
(
8) OJ No C 15, 18. 1. 1994, p. 6. 
O OJ No C 158, 26. 6. 1989, p. 477. 
(
10) OJ No C 158, 17. 6. 1991, p. 45. 
(") OJ No C 329, 6. 12. 1993, p. 375. 
C
2) OJ No C 326, 11. 12. 1992, p. 1. 
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Health of the Member States meeting within the 
Council invited the Commission to consider 
the existing arrangements which provide for 
cooperation between Member States in the field of 
monitoring and control of communicable diseases; 
(11) Whereas the actions undertaken at Community 
level in the field of AIDS need to be continued, 
extended to cover certain other communicable 
diseases, in particular sexually-transmissible 
diseases (STDs), and consolidated within the 
framework of the action in the field of public 
health set out by the Commission, in a manner 
consistent with measures against exclusion and 
situations of vulnerability; 
(12) Whereas these actions must take into account, as 
the Council and the Ministers for Health of the 
Member States meeting within the Council 
requested in their Resolution of 27 May 1993 ('), 
other actions undertaken by the Community in the 
field of public health or having an impact on public 
health; 
cooperation with the Member States; whereas, to 
that end, provision should be made for a procedure 
to ensure that Member States are fully involved in 
implementing the programme; 
(19) Whereas a modus vivendi between the European 
Parliament, the Council and the Commission 
concerning the implementing measures for acts 
adopted in accordance with the procedure laid 
down in Article 189b of the Treaty was concluded 
on 20 December 1994; 
(20) Whereas, from an operational point of view, the 
investment made under the preceding action plans 
in terms of both the European pilot networks and 
the mobilization of all those involved in combating 
AIDS and other communicable diseases should be 
safeguarded and developed; 
(21) Whereas this programme must take account of past 
and current measures implemented in the Member 
States either by the competent authorities or by 
other parties involved in health policy; 
(13) Whereas, by reason of its scale and effects, 
Community action in support of the prevention of 
AIDS and other communicable diseases enables the 
desired objectives to be attained more effectively; 
(14) Whereas policies and programmes formulated and 
implemented at Community level should be 
compatible with the aims and objectives of 
Community action on the prevention of AIDS 
and other communicable diseases; whereas, in 
particular, implementation of actions under the 
Community's biomedical and health research 
programme, in particular the development of 
vaccines and new forms of treatment, must be 
closely coordinated with the implementation of 
Community actions to ptevent infection by the HIV 
virus and certain other communicable diseases; 
(15) Whereas it is necessary to promote studies in the 
Member States to identify the most effective 
methods of prevention and to publish the most 
significant results of this work; 
(16) Whereas cooperation with the competent 
international organizations and with non-member 
countries should be strengthened; 
(17) Whereas a multiannual programme is required, 
defining the objectives of Community action, the 
priority actions for the prevention of AIDS and 
other communicable diseases, and the appropriate 
evaluation mechanisms; 
(18) Whereas it is important that the Commission 
ensures implementation of the programme in close 
(') OJ No C 174, 25. 6. 1993, p. 1. 
(22) Whereas, however, possible duplication of effort 
should be avoided by the promotion of exchanges 
of experience and by the joint development of basic 
information modules for the general public, for 
health education and for training members of the 
health-care professions, which may be targeted 
on specific groups and on non-governmental 
organizations, including patients' associations; 
(23) Whereas the provision of information to children 
and young people must begin at a very early age in 
the general context of information on hygiene and 
sexuality and health education; 
(24) Whereas the objective of this programme must be 
to contribute towards stemming the spread of AIDS 
and other communicable diseases in the 
Community by improving knowledge concerning 
their prevalence and patterns, improving 
recognition of high-risk situations and practices and 
improving early detection and social, health and 
medical support, with a view to preventing the 
transmission of AIDS and other communicable 
diseases and thus reducing the associated mortality 
and morbidity as well as combating all forms of 
discrimination against people suffering from AIDS 
or infected with the HIV virus; 
(25) Whereas, in order to increase the value and impact 
of this programme, a continuous assessment of the 
measures undertaken should be carried out, with 
particular regard to their effectiveness and the 
achievement of objectives at both national and 
Community level and, where appropriate, the 
necessary adjustments should be made; 
(26) Whereas the objective of this programme and of the 
measures undertaken to implement it form part of 
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the health protection requirements referred to in 
the third subparagraph of Article 129 (1) of the 
Treaty and as such form a constituent part of the 
Community's other policies; 
(27) Whereas access to this programme should be 
facilitated, with particular stress on reaching 
organizations which lack means of easy access to 
information on Community programmes; 
(28) Whereas the procedures for granting financial aid 
should be simple and accessible, and there should 
be guarantees of total transparency of these 
procedures and the relevant controls; 
(29) Whereas this Decision lays down, for the entire 
duration of the programme, a financial framework 
constituting the principal point of reference, within 
the meaning of point 1 of the Declaration by the 
European Parliament, the Council and Commission 
of 6 March 1995, for the budgetary authority 
during the annual budgetary procedure; 
(30) Whereas this programme should run for five years 
in order to allow sufficient time for actions to be 
implemented to achieve the objectives set, 
D. Support for persons with HIV/AIDS and combating 
discrimination. 
Article 2 
Implementation 
1. The Commission shall ensure the implementation, 
in close cooperation with Member States, of the actions 
set out in the Annex, in accordance with Article 5. 
2. The Commission shall cooperate with the 
institutions and organizations which are active in 
preventing AIDS and other communicable diseases. 
Article 3 
Budget 
1. The financial framework for implementation of this 
programme for the period referred to in Article 1 shall be 
ECU 49,6 million. 
2. The annual appropriations shall be authorized by 
the budgetary authority within the limits of the financial 
perspective. 
HAVE DECIDED AS FOLLOWS:  Article 4 
Article 1 
Establishment of the programme 
1. A programme of Community action on the 
prevention of AIDS and certain other communicable 
diseases, hereinafter referred to as 'this programme', 
shall be adopted for the period 1 January 1996 to 
31 December 2000 within the framework for action in 
the field of public health. 
2. The objective of this programme shall be to help 
contain the spread of AIDS and reduce mortality and 
morbidity due to communicable diseases, by encouraging 
cooperation between Member States, promoting 
cooperation between prevention policies and programmes 
and supporting the activities of non-governmental 
organizations, including organizations for people affected 
by HIV. 
3. The actions to be implemented under this 
programme and their specific objectives are set out in the 
Annex under the following headings: 
A. Surveillance and monitoring of communicable 
diseases 
B. Combating transmission 
C. Information, education and training 
Consistency and complementarity 
The Commission shall ensure that there is consistency 
and complementarity between actions to be implemented 
under this programme and the other relevant Community 
programmes and initiatives, including the biomedical and 
health research programme under the Community's 
framework programme for research and Community 
action in developing countries. 
Article 5 
Committee 
1. The Commission shall be assisted by a Committee 
consisting of two members designated by each Member 
State and chaired by a representative of the 
Commission. 
2. The representative of the Commission shall submit 
to the Committee a draft of the measures to be taken 
concerning: 
(a) the Committee's rules of procedure; 
(b) an annual work programme indicating the priorities 
for action; 
(c) the arrangements, criteria and procedures for 
selecting and financing projects under this 
programme, including those involving cooperation 
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with international organizations competent in the 
field of public health and participation of the 
countries referred to in Article 6 (2); 
(d) the evaluation procedure; 
(e) the arrangements for dissemination and transfer of 
results; 
(f) the arrangements for cooperating with the 
institutions and organizations referred to in 
Article 2 (2). 
The Committee shall deliver its opinion on the draft 
measures referred to above within a time limit which the 
Chairman may lay down according to the urgency of the 
matter. The opinion shall be delivered by the majority 
laid down in Article 148 (2) of the Treaty in the case 
of decisions which the Council is required to adopt 
on a proposal from the Commission. The votes of 
the representatives of the Member States within the 
Committee shall be weighted in the manner set out in 
that Article. The Chairman shall not vote. 
The Commission shall adopt measures which shall apply 
immediately. However, if these measures are not in 
accordance with the opinion of the Committee, they shall 
forthwith be communicated by the Commission to the 
Council. In that event: 
— the Commission shall defer application of the 
measures which it has decided upon for a period of 
two months from the date of such communication, 
— the Council, acting by a qualified majority, may take 
a different decision within the time limit laid down in 
the first indent. 
3. In addition, the Commission may consult the 
Committee on any other matter concerning the 
implementation of this programme. 
The representative of the Commission shall submit to the 
Committee a draft of the measures to be taken. The 
Committee shall deliver its opinion on the draft within a 
time limit which the Chairman may lay down according 
to the urgency of the matter, if necessary by taking a 
vote. 
The opinion shall be recorded in the minutes; in addition, 
each Member State shall have the right to ask to have its 
opinion recorded in the minutes. 
The Commission shall take the utmost account of the 
opinion delivered by the Committee. It shall inform the 
Committee of the manner in which its opinion has been 
taken into account. 
4. The representative of the Commission shall keep the 
Committee regularly informed about: 
— financial assistance granted under this programme 
(amounts, duration, breakdown and beneficiaries), 
Commission proposals or Community initiatives and 
the implementation of programmes in other policy 
areas which are directly related to the attainment of 
the objectives of this programme, with a view to 
ensuring the consistency and complementarity referred 
to in Article 4. 
Article 6 
International cooperation 
1. In the course of implementing this programme, 
cooperation with non-member countries and with 
international organizations competent in the field of 
public health, especially the United Nations and in 
particular the World Health Organization, the Council of 
Europe and non-governmental organizations competent 
in the field of public health or particularly involved in 
the fight against AIDS and other communicable diseases 
and the prevention thereof, will be encouraged and 
implemented in accordance with the procedure laid down 
in Article 5. 
2. This programme shall be open to participation by 
the associated countries of Central and Eastern Europe 
(Accee), in accordance with the conditions laid down in 
the Additional Protocols to the Association Agreements 
relating to participation in Community programmes, to 
be concluded with those countries. This programme shall 
be open to participation by Cyprus and Malta on the 
basis of additional appropriations in accordance with the 
same rules as those applied to the EFTA countries, in 
accordance with procedures to be agreed with those 
countries. 
Article 7 
Monitoring and evaluation 
1. The Commission, taking into account the reports 
drawn up by the Member States and with the 
participation, where necessary, of independent experts, 
shall ensure that an evaluation is made of the actions 
undertaken. 
2. The Commission shall submit to the European 
Parliament and the Council an interim report halfway 
through this programme and a final report on completion 
thereof. It shall incorporate into these reports the results 
of the evaluations. It shall also send the reports to the 
Economic and Social Committee and the Committee of 
the Regions. 
Done at Brussels, 29 March 1996. 
For the European Parliament 
The President 
K. HÄNSCH 
For the Council 
The President 
T. TREU 
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ANNEX 
PROGRAMME OF COMMUNITY ACTION ON THE PREVENTION OF AIDS AND CERTAIN 
OTHER COMMUNICABLE DISEASES (1996 to 2000) 
A. SURVEILLANCE AND MONITORING OF COMMUNICABLE DISEASES 
Objective 
To help to improve knowledge and dissemination of information and data concerning HIV/AIDS and 
other communicable diseases, taking into account international disease-classification provisions, and to 
improve the coordination of systems for monitoring these diseases and coordinating Community-level 
responses, particularly in the event of an epidemic outbreak. 
Actions 
1. Exploration with Member States of ways to increase the amount and improve the quality, 
comparability and availability of data and provide support for strengthening national or regional 
monitoring systems and implementing them as part of a network and, in the case of HIV/AIDS and 
connected diseases, support for the European Centre for the Epidemiological Monitoring of 
AIDS. 
2. Contribution towards improving the quality and coordination of Member States' epidemiological 
monitoring systems and participation in the development of surveillance networks on the basis of 
the jointly-defined methodologies and conditions for data transmission, prior consultation and 
coordination of replies. 
3. Setting up of a Community network of public health epidemiologists for the purpose of defining 
common surveillance methods and tools and enhancing the ability to respond in a coordinated way 
to the development of communicable diseases, especially in the case of epidemic outbreaks. 
4. Contributing, in particular by the provision of the logistical support necessary, to the production 
and dissemination of a regular information notice and of a Community bulletin on communicable 
diseases surveillance, comprising both routine surveillance data and reports on specific 
epidemiological investigations. 
5. Encouraging action aimed at increasing awareness of the problems and including comparable and 
reliable data on nosocomial infections particularly in routine surveys of hospital conditions; 
promoting knowledge and exchanges of experience on the ways in which surveillance results 
concerning infections caused by germs resistant to normal treatment (antibiotics) are analysed, 
processed and used by the actors in the field. 
6. Promotion of investigations of the effectiveness and feasibility of screening for certain types of 
communicable diseases (tuberculosis, hepatitis, etc.), in particular among pregnant women. 
Coordination of research to minimalize transmission of diseases from mother to child. 
B. COMBATING TRANSMISSION 
Objective 
To assist efforts to prevent the transmission of HIV and other sexually-transmitted diseases (STDs), 
particularly as regards high-risk environments and behaviour and ensure optimum vaccination covet in 
the Community for certain communicable diseases. 
Actions 
Coordination of studies and information on the problems and situations of persons whose 
behaviour places them at risk (parenteral drug use, prostitution and at-risk sexual relations, etc.), 
or placed in particular situations (travel, penal institutions, etc.) and modes of ttansmission; 
exchange of experience on preventive action including the promotion of risk-reduction measures; 
promotion of appropriate preventive measures and of pilot projects, including promotion of the use 
and availability of good-quality condoms, with instructions for use so as to avoid sexual 
transmission of disease, and promotion of facilitated access to such condoms. 
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8. Exchange of views and experience on information, advice and counselling for women who are 
pregnant or wanting to have children and who may be at risk of transmitting HIV to their 
babies. 
9. Exchanges of information on messages and promotion of appropriate measures for the 
dissemination of effective messages aimed at the general public and at target groups, notably 
through campaigns to inform, educate and raise awareness concerning means of protection against 
the risk of sexual transmission of diseases, the problems they raise and their use. 
10. Promotion of cooperation and of exchange of information between Member States on their 
vaccination policies and programmes as well as their arrangements for implementing them and 
their results among the general population and especially among children, groups exposed to risk 
and persons living in certain risk situations. Promotion of exchange of experience and information 
as regards determining vaccination cover, vigilance concerning vaccines and encouragement of 
measures and initiatives to ensure optimum vaccination cover. 
C. INFORMATION, EDUCATION AND TRAINING 
Objective 
To help to increase awareness and improve public information and education and provide, including 
with regard to the early detection of communicable diseases, better training for health professionals and 
relevant personnel. 
Actions 
11. Evaluation of the impact of information campaigns on communicable diseases and their 
prevention; encouragement of exchanges between Member States on information campaigns at all 
levels; development of ways of linking and reinforcing campaigns in the Member States, such as 
provision of specific materials; utilization of telephone and other response mechanisms; definition 
and promotion of activities to complement national efforts, including the setting-up or 
strengthening of networks and the exchange of experience and expertise. 
12. Gathering and analysis of information concerning preventive measures and promotion of the 
dissemination of the information; promotion of the development and use of assessment methods to 
determine the effectiveness of preventive measures and information campaigns aimed at the general 
public and target groups. 
13. Encouragement of initiatives to ascertain and disseminate existing information about the 
knowledge, attitudes and behaviour of the general public and certain target groups, particularly 
children and young people, regarding HIV/AIDS and other STDs and about rhe preventive 
measures taken in the European Community; examination and evaluation of current practice in 
providing information both within and outside formal structures such as schools, training 
institutions and sports clubs; promotion of the exchange of educational and training material and 
methods, and support for pilot projects, especially those centred on groups of young people 
without any specific organizational framework or formal educational structure; development of 
training suited to every stage of the individual's development and exchange of educational material 
for this purpose. 
Promotion of information campaigns in the Member States on the utilization and proper use of 
condoms as a means of preventing transmission of the HIV virus. 
Carrying out new Eurobarometer surveys on trends in knowledge and behaviour with regard to 
HIV/AIDS, where existing information is inadequate. 
14. Encouragement of initiatives relating to messages intended to inform and educate migrants in the 
Member States, taking particular account of cultural and linguistic differences. 
15. Surveys and exchange of experience on training given to health professionals and those who, 
through their work, are brought into contact with certain communicable diseases or can act to 
prevent them, including personnel responsible for social support and counselling for HIV-infected 
persons and those living with them, in order to identify weaknesses and gaps in them and to help 
in devising and promoting new further training programmes; promotion of exchanges among the 
health professionals involved, where such action is not covered by existing Community 
programmes. 
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16. Support for the training of health personnel, in particular in the context of epidemiology and early 
detection of and screening for communicable diseases, including personal advice at the time of 
screening. 
D. SUPPORT FOR PERSONS WITH HIV/AIDS AND COMBATING DISCRIMINATION 
Objective 
To assist efforts to ensure that persons suffering from HIV/AIDS receive assistance in line with their 
needs and are not discriminated against in any way. 
Actions 
17. Exchanges of experience and information concerning modes of assistance and support for those 
testing seropositive, those infected with AIDS and persons living with them. Promotion of studies, 
pilot projects and actions on the psycho-social aspects of HIV/AIDS, including the subject of 
HIV-positive children in the school environment. 
18. Production and dissemination of information bulletins and directories giving the latest information 
on organizations providing information and support; encouragement of networks of associations 
providing information and psycho-social support. 
19. Examination of actual or potential discriminatory situations in the Member States. Exchange of 
information on measures taken in the Member States to avoid or combat discrimination, 
particularly as regards employment, insurance, credit, housing, education and health care. 
Exchange of information and experience on HIV-testing policies and practices and drawing-up of a 
code of good practice on the matter. 
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II 
(Preparatory Acts) 
COMMISSION 
Proposal for a European Parliament and Council Decision creating a network for the epidemi-
ological surveillance and control of communicable diseases in the European Community 
(96/C 123/08) 
(Text with EEA relevance) 
COM(96) 78 final— 96/0052(COD) 
(Submitted by the Commission on 8 March 1996) 
THE EUROPEAN PARLIAMENT AND THE COUNCIL 
OF THE EUROPEAN UNION, 
Having regard to the Treaty establishing the European 
Community, and in particular Article 129 thereof, 
Having regard to the proposal from the Commission, 
Having regard to the opinion of the Economic and 
Social Committee, 
Having regard to the opinion of the Committee of the 
Regions, 
1. Whereas the prevention of diseases, and in particular 
of the major health scourges, is a priority for 
Community action, requiring a global and coor-
dinated approach between Member States; 
Whereas the European Parliament, in its resolution 
on public health policy after Maastricht ('), invited 
the Commission to set up a trans-frontier network to 
devise working definitions of notifiable diseases, to 
collect, update, analyze and disseminate Member 
State data on notifiable diseases and to work with 
national and international agencies on these matters; 
Whereas in its resolution of 2 June 1994 on the 
framework for Community action in the field of 
public health (') the Council agreed that priority 
should be given at present to communicable diseases 
in particular; 
4. Whereas in its conclusions of 13 December 1993 (
3), 
the Council considers that there is a need to develop 
at Community level a network for the surveillance 
and control of communicable diseases, the main 
purpose of which would be to collect and coordinate 
information from monitoring networks in the 
Member States; 
Whereas in these same conclusions the Council 
requests the Commission to devote special attention, 
in its proposals relating to the framework for action 
in the field of public health (
4), to setting up an 
epidemiological network in the Community, taking 
account of current proceedings and mechanisms 
existing at Community level and that of Member 
States, and ensuring the comparability and compati-
bility of data; 
Whereas in their resolution of 13 November 
1992 (
s), the Council and the Ministers for Health 
meeting within the Council underline the desirability 
of improving, within the Community, the coverage 
and effectiveness of existing networks between 
Member States (including data-processing net-
works), and of maintaining, establishing or 
strengthening coordination between them for moni-
toring outbreaks of communicable diseases, where 
such action could add to the value of existing 
measures; 
7. Whereas in this same resolution, the Council and the 
Ministers for Health meeting within the Council 
underline the value of collecting data from the 
Member States on a limited number of rare and 
serious diseases which require large samples for 
epidemiological -study; 
(') OJ No C 329, 6. 12. 1993, p. 375. 
(') OJ No C 165, 17. 6. 1994, p. 1. 
(') OJ No C 15, 18. 1. 1994, p. 6. 
(') COM(93) 559 final, 24. 11. 1993. 
O OJ No C 326, 11. 12. 1992, p. 1. 
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8. Whereas in this same resolution, the Council and the 
Ministers for Health meeting within the Council 
invite the Commission to examine the desirability of 
giving priority to certain suitable proposals relating 
to the control and surveillance of communicable 
diseases, in the light, inter-alia, of their estimated 
cost-effectiveness ; 
9. Whereas, in accordance with the principle of sub-
sidiarity, any new measure taken in an area which 
does not fall within the exclusive competence of the 
Community, such as the epidemiological surveillance 
and control of communicable diseases, may be taken 
by the Community only if, by reason of the scale or 
effects of the proposed action, the objectives of the 
proposed action can be better achieved by the 
Community than by one or more Member States; 
cations (') apply equally to information concerning 
zoonoses which affect human beings, and whereas 
the same Directive provides for a system for 
collecting and transmitting information on specified 
zoonoses and zoonotic agents; 
17. Whereas the setting up of a network for the epi-
demiological surveillance and control of 
communicable diseases at Community level neces-
sarily presupposes observance of the legal provisions 
concerning the protection of individuals with regard 
to the processing of personal data and the intro-
duction of arrangements to guarantee the confiden-
tiality and security of such data and information; 
whereas in this connection the European Parliament 
and the Council adopted Directive 95/46/EC on 24 
October 1995; 
10. Whereas measures in the health field must take into 
account other actions undertaken by the Community 
in the field of public health or which have an impact 
on public health; 
11. Whereas European Parliament and Council Decision 
.../.. ./EC adopting a programme of Community 
action on the prevention of AIDS and certain other 
communicable diseases within the framework for 
action in the field of public health envisages a 
number of Community actions for the creation and 
development of networks for the control and 
surveillance of certain communicable diseases, the 
early detection of such diseases, and promotion of 
the training of field epidemiologists; 
12. Whereas cooperation with the competent inter-
national organizations, notably with regard to 
disease classification, must be fostered; 
13. Whereas cooperation with third countries, notably in 
the case of the emergence or resurgence of serious 
communicable diseases, must be supported; 
18. Whereas the Community projects in the field of the 
telematic interchange of data between adminis-
trations (IDA) (
2) and the G7 projects should be 
closely coordinated with the implementation of the 
Community actions relating to the epidemiological 
surveillance and control of communicable diseases; 
19. Whereas it is important, in an emergency situation, 
that the competent national structures should 
strengthen their cooperation, notably with regard to 
the identification of biological samples; 
20. Whereas these Community arrangements for the 
rapid exchange of information do not affect the 
Member States' rights and obligations under Treaties 
or bilateral and multilateral conventions; 
21. Whereas it is important that the Commission should 
implement the Community network in close co-
operation with the Member States; whereas a 
procedure therefore needs to be established to ensure 
the Member States' full participation in this 
implementation; 
14. Whereas the emergence or recent resurgence of 
serious communicable diseases has demonstrated that 
when an emergency situation occurs all relevant 
information must be communicated swiftly to the 
Commission in an agreed form of presentation; 
15. Whereas the introduction of specific Community 
arrangements will help to ensure that all Member 
States are swiftly informed in the event of such an 
emergency situation, so that the protection of the 
population can be ensured; 
16. Whereas the provisions of Council Directive 
92/117/EEC of 17 December 1992 concerning 
measures for protection against specified zoonoses 
and specified zoonotic agents in animals and 
products of animal origin in order to prevent 
outbreaks of food-borne infections and intoxi-
22. Whereas an agreement on a modus vivendi between 
the European Parliament, the Council and the 
Commission concerning measures for the implemen-
tation of acts adopted under the procedure laid 
down in Article 189b of the Treaty was reached on 
20 December 1994, 
HAVB DECIDED AS FOLLOWS: 
Article 1 
A general network for the epidemiological surveillance 
and control of communicable diseases shall be set up in 
the European Community. 
(') OJ No L 62, 15. 3. 1993, p. 38. 
(') OJ No L 269, 11. 11. 1995, p. 23. 
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This Community network shall be formed by putting 
into permanent communication with one another, 
through all appropriate technical means, structures 
which, at the level of each Member State and under the 
responsibility of the Member State, are charged with 
collecting information relating to epidemiological 
surveillance and coordinating control measures. 
Article 2 
For the purposes of this Decision the following terms 
shall have the following meanings: 
is required to adopt on a proposal from the Commission. 
The votes of the representatives of the Member States 
within the committee shall be weighted in the manner set 
out in that Article. The chairman shall not vote. 
The Commission shall adopt the measures envisaged if 
they are in accordance with the opinion of the 
committee. If the measures envisaged are not in 
accordance with the opinion of the committee, or if no 
opinion has been delivered, the Commission shall 
forthwith submit to the Council a proposal concerning 
the measures to be taken. The Council shall act by a 
qualified majority. 
epidemiological surveillance: the ongoing systematic 
collection, analysis, interpretation and dissemination 
of health data concerning communicable diseases, for 
the purpose of enabling appropriate counter-
measures to be taken, 
control of communicable diseases: the range of 
measures taken by the competent public health auth-
orities to stop the spread of communicable diseases, 
as well as epidemiological studies, in particular of the 
pattern of spread of such diseases over time and 
space and analysis of the risk factors for contracting 
such diseases, the results of which enable appropriate 
preventive measures to be devised. 
Article 3 
For every Member State, the epidemiological surveillance 
and control of communicable diseases at Community 
level shall apply to: 
(a) the appearance or resurgence on its territory of cases 
of serious and/or rare communicable diseases as 
listed in the Annex; 
(b) the importation onto its territory, from another 
Member State or a non-Community country, of 
cases of serious and/or rare communicable diseases 
as listed in the Annex. 
Article 4 
For the purposes of implementing this Decision the 
Commission shall be assisted by a committee consisting 
of representatives from the Member States and chaired 
by a representative of the Commission. 
The Commission representative shall submit to the 
committee a draft of the measures to be taken. The 
committee shall deliver its opinion on this draft within a 
time limit which the chairman shall lay down according 
to the urgency of the matter. The opinion shall be 
delivered by the majority laid down in Article 148 (2) of 
the EC Treaty in the case of decisions which the Council 
If, within three months of the matter being referred to it, 
the Council has not adopted measures, the Commission 
shall adopt the measures proposed and implement them 
immediately. 
Article 5 
The measures referred to in Article 4 concern in 
particular: 
1. case definitions, in particular the clinical definition 
and, where appropriate, the microbiological charac-
terisation of the agent responsible; 
2. the nature and type of data and information to be 
collected by the structures referred to in Article 1 in 
the field of epidemiological surveillance; 
3. the epidemiological and microbiological surveillance 
methods; 
4. the protective measures to be taken, in particular at 
ports and airports, notably in emergency situations; 
5. information, recommendations and guides to good 
practice for the public. 
Article 6 
Each structure referred to in Article 1 shall communicate 
to the Community network and the Commission: 
(a) information on the communicable diseases referred 
to in Article 2, together with information on control 
measures applied; 
(b) any useful information concerning the progression of 
epidemic situations in the Member State to which the 
institution belongs; 
(c) any evaluation element which will aid cooperation 
between Member States for the purpose of the 
control of communicable diseases, in particular the 
conservation of biological samples taken from 
patients for transmission to specialist laboratories 
linked to the Community network. 
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Article 7 
Each Member State shall appoint, within six months 
following the entry into force of this Decision, the 
structure or structures referred to in Article 1, and shall 
notify the Commission thereof. 
Article 8 
The Commission may amend or supplement the Annex 
in accordance with the procedure provided for in 
Article 4. 
Article 9 
This Decision shall apply without prejudice to Council 
Directive 92/117/EEC concerning measures for 
protection against specified zoonoses and specified 
zoonotic agents in animals and products of animal origin 
in order to prevent outbreaks of food-borne infections 
and intoxications, and shall take account of the 
information collection and transmission procedure 
provided for in that Directive. 
Article 10 
This Decision shall apply without prejudice to European 
Parliament and Council Directive 95/46/EC on the 
protection of individuals with regard to the processing of 
personal data and on the free movement of such data, 
and to Council Decision 95/468/EC on a Community 
contribution for telematic interchange of data between 
administrations in the Community (IDA). 
Article 11 
This Decision shall not affect Member States' reciprocal 
rights and obligations deriving from existing or future 
bilateral or multilateral agreements or conventions in the 
domain covered by the Decision, and which are in line 
with the Decision's subject, methods of implementation 
and objectives. 
Article 12 
This Decision is addressed to the Member States and 
shall enter into force three months after the date of its 
publication in the Official journal of the European 
Communities. 
ANNEX 
The communicable diseases referred to in Article 3 are divided into groups of serious and/or rare 
disorders, namely: 
— concerning paragraph (a): 
diseases requiring measures to be taken at local level and reported on periodically to the Member 
States' public health authorities in accordance with arrangements specific to each of these diseases and 
defined in accordance with Article 5, notably: 
1. diseases preventable by vaccination (tuberculosis, tetanus, poliomyelitis, diphtheria, meningitis, 
measles, mumps, rubella, influenza and influenza syndromes, etc.); 
2. sexually-transmitted diseases (hepatitis B, AIDS/HIV, chlamydiasis, etc.); 
3. viral hepatitis (including hepatitis C and other as yet unclassified categories of hepatitis); 
4. food-borne diseases (listeriosis, salmonellosis, etc.); 
5. water-borne diseases and diseases of environmental origin (legionellosis, etc.); 
6. nosocomial infections; 
7. other diseases transmissible by non-conventional agents (including Creutzfeldt-Jakob disease, etc.); 
— concerning paragraph (b) 
the same diseases as under paragraph (a), plus diseases requiring exceptional measures to be taken at 
national and international levels, such as: 
1. diseases covered by the International Health Regulations (yellow fever, cholera, plague); 
2. other diseases (rabies, typhus fever, African haemorrhagic fevers, malaria and any other as yet 
unclassified serious epidemic disease, etc.). 
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COMMON POSITION (EC) No 35/96 
adopted by the Council on 18 June 1996 
with a view to adopting Decision No 220/96/EC of the European Parliament and of the 
Council adopting a programme of Community action on health monitoring within the 
framework for action in the field of public health 
(96/C 220/04) 
THE EUROPEAN PARLIAMENT AND THE COUNCIL OF 
THE EUROPEAN UNION, 
Having regard to the Treaty establishing the European 
Community, and in particular Article 129 thereof, 
Having regard to the proposal from the Commission ('), 
Whereas the European Parliament, in its resolution 
on public health policy after Maastricht (
6), stressed 
the importance of having sufficient and relevant 
information as a basis for the development of 
Community actions in the field of public health; 
whereas the European Parliament called on the 
Commission to collect and examine health data 
from Member States with a view to analysing the 
effects of public health policies on health status in 
the Community; 
Having regard to the opinion of the Economic and Social 
Committee (
2), 
Having regard to the opinion of the Committee of the 
Regions (
3), 
Acting in accordance with the procedure referred to in 
Article 189b of the Treaty)
4), 
Whereas, pursuant to Article 3 (o) of the Treaty, 
Community action must include a contribution 
towards the attainment of a high level of health 
protection; whereas Article 129 of the Treaty 
expressly provides for Community competence in 
this field insofar as the Community contributes to it 
by encouraging cooperation between the Member 
States and, if necessary, by lending support to their 
action; 
Whereas the Council, in its resolution of 27 May 
1993 on future action in the field of public 
health)
5), considered that improved collection, 
analysis and distribution of health data, as well as 
an improvement in the quality and comparability of 
available data, are essential for the pteparation of 
future programmes; 
4. Whereas the Commission, in its communication of 
24 November 1993 on the framework for action in 
the field of public health, identified increased 
cooperation on standardization and collection of 
comparable/compatible data on health, and the 
promotion of systems of health monitoring and 
surveillance as a prerequisite for the establishment of 
a framework for supporting Member States' policies 
and programmes; whereas the area of health 
monitoring, including health data and indicators, 
has been identified as a priority area for proposals 
on multiannual Community programmes in the field 
of public health; 
5. Wheteas in its resolution of 2 June 1994 on the 
framework for action in the field of Community 
health (
7), the Council indicated that the collection of 
health data should be accorded priority and invited 
the Commission to present relevant proposals; 
whereas the Council considered that data and 
indicators used should include measures relating to 
the quality of life of the population, accurate 
assessments of health needs, estimates of the 
avoidable deaths from the prevention of diseases, 
socio-economic factors in health among different 
population groups, and, where appropriate and if 
the Member States judge it necessary, health aid, 
medical practices, and the impact of reforms; 
(') 
(
2) 
(
3) 
(
4) 
ñ 
OJ No C 338, 16. 12. 1995, p. 4. 
OJ No C 174, 17. 6. 1996, p. 3. 
OJ No C 129, 2. 5. 1996, p. 50. 
Opinion of the European Parliament of 17 April 1996 (OJ 
No C 141, 13. 5. 1996, p. 94), Council common position of 
.. . (not yet published in the Official Journal) and Decision 
of the European Parliament of . . . (not yet published in the 
Official Journal). 
OJ No C 174, 25. 6. 1993, p. 1. 
Whereas health monitoring at the Community level 
is essential for the planning, monitoring, and 
assessment of -Community actions in the field of 
public health, and the monitoring and assessment of 
the health impact of other Community policies; 
(
6) OJ No C 329, 6. 12. 1993, p. 375. 
(
7) OJ No C 165, 17. 6. 1994, p. 1. 
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7. Whereas, on the basis in particular of knowledge of 
data relating to public health in Europe obtained by 
setting up a Community health monitoring system, it 
will be possible to monitor public health trends and 
define public health priorities and objectives; 
Whereas health monitoring, for the purposes of this 
Directive, encompasses the establishment of 
Community health indicators and the collection, 
dissemination, and analysis of Community health 
data and indicators; 
9. Whereas in Decision 93/464/EEC of 22 July 1993 
on the framework programme for priority actions in 
the field of statistical information 1993 to 1997('), 
the Council identified under the heading 'Health and 
safety statistics' the analysis of mortality and 
morbidity by cause as one of the fields of priority 
actions under the sectoral programmes for social 
policy, economic and social cohesion and consumer 
protection; 
10. Whereas in Decision 94/913/EC of 15 December 
1994 adopting a specific programme of research and 
technological development, including demonstration, 
in the field of biomedicine and health (1994 to 
1998) (
2), the Council identified a specific research 
task of coordination and comparison of European 
health data, including nutritional data, from the 
various Member States; whereas this was taken up 
in the relevant research work programme; 
provisions more stringent, should be carefully 
examined with respect to the desired performance, 
flexibility and the costs and benefits involved; 
whereas a flexible system is required which can 
incorporate features which are deemed valuable at 
present while adapting to new requirements and 
other priorities; whereas such a system should 
include the definition of sets of Community health 
indicators and the collection of the data necessary 
for the establishment of such indicators; 
14. Whereas Community health data and indicators 
should draw from existing European data and 
indicators, such as those held by Member States or 
transmitted by them to international organizations, 
so as to avoid unnecessary duplication of work; 
15. Whereas the situation with regard to the collection 
of data varies from one Member State to another; 
16. Whereas a Community health monitoring system 
would benefit from the establishment of a telematics 
network for the collection and distribution of 
Community health data and indicators; 
17. Whereas the Community health monitoring system 
should be capable of producing data for the 
preparation of regular reports on health status in the 
European Community, analyses of trends and health 
problems, and should help produce and disseminate 
health information; 
11. Whereas health monitoring at Community level 
should enable measurements of health status, trends 
and determinants to be carried out, facilitate the 
planning, monitoring and evaluation of Community 
programmes and actions, and provide Member 
States with health information supporting the 
development and evaluation of their health policies; 
12. Whereas, in order to give full effect to requirements 
and expectations in this area, a Community health 
monitoring system should be developed, comprising 
the establishment of health indicators and the 
collection of health data, a network for transmission 
and sharing of health data and indicators, and a 
capacity for analysis and dissemination of health 
information; 
13. Whereas available options and possibilities for 
developing the various parts of a Community health 
monitoring system, including those making existing 
18. Whereas the setting up of a health-monitoring 
system at Community level necessarily presupposes 
compliance with provisions concerning the 
protection of data and the introduction of measures 
to guarantee their confidentiality and security, such 
as the provisions laid down in Directive 95/46/EC of 
the European Parliament and of the Council of 
24 October 1995 on the protection of individuals 
with regard to the processing of personal data and 
on the free movement of such data(
3) and in 
Council Regulation (Euratom, EEC) No 1588/90 of 
11 June 1990 on the transmission of data subject to 
statistical confidentiality to the Statistical Office of 
the European Communities (
4); 
19. Whereas a multiannual programme should be 
launched within the framework for action in the 
field of public health, in order to permit the 
development of a Community health monitoring 
(') OJ No L 219, 28. 8. 1993, p. 1. 
(
2) OJ No L 361, 31. 12. 1994, p. 40. 
(
3) OJ No L 281, 23. 11. 1995, p. 31. 
(
4) OJ No L 151, 15. 6. 1990, p. 1. Regulation as amended by 
the 1994 Act of Accession. 
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system and of appropriate mechanisms for its 
evaluation; 
20. Whereas, in accordance with the principle of 
subsidiarity, action on matters not falling within the 
exclusive competence of the Community, such as 
action on health monitoring, must be undertaken by 
the Community only if, by reason of their scale 
or effects, it can be better achieved by the 
Community; 
21. Whereas policies and programmes formulated and 
implemented at Community level, in particular those 
undertaken within the framework for action in the 
field of public health, should be compatible with the 
targets and objectives of Community action on 
health monitoring; whereas the implementation of 
Community actions on health monitoring should be 
coordinated with and take account of relevant 
research activities under the Community's 
Framework Programme for Research and 
Technological Development; whereas projects on 
telematics applications in the health field under the 
Community's RTD Framework must be coordinated 
with Community actions on health monitoring; 
whereas actions under the Community's framework 
programme for statistical information, the 
Community projects in the field of telematic 
interchange of data between administrations (IDA) 
and G-7 health-related projects must be closely 
coordinated with the implementation of Community 
actions on health monitoring; whereas the work 
undertaken by the specialized European agencies, 
such as the European Monitoring Centre for Drugs 
and Drug Addiction (EMCDDA) and the European 
Environment Agency, should be taken into 
account; 
26. Whereas data are insufficiently comparable at 
present and unnecessary duplication of effort should 
be avoided by the joint development of comparison 
and conversion methods, criteria and techniques, 
suitable data collection tools such as surveys, 
questionnaires or parts thereof, and content 
specifications for health information to be shared 
using in particular a telematics network; 
27. Whereas, in order to increase the value and impact 
of the action programme, a continuous assessment 
of the measures undertaken should be carried out, 
with particular regard to their effectiveness and the 
achievement of objectives at both national and 
Community level, and, where appropriate, the 
necessary adjustments should be made; 
28. Whereas this Decision lays down, for the entire 
duration of this programme, a financial framework 
constituting the principal point of reference, within 
the meaning of point 1 of the Declaration of the 
European Parliament, the Council and the 
Commission of 6 March 1995 (
2), for the budgetary 
authority during the annual budgetary procedure; 
29. Whereas this programme should run for five years in 
order to allow sufficient time for actions to be 
implemented to achieve the objectives set, 
HAVE DECIDED AS FOLLOWS: 
Article 1 
22. Whereas cooperation with the competent 
international organizations and with non-member 
countries should be strengthened; 
23. Whereas, from an operational point of view, the 
investments made in the past in terms both of the 
development of Community networks and of 
cooperation with international otganizations 
competent in this field should be safeguarded and 
further developed; 
24. Whereas it is important that the Commission should 
ensure implementation of this programme in close 
cooperation with the Member States; 
25. Whereas a modus vivendi between the European 
Parliament, the Council and the Commission 
concerning the implementing measures for acts 
adopted in accordance with the procedure laid down 
in Article 189b of the Treaty was concluded on 
20 December 1994('); 
Establishment of the programme 
1. A programme of Community action on health 
monitoring, hereinafter referred to as 'the programme', 
shall be adopted for the period 1 January 1997 to 
31 December 2001 within the framework for action in 
the field of public health. 
2. The objective of the programme shall be to 
contribute to the establishment of a Community 
health-monitoring system which helps to: 
(a) measure health status, trends and determinants 
throughout the Community; 
(b) facilitate the planning, monitoring and evaluation of 
Community programmes and actions; and 
(c) provide Member States with appropriate high-quality 
health information to make comparisons and to 
support their national health policies, 
(') OJ No C 102, 4. 4. 1996, p. 1.  (
2) OJ No C 102, 4. 4. 1996, p. 4. 
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by encouraging cooperation between Member States and, 
if necessary, by supporting their action through 
promoting coordination of their policies and programmes 
in this field and encouraging cooperation with 
non-member countries and the relevant international 
organizations. 
3. The actions to be implemented under the 
programme and their specific objectives are set out in 
Annex I under the following headings: 
A. Establishment of Community health indicators; 
B. Development of a Community-wide network for 
sharing health data; 
C. Analyses and reporting. 
A non-exhaustive list of areas in which health indicators 
could be established is set out in Annex II. 
Article 2 
Implementation 
1.  The Commission shall ensure the implementation, 
in close cooperation with the Member States, of the 
actions set out in Annex I, in accordance with Article 5. 
2. The Commission shall cooperate with the 
institutions and organizations which are active in the 
field of health monitoring. 
Article 3 
Budget 
1. The financial framework for the implementation of 
the programme for the period referred to in Article 1 
shall be ECU 13 million. 
2. The annual appropriations shall be authorized by 
the budgetary authority within the limits of the financial 
perspective. 
Article 4 
Consistency and complementarity 
The Commission, with the assistance of the Member 
States, shall ensure that there is consistency and 
complementarity between actions to be implemented 
under this programme and the other relevant Community 
programmes and initiatives, covering those that are 
situated in the context of public-health action as well as, 
in particular, the framework programme for statistical 
information, projects in the field of telematic interchange 
of data between administrations and the framework 
programme for research and technological development, 
in particular the telematics applications of the latter. 
Article 5 
Committee 
1. The Commission shall be assisted by a committee, 
consisting of two members designated by each Member 
State and chaired by a representative of the 
Commission. 
2. The representative of the Commission shall submit 
to the committee a draft of the measures to be taken 
concerning: 
(a) the committee's rules of procedure; 
(b) an annual work programme indicating the priorities 
for action; 
(c) the arrangements, criteria and procedures for 
selecting and financing projects under the 
programme, including those involving cooperation 
with international organizations competent in the 
field of public health and participation of the 
countries referred to in Article 6 (2) 
(d) the evaluation procedure; 
(e) the arrangements for dissemination and transfer of 
results; 
(f) the arrangements for cooperating with the 
institutions and organizations referred to in 
Article 2 (2); 
(g) the provisions applicable to reporting the data, 
conversion thereof and other methods for making 
the data comparable in order to achieve the objective 
referred to in Article 1 (2); 
(h) the provisions for the definition and selection of 
indicators; 
(i) the provisions for the content specifications 
necessary for setting up and operation of the relevant 
networks; 
The committee shall deliver its opinion on the draft 
measures referred to above within a time limit which the 
chairman may lay down according to the urgency of the 
matter. The opinion shall be delivered by the majority 
laid down in Article 148 (2) of the Treaty in the case of 
decisions which the Council is required to adopt on a 
proposal from the Commission. The votes of the 
representatives of the Member States within the 
committee shall be weighted in the manner set out in that 
Article. The chairman shall not vote. 
The Commission shall adopt measures which shall apply 
immediately. However, if these measures are not in 
accordance with the opinion of the committee, they shall 
be communicated by the Commission to the Council 
forthwith. In that event: 
— the Commission shall defer application of the 
measures which it has decided upon for a period of 
two months from the date of such communication, 
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— the Council, acting by a qualified majority, may take 
a different decision within the time limit laid down in 
the first indent. 
3. In addition, the Commission may consult the 
committee on any other matter concerning the 
implementation of this programme, including" the 
arrangements for coordination with the other 
programmes and initiatives referred to in Article 4. 
The representative of the Commission shall submit to the 
committee a draft of the measures to be taken. The 
committee shall deliver its opinion on the draft within a 
time limit which the chairman may lay down according 
to the urgency of the matter, if necessary by taking a 
vote. 
The opinion shall be recorded in the minutes; in addition, 
each Member State shall have the right to ask to have its 
opinion recorded in the minutes. 
The Commission shall take the utmost account of the 
opinion delivered by the committee. It shall inform the 
committee of the manner in which its opinion has been 
taken into account. 
4. The representative of the Commission shall keep the 
committee regularly informed of: 
— financial assistance gianted under the programme 
(amount, duration, breakdown and beneficiaries), 
— Commission proposals or Community initiatives and 
the implementation of programmes in other areas 
which are of direct relevance to achievement of the 
objectives of the programme, with a view to ensuring 
the consistency and complementarity referred to in 
Article 4. 
Article 6 
International cooperation 
1. In the course of implementing the programme, 
cooperation with non-member countries and with 
international organizations competent in the field of 
public health, in particular the World Health 
Organization, the Organization for Economic 
Cooperation and Development and the International 
Labour Organization, shall be encouraged and 
implemented in accordance with the procedure laid down 
in Article 5. 
2. The programme shall be open to participation by 
the associated countries of Central and Eastern Europe 
(ACCEE) in accordance with the conditions laid down in 
the additional protocols to the association agreements 
relating to patticipation in Community programmes, to 
be concluded with those countries. The programme shall 
be open to participation by Cyprus and Malta on the 
basis of additional appropriations in accordance with the 
same rules as those applied to the European Free Trade 
Association (EFTA) countries, in accordance with 
procedures to be agreed with those countries. 
Article 7 
Monitoring and evaluation 
1. The Commission, taking into account the reports 
drawn up by the Member States and with the 
participation, where necessary, of independent experts, 
shall ensure that an evaluation is made of the actions 
undertaken. 
2. The Commission shall submit to the European 
Parliament and the Council an interim report halfway 
through the programme and a final report on completion 
thereof. The Commission shall incorporate into these 
reports information on Community financing in the 
various fields of action and on complementarity with the 
other programmes and initiatives referred to in Article 4, 
as well as the results of the evaluation referred to in 
paragraph 1. It shall also send the teports to the 
Economic and Social Committee and the Committee of 
the Regions. 
3. On the basis of the evaluations referred to in 
paragraph 1, the Commission may, if appropriate, make 
relevant proposals with a view to the continuation of this 
programme. 
Done at 
For the European Parliament 
The President 
For the Council 
The President 
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ANNEX I 
SPECIFIC OBJECTIVES AND ACTIONS 
A. ESTABLISHMENT OF COMMUNITY HEALTH INDICATORS 
Objective 
To establish Community health indicators by a critical review of existing health data and indicators and 
develop appropriate methods for the collection of health data and for making such data comparable, in 
accordance with the objective referred to in Article 1 (2). 
1. Carrying out an identification, review and critical analysis of existing health indicators and data at 
European level and at Member State level, taking as a basis data validated by the Member States ¡n 
order to determine their relevance, quality and coverage with regard to the establishment of 
Community health indicators. 
2. Identification of a set of Community health indicators, including a subset of core indicators for the 
monitoring of Community programmes and actions in public health and a subset of background 
indicators for the monitoring of other Community policies, programmes and actions, for providing 
Member States with common measurements for making comparisons. A non-exhaustive list of the 
areas in which health indicators could be established is set out in Annex II. 
3. Development of the routine collection of data and of methods for making health data comparable, 
in order to achieve the objective referred to in Article 1 (2), including support for drawing up data 
dictionaries and the establishment of appropriate conversion methods and rules. 
4. Contributing to the collection of comparable data by supporting the preparation of surveys, 
including Community-wide surveys in support of the framing of Community policies, or drawing 
up agreed specimen modules or questionnaires for use in existing surveys. 
5. Fostering cooperation with international organizations competent in the field of Community health 
data and indicators and networks for the exchange of health data covering specific areas in public 
health, in order to enhance compatability of data. 
6. Encouragement and support for the assessment of the feasibility and cost-effectiveness of 
developing standardized health-resource statistics with the aim of including them in a future 
Community health-monitoring system. 
B. DEVELOPMENT OF A COMMUNTY-WIDE NETWORK FOR SHARING HEALTH DATA 
Objective 
To enable the establishment of an effective and reliable system for the transfer and sharing of health 
data and indicators using telematic interchange of data as the principal means. 
7. Encouragement and support for the development of a network for transferring and sharing health 
data, mainly using telematic interchanges and a system of distributed databases, in particular by 
the establishment of data specifications and of procedures with regard to access, retrieval, 
confidentiality and security for the different types of information to be included in the system. 
C. ANALYSES AND REPORTING 
Objective 
To develop methods and tools necessary for analysis and reporting and to support analyses and 
reporting on health status, trends and determinants and on the effect of policies on health. 
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8. Encouragement and support for the development of capacity for analyses by enhancing existing 
capabilities and for feasibility studies for possible new structures of comparative and predictive 
methodologies and tools, the testing of hypotheses and models and the evaluation of health 
scenarios and outcomes. 
9. Support for the analysis of the impact of Community actions and programmes in the field of public 
health, and for drawing up and disseminating reports evaluating such impact. 
10. Support for the preparation, production and dissemination of reports and other information 
material on health status and trends, health determinants and the impact on health of other 
policies. 
ANNEX 11 
Non-exhaustive list of areas in which health indicators may be established 
A. Health status 
1. Life expectancy: 
— life expectancy at certain ages, 
— health expectancies. 
2. Mortality: 
— overall, 
— causes of death, 
— disease-specific survival rates. 
3. Morbidity: 
— disease-specific morbidity, 
— co-morbidity. 
4. Functioning and quality of life: 
— self-perceived health, 
— physical disability, 
— activity limitations, 
— functional status/ability, 
— health-related work loss, 
— mental health. 
5. Anthropometric characteristics 
B. Life style and health habits 
1. Tobacco consumption. 
2. Alcohol consumption. 
3. Illegal drug consumption. 
4. Physical activities. 
5. Diet. 
6. Sex life, 
7. Other. 
C. Living and working conditions 
1. Employment/unemployment: 
— occupation. 
2. Work environment: 
— accidents, 
— exposure to carcinogenic and other dangerous substances, 
— occupational diseases. 
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3. Housing conditions. 
4. Home and leisure activities: 
— accidents at home, 
— leisure. 
5. Transport: 
— car accidents. 
6. External environment: 
— air pollution, 
— water pollution 
— other types of pollution, 
— radiation, 
— exposure to carcinogenic and other dangerous substances outside the work environment. 
D. Health protection 
1. Sources of financing. 
2. Facilities/manpower: 
— health-resource utilization, 
— health-care personnel. 
3. Cost/expenditure: 
— in-patient care, 
— out-patient care, 
— pharmaceutical products. 
4. Consumption/uses: 
— in-patient care, 
— out-patient care, 
— pharmaceutical products. 
5. Health promotion and disease prevention. 
E. Demographic and social factors 
1. Gender. 
2. Age. 
3. Marital status. 
4. Region of residence. 
5. Education. 
6. Income. 
7. Population subgroups. 
8. Health-insurance status. 
F. Miscellaneous 
1. Product safety. 
2. Others. 
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STATEMENT OF THE COUNCIL'S REASONS 
I. INTRODUCTION 
1. On 17 October 1995, the Commission submitted a proposal for a Decision adopting a 
Community action programme on health monitoring within the framework for action in 
the field of public health, based on Article 129 of the EC Treaty ('). 
2. The European Parliament delivered its opinion on 17 April 1996 (
2). 
The Economic and Social Committee and the Committee of the Regions delivered their 
opinions on 27 March (
3) and 18 January 1996(
4) respectively. 
In the light of these opinions, the Commission submitted an amended proposal (
5) on 
15 May 1996. 
3. On 17 June 1996, the Council adopted its common position in accordance with 
Article 189b of the EC Treaty. 
II. OBJECTIVE 
The Decision concerns the fifth Community action programme, proposed in the framework 
for action in the field of public health and designated a priority by the Council in its 
resolution of 2 July 1994 (
6). 
The purpose of the programme is to establish a Community health monitoring system 
which will make it possible to measure the health situation, and health trends and 
determinants in the Community, and to make comparisons and support national health 
policies. 
III. ANALYSIS OF THE COMMON POSITION 
1. Amendments made to the Commission proposal 
General remark 
In the main, the Council accepted the approach proposed by the Commission and, 
regarding in particular the content of the programme, included all the actions in 
Annex I to the proposal. 
Financial framework (Article 3 (1)) 
The Council adopted an amount — ECU 13 million — which, though not quite the 
same as that proposed, is extremely close to it and represents a balance between the 
need to implement and follow up the programme's actions, and the need to take 
account of budgetary discipline. 
Committee procedure (Article 5 (2) and (3)) 
Here, however, the Council deviated from the proposed procedure and opted, as in the 
case of the programmes already adopted, for a mixed procedure which made it possible 
(') OJ No C 383, 16. 12. 1995, p. 4. 
(
2) OJ No C 141, 13. 5. 1996, p. 94. 
(
3) OJ No C 174, 17. 6. 1996, p. 3. 
(
4) OJ No C 129, 2. 5. 1996, p. 50. 
(
s) COM(96) 222 final — COD 95/0238 (not yet published in the Official Journal). 
(
6) OJ No C 165, 17. 6. 1994, p. 1. 
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to reconcile the requirement for flexibility in the management of the programme with 
the need to involve the Member States more actively in certain important decisions: 
management committee procedure for important decisions and, for the others, including 
detailed rules for coordination, the advisory committee procedure. 
More specific points 
In addition, it introduced certain specifications, clarifications or additions of limited 
scope, in particular regarding the reference to data protection provisions (recital 18), the 
objective of the programme (Article 1 (2)), consistency and complementarity (Article 4), 
international cooperation (Article 6 (1)) and follow-up and assessment (Article 7 (3) 
regarding possible action further to the programme). With regard to the collection of 
comparable data (Article 5 (2) (g) and Annex I, part A, specific objective and point 3), it 
opted for a broader, more flexible form of words. 
2. European Parliament amendments 
(a) Amendments accepted by the Commission in its amended proposal 
Of the 44 amendments adopted by the European Parliament at first reading, the 
Commission accepted 28: 
— seven in full (amendments 12, 16, 17, 18, 20, 23 and 29), and 
— 21 in part (amendments 1 to 3, 4, 6, 7, 8, 9, 10, 11, 13, 19, 25, 33 to 40 and 
42). 
(i) Amendments accepted by the Council 
The Council included unaltered in its common position the following 
Parliament amendments: 17 and 20. 
In addition, it included in part or in another form amendments 1, 4, 7, 8, 9, 11, 
19, 23, 25, 29 (Article 1 (3) and Annex I, part A, point 2, 33, 35 to 40 and 42 
(as a matter of form), in most cases adopting the version proposed by the 
Commission. 
(ii) Amendments not accepted by the Council 
The Council felt unable to support the Commission in respect of the following 
amendments proposed by the European Parliament: 
Amendments accepted in full by the Commission 
— Amendment 12 (recital 15a) 
The Council did not include this amendment concerning cooperation in the 
field of occupational health and safety, since it considered that such 
cooperation would exceed the scope of the programme and create budgetary 
difficulties within it. 
It should, however; be pointed out that, in respect of international 
cooperation, Article 6 of the common position makes provision for the 
encouragement of cooperation with, inter alia, the International Labour 
Organization. 
— Amendments 16 and 18 (new recital 16a replacing recital 23) 
The Council did not feel it necessary to change the original position of this 
recital. 
Amendments accepted in part by the Commission 
— Amendment 3 (new recital 3b) 
— Amendment 6 (new recital 11a) 
— Amendment 34 (Annex I, part A, new point 6a). 
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The Council was unable to accept these amendments, which aim to establish a 
permanent structure (in particular in the form of a European health 
observatory), since it considered it inappropriate to prejudge the establishment 
of such structures in the context of this programme (which is of limited 
duration). 
Accordingly, the Council confined itself to including, in a general form, the 
changes introduced in the Commission's amended proposal, which are on the 
same lines as these European Parliament amendments: 
— a reference to 'making existing provisions more stringent' in recital 13 of the 
common position (former recital 12), and 
— a reference to 'boosting existing capacity' in point 8 of part C of Annex I. 
— Amendment 10 (recital 14) 
The Council considered that the text of the initial proposal, which it retained, 
enabled the European Parliament's concerns to be covered, while offering 
greater flexibility in the technical procedures for organizing the monitoting 
system. 
— Amendment 13 (recital 16) 
The Council considered that the text of recital 18 of its common position took 
full account of existing obligations regarding the confidentiality and security of 
data. 
(b) Amendments not accepted by the Commission in its amended proposal 
(i) In general, the Council agreed with the reasons which prompted the 
Commission to reject certain European Parliament amendments, i.e. that the 
amendments: 
— were not in line with the text or with the spirit of Article 129 of the EC 
Treaty, or were not compatible with the corresponding provisions in other 
public health programmes, or exceeded the framework of the proposed 
programme (amendments 2, 15, 21, 32, 43 and 47), 
— proposed a less flexible text and/or one which restricts the scope of the 
programme (amendments 5, 14, 30 and 45), 
NB: Regarding Amendment 30 (Annex I, part A, point 3), see comment in 
the fourth paragraph ('More specific points') of part III. 1 of this 
document, 
— were taken into account elsewhere (amendments 26, 27 and 28). 
(ii) The Council accepted, in part or in another form: 
— the substance of Amendment 31 (Annex I, part A), by means of an addition 
to the text of point 1, 
— amendment 46, through the adoption of a wording for Article 3 identical 
to that approved for the corresponding provisions in the Decisions already 
adopted (recital 28 of the common position). 
IV. CONCLUSIONS 
The Council, while opting for a procedure for implementing the programme which was 
similar to that approved in the context of the programmes already adopted, retained the 
substance of the Commission proposal as amended in response to the European 
Parliament's opinion. 
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